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Functions of the Mineralocorticoid Receptor in the Hippocampus 
by 
Aaron M. Rozeboom 
 
Chair: Audrey F. Seasholtz 
 
 
In the central nervous system, glucocorticoids influence neuroendocrine function, 
cognition, neurogenesis, neurodegeneration, and cell survival.  Glucocorticoid hormones 
signal through the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR), 
closely related members of the steroid hormone receptor superfamily.  Their expression 
profiles and modes of action suggest both overlapping and distinct functions in mediating 
glucocorticoid effects.  As GR function has been widely examined, research in this thesis 
focuses on the roles of MR action in the central nervous system using both in vivo and in 
vitro approaches.  First, we generated a transgenic mouse model that overexpresses MR 
in the forebrain (MRov).  Relative to wild-type littermate controls, MRov mice display 
reduced anxiety-like behaviors and exhibit suppressed HPA axis activity in response to 
stress.  These data demonstrate that functions of forebrain MR can both overlap 
(regulation of neuroendocrine function) and oppose (modulation of anxiety-like behavior) 
 
ix 
GR-mediated actions.  Second, we utilized the mouse hippocampal cell line, HT-22, to 
address corticosteroid receptor-mediated effects on both cell survival and regulation of 
transcription in an in vitro system.  HT-22 cells express GR but not MR, and have been 
shown to be sensitive to glutamate toxicity in a manner that is exacerbated by activation 
of GR.  To address the role of MR in this “glucocorticoid endangerment”, we generated 
stable clones of HT-22 cells that express MR in addition to GR.  Using these cell lines, 
we confirmed that while GR activation enhanced glutamate toxicity, the co-activation of 
MR and GR in the HT-22/MR clone attenuated the glucocorticoid endangerment of the 
cells.  Finally, MR- and GR-mediated regulation of glucocorticoid responsive genes was 
monitored at the transcriptome level in HT-22/Parent and HT-22/MR cells.  This research 
demonstrated that co-activation of MR and GR resulted in the regulation of a 
substantially larger set of genes relative to GR activation alone, including classes of 
genes known to regulate cell survival and proliferation, suggesting that changes in the 
balance of receptor levels may result in functionally significant alterations in global 
transcriptome regulation.  Together, these data reveal important overlapping and distinct 








When an organism is confronted with a situation that is perceived as threatening, 
a myriad of events occur that prepare the organism for a response that is typically 
characterized as “fight-or-flight”.  Physiological manifestations of this fight-or-flight 
response that are common to all mammals include but are not limited to, increased heart 
rate, increased respiration, and increased vigilance.  The body also mobilizes energy 
sources and redirects the use of that energy to areas that most need it.  These efforts are 
energetically costly but serve one very important purpose, the maintenance of an internal 
equilibrium that allows the organism to survive in a constantly changing environment.   
This concept was formally proposed by Claude Bernard who noted in his 1865 
work, Introduction to Experimental Medicine, “Constance of the internal environment is 
the condition for a free and independent life” (Bernard 1865).  It was over half a century 
later, however, before Walter Cannon used the term “homeostasis” to describe the 
“fundamental condition of stability” of an organism, and the ability of “various 
physiological arrangements which serve to restore the normal state when it has been 
disturbed” (Cannon 1932).  Cannon was the first to describe the acute changes in 
secretions from the adrenal gland that were associated with what he called the fight-or-
flight response.  He found that any number of a variety of threats to homeostasis, such as 
hypoglycemia, cold exposure, or emotional distress resulted in the activation of both the 
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adrenal medulla and the sympathetic nervous system, or the “sympathoadrenal” system 
that was thought to function as a single unit.  Cannon also proposed that adrenaline was 
the factor that was both released by the adrenal medulla and which served as the 
neurotransmitter of the sympathetic nervous system, although it was later determined that 
noradrenaline actually served as the primary neurotransmitter of the sympathetic nervous 
system (Goldstein and Kopin 2007).  It was thought that deviations from normal 
parameters were brought back in line automatically by local negative feedback 
mechanisms in each organ. 
While earlier researchers paved the way with the concepts of homeostasis, Hans 
Selye was instrumental in formalizing the concept of “stress”.  Selye defined stress as 
“the nonspecific response of the body to any demand upon it” (Selye 1936).  His research 
suggested that an organism exhibited three universal stages of coping with exposure to 
stress, or the “General Adaptation Syndrome”.  Selye termed the first stage of this 
syndrome the “general alarm reaction”, analogous to Walter Cannon’s fight-or-flight 
response.  The second stage was characterized as a period of adaptation where the 
organism showed resistance to the stressor.  Finally, if the stress was of sufficient 
intensity and occurred over a long period of time, a third stage would be reached that was 
characterized as a period of exhaustion and eventual death.  Selye’s work also 
emphasized the activity of another body system in the general stress response, the 
hypothalamic-pituitary-adrenal (HPA) axis.  It was later demonstrated that steroid 
hormones released from the adrenal gland during stress were capable of participating in 
both the resistance to the stressor and eventually to the pathological states resulting from 
extended exposure to stress, concepts that are key to the research of this thesis. 
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The works of both Cannon and Selye emphasized one concept that has more 
recently been challenged, the idea of the general nature of the stress response.  It was 
originally believed that any kind of stressor would result in the same pattern of activation 
of the “sympathoadrenal” and HPA systems.  As more intensive research ensued, 
however, it became clear that this was not always the case.  Table 1-1 depicts data from a 
large number of studies indicating the relative activation levels of the HPA axis, the 
adrenomedullary hormone system (AHS), which releases adrenaline into the blood 
stream, and the sympathetic noradrenergic system (SNS) during exposure to different 
stressors.  It is clear that different stressors elicit different response patterns from each of 
the three systems, and that activation of the AHS actually more closely resembles 
activation of the HPA axis.  This last observation serves to functionally uncouple the 
activities of the AHS and SNS for many types of stressors. 
Along with the realization that different stressors are capable of eliciting different 
patterns of activation, the broader realization that almost every physiological parameter 
changes dramatically throughout the day and in response to varying physiological and 
psychological demands required a new concept of “stress”.  In 1988, Sterling and Eyer 
introduced the idea of “allostasis”, broadly meaning stability through change.  Instead of 
a model dictating that the internal equilibrium is maintained by the local actions of each 
individual organ, the allostatic model dictates that the internal environment is always 
changing to meet perceived and anticipated demands.  Moreover, local homeostatic 
control of individual organs is subordinate to the brain, the site where the effects of 
different stressors are realized and where appropriate behavioral and physiological 




Table 1-1 Hypothalamo-pituitary-adrenocortical (HPA), adrenomedullary 
hormonal system (AHS), and sympathetic nervous system (SNS) responses to 
different stressors  
 HPA AHS SNS 
Cold Exposure, No Hypothermia 0 + +++ 
Active Escape/Avoidance + + ++ 
Hemorrhage, No Hypotension + + ++ 
Surgery + + ++ 
Exercise + ++ +++ 
Cold Exposure, Hypothermia + ++ ++++ 
Social Stress in Monkey ++ ++ ++ 
Laboratory Mental Challenge ++ ++ + 
Hemorrhagic Hypotension +++ +++ + 
Passive/Immobile Fear ++ +++ + 
Public Performance ++ +++ + 
Pain ++ +++ ++ 
Exercise to Exhaustion ++ +++ ++++ 
Glucoprivation +++ ++++ + 
Fainting ++ ++++ 0 
Immobilization in Rat ++++ ++++ ++++ 
Cardiac Arrest +++ ++++ ++ 
 
Reprinted from Stress: The Biology of Stress 10(2), Goldstein, D.S. and Kopin I.J., 
Evolution of concepts of stress,109-20, (2007), with permission from Informa Healthcare.   
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through allostatic processes is dependent on genetic makeup, developmental history, and 
previous experiences.   
The HPA axis plays a critical role in the ability of an organism to adapt to a 
homeostatic challenge.  The end result of HPA axis activation is secretion of 
glucocorticoid hormones (corticosterone in rodents, cortisol in humans) into the 
bloodstream that serve to mobilize and redirect energy resources throughout the body.  
The physiological parameters that are altered in this transition from basal to active are 
largely catabolic in nature, resulting in the breakdown of metabolic compounds to 
produce energy.  As a consequence of this biochemically catabolic state of “arousal”, 
other physiological processes associated with anabolic processes, such as immune system 
function, digestion, reproduction, and wound healing are all suppressed (Sterling P 1988).  
While the short-term activation of these allostatic processes are highly adaptive, long-
term activation may have cumulative adverse effects including osteoporosis, 
hypertension, and increased risk for the development of multiple mood disorders 
including major depression and several anxiety disorders (De Kloet, Vreugdenhil et al. 
1998).  This process of harm caused by allostatic processes is referred to as “allostatic 
load” (McEwen 2000). 
The following sections will focus on both physiological and molecular aspects of 
the activation and regulation of the HPA axis as an allostatic system that is necessary for 
survival.  Dysregulation of the system and subsequent pathologies associated with 
allostatic load derived from over-activation of the HPA axis will also be discussed with 
particular emphasis on mood disorders. 
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HPA axis activity: 
 The HPA axis operates in two distinct realms of activity, the basal unstressed state 
and the stressed state.  Under basal resting conditions, the HPA axis is activated in a 
circadian fashion with low levels of circulating corticosteroids at the circadian trough 
(sleeping phase) and higher levels at the circadian peak (waking phase).  Several studies 
suggest that the suprachiasmatic nucleus (SCN) regulates the circadian control as lesions 
of the SCN results in the disappearance of the rhythm of corticosteroid release (Moore 
and Eichler 1972; Abe, Kroning et al. 1979; Watanabe and Hiroshige 1981).  HPA axis 
activity is also regulated under stress conditions; here, two primary modes of activation 
can be identified.  Herman and colleagues distinguish between “reactive” and 
“anticipatory” stress responses (Herman, Figueiredo et al. 2003).  “Reactive” stress 
responses are characterized by a homeostatic challenge that is of physiological origin.  
This would include abrupt changes in cardiovascular tone, hypoglycemia, or blood-borne 
cytokine factors signaling an infection (Table 1-2).  “Anticipatory” stress responses, on 
the other hand, occur in the absence of a physiological challenge.  Instead, the HPA axis 
is activated in response to a perceived threat to homeostasis, such as predator odor, or 
restraint (Table 1-2).   
Stress regulation of the HPA axis by either the “reactive” or “anticipatory” modes 
occurs through activation of corticotropin releasing hormone (CRH)- and arginine 
vasopressin (AVP)-containing neurons located within the hypothalamic paraventricular 
nucleus (PVN).  These neurons are stimulated to synthesize and release CRH and AVP 
by various signaling mechanisms generated from afferent pathways that are relayed to the  
PVN via different brain regions depending on the mode of activation (“reactive” vs.  
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Table 1-2 Stimuli triggering “reactive” vs. “anticipatory” HPA stress responses 
 
Reprinted from Frontiers in Neuroendocrinology 24, Herman, J.P., Figueirido H, Central 
mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-
pituitary-adrenal responsiveness, 151-180, (2003), with permission from Elsevier. 
 
“Reactive” Responses “Anticipatory” Responses 
Pain 
     Visceral 
      Somatic 
Neuronal homeostatic signals 
      Chemoreceptor stimulation 
      Baroreceptor stimulation 
      ‘Osmoreceptor’ stimulation 
Humoral homeostatic signals 
      Glucose 
      Leptin 
      Insulin 
      Renin-angiotensin 
      Atrial natriuretic peptide 
      Others 
Humoral inflammatory signals 
      IL-1 
      IL-6 
      TNF-α 
      Others 
Innate programs 
      Predators 
      Unfamiliar environments/situations 
      Social challenges 
      Species-specific threats 
- illuminated spaces for rodents 
- dark spaces for humans 
Memory programs 
      Classically conditioned stimuli 
      Contextually conditioned stimuli 
      Negative reinforcement/frustration 
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“anticipatory”, Figure 1-1).  Upon release, CRH travels through the hypophyseal portal 
 system to anterior pituitary corticotropes where it increases the synthesis and release of 
ACTH.  ACTH travels through the blood and stimulates the production and release of 
glucocorticoid hormones from the adrenal gland.  The “reactive” pathways arising from 
brainstem regions signal directly to the PVN.  Conversely, “anticipatory” pathways 
arising from various forebrain limbic structures such as the hippocampus, amygdala, and 
the prefrontal cortex, are thought to relay through multiple other brain regions that in turn 
signal to the PVN.  Interestingly, some of these “anticipatory” pathways relay through 
regions that overlap with the “reactive” pathway of HPA axis activation (Herman, 
Figueiredo et al. 2003).  
While the “reactive” pathway is largely excitatory for CRH release, “anticipatory” 
signaling from various brain limbic regions is both excitatory and inhibitory.  Lesioning 
and stimulation studies of the hippocampus suggest that this region largely provides 
inhibitory input to the PVN.  Lesions have been shown to promote both basal 
hypersecretion of corticosteroids (Fendler, Karmos et al. 1961), as well as prolong the 
corticosteroid response to stress (Herman, Cullinan et al. 1995).  Conversely, stimulation 
of the hippocampus reduces HPA axis activity in both humans (Rubin, Mandell et al. 
1966) and rats (Casady and Taylor 1976).  The medial prefrontal cortex has also been 
shown to provide negative feedback to the HPA axis.  Lesions of this region enhance 
ACTH and corticosterone responses to restraint stress but do not affect basal circadian 
ACTH or corticosterone levels, suggesting that regulation from this region is selective for 
stress-induced modulation of HPA axis activity (Diorio, Viau et al. 1993; Figueiredo, 






Figure 1-1 Overview of the HPA axis, including principal classes of regulatory 
afferents and corticosteroid actions. 
CRH neurons located within the hypothalamic PVN drive pituitary corticotropes via the 
portal vasculature, stimulating the release of ACTH which, in turn, stimulates the 
synthesis and release of corticosteroids (Cort) from the adrenal glands.  CRH neurons in 
the PVN are regulated by sensory afferents from the brainstem that provide largely 
“reactive” signals that are generally excitatory and relatively direct.  Conversely, it is 
hypothesized that “anticipatory” signals are conveyed from forebrain limbic structures to 
the PVN via multisynaptic pathways and include both excitatory and inhibitory 
information.  Reprinted from Frontiers in Neuroendocrinology 24, Herman, J.P., 
Figueirido H, Central mechanisms of stress integration: hierarchical circuitry controlling 
hypothalamo-pituitary-adrenal responsiveness, 151-180, (2003), with permission from 
Elsevier. 
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activity, signaling from the amygdala appears to activate it.  Electrical stimulation of the 
amygdala promotes corticosteroid secretion in rats (Redgate and Fahringer 1973), and 
lesion studies suggest that selective damage of the central nucleus of the amygdala 
decreases ACTH and corticosteroid release after immobilization stress (Beaulieu, Di 
Paolo et al. 1986). 
These findings fit well with an allostatic model of stress integration for HPA axis 
activity.  The initiation of HPA axis activity occurs through the coordinated actions of 
multiple pathways.  As the “reactive” pathway partially overlaps with the “anticipatory” 
pathway that involves limbic regions concerned with both learning and memory and the 
integration of behavioral responses to fear and anxiety, the ultimate release of CRH from 
the PVN in response to any particular stressor could be experience-dependent.  This 
mnemonic aspect of stress integration could, for example, reduce HPA responsiveness to 
contextual stimuli with repeated exposure, allowing the organism to habituate and reduce 
future HPA activation (Herman, Figueiredo et al. 2003).  Thus, the allostatic model 
allows a more fine-tuned response to a stressor.  
 
HPA axis activation and mood disorders: 
 Proper function of the HPA axis is necessary for survival.  Glucocorticoids are 
important for maintenance of blood pressure and cardiovascular function; in addition, 
they regulate metabolism, slow the immune system’s inflammatory response and help to 
maintain proper arousal.  As all of these functions are essential for survival and for 
adaptation and coping with psychological and physiological stressors, dysregulation of 
the HPA axis forms the basis of pathology associated with a number of psychiatric 
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disorders including major depressive disorder (MDD), psychotic depression, bipolar 
disorder and several anxiety disorders (Chrousos and Gold 1992).  A high percentage of 
patients with MDD exhibit increased corticosteroid levels indicative of a “hyperactive” 
HPA axis.  Evidence that corticosteroid exposure by itself can have negative effects on 
mood is seen in patients that receive long-term treatment with corticosteroids.  Changes 
in mood including hypomania, mania, psychosis and depression have been reported 
(Brown and Suppes 1998).  Similarly, patients with Cushing’s syndrome, who suffer 
from excess plasma cortisol levels, exhibit higher rates of depression that appear to be 
reversed upon treatment that reduces cortisol levels (Starkman, Schteingart et al. 1986).  
 Further evidence linking hypercortisolemia to depression comes from three 
classes of studies.  The first studies showed that the corticosteroid synthesis inhibitor, 
metyrapone, proved effective in producing antidepressant-like behavior in rodent models 
(Healy, Harkin et al. 1999), as well as in clinical trials (O'Dwyer, Lightman et al. 1995).  
A second study showed that blocking glucocorticoid action proved to be efficacious in 
the treatment of psychotic depression (DeBattista and Belanoff 2006).  Finally, multiple 
studies have shown that clinically efficacious treatment with antidepressants was 
preceded by a normalization of HPA axis activity in those depressed patients who were 
typified by hypercortisolemia, (Holsboer, Dorr et al. 1982; Greden, Gardner et al. 1983; 
Holsboer, Steiger et al. 1983).  Conversely, the persistence of HPA axis dysfunction 
during antidepressant treatment appeared to be associated with a higher probability of 
relapse (Ribeiro, Tandon et al. 1993; Heuser, Schweiger et al. 1996).  
While the exact mechanisms underlying the hyperactivity of the HPA axis remain 
unclear, both dysregulation in negative corticosteroid feedback as well as an increased 
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drive of the HPA axis have been suggested (Young, Kotun et al. 1993; Young, Haskett et 
al. 1994; Steckler, Holsboer et al. 1999).  However, the pertinent question of whether 
increased drive of the HPA axis is the cause or the consequence of disturbed negative 
feedback is not known at this point.  Regardless of this distinction, evidence that there is 
a profound dysregulation in the HPA axis comes from a neuroendocrine function test 
known as the combined dexamethasone/CRH challenge test.  In this test, dexamethasone 
pretreatment is used to suppress corticosterone production and then the axis is stimulated 
with a dose of CRH.  A high percentage of depressed patients demonstrate two features in 
this test: 1) a non-suppression of cortisol to dexamethasone pretreatment; and 2) a 
subsequent hyperactive cortisol response to the CRH treatment [see Figure 1-2 (von 
Bardeleben and Holsboer 1991)].  Both of these responses are consistent with disturbed 
glucocorticoid feedback (Modell, Yassouridis et al. 1997).  
 It is hypothesized that the chronic elevations in corticosteroids seen in some 
depressed patients can be damaging to the brain in general, and to the hippocampus in 
particular, possibly contributing to deleterious effects on its structure and function and to 
the behavioral and physiological sequelae that accompany many diseases of affect (Lee, 
Ogle et al. 2002).  As the hippocampus is a site of negative feedback for the HPA axis, 
the decrease in functional hippocampal integrity results in continued elevation of 
corticosteroid levels and further degeneration.  This glucocorticoid feed-forward cascade 
may be a potential mechanism to explain the degenerative process.  In the following 
sections, I will introduce the two corticosteroid receptors and discuss their roles in HPA 
axis regulation and anxiety-related behavior as well as their contributing roles to 






Figure 1-2 Disturbed feedback in patients with major depressive disorder. 
After dexamethasone pretreatment (1.5mg), plasma concentrations of cortisol were 
increased the next day among patients with major depression.  Upon stimulation with 
CRH (100μg at 1600hours after dexamethasone), patients responded with much higher 
plasma cortisol levels relative to controls suggesting disturbed feedback regulation of the 
HPA axis in depression.  Reprinted from Biological Psychiatry 29(10), Bardeleben, U., 
and Holsboer, F., Effect of age on the cortisol response to human corticotropin-releasing 
hormone in depressed patients pretreated with dexamethasone, 1042-1050, (1991), with 




Corticosteroid Receptors: Mineralocorticoid Receptor (MR) and Glucocorticoid 
Receptor (GR) 
 A vast array of developmental, physiological, and behavioral processes are 
controlled by steroid hormones.  The actions of these hormones are mediated by an 
evolutionarily conserved family of intracellular receptors that function as ligand-activated 
transcription factors to coordinate the expression of gene networks (Evans 1988).  
Sequence homology studies reveal that a prominent feature of members of this family is 
their organization into three main functional domains: 1) an N-terminal domain that 
contains sequences important for transcriptional regulation; 2) a central region containing 
sequences necessary for receptor/DNA interactions; and 3) a carboxy-terminal ligand-
binding domain required for receptor/hormone interactions and transcriptional regulation.  
The actions of corticosteroid hormones in the brain are mediated by two of these 
receptors, the type I mineralocorticoid receptor (MR) and the type II glucocorticoid 
receptor (GR).  MR and GR are two of the most closely related members of this family of 
hormone receptors and as such, they share several features in common.  The ligand 
binding domain of MR and GR share 57% amino acid identity, consistent with their 
ability to bind a similar group of glucocorticoid hormones.  However, MR can bind many 
corticosteroids with an affinity that is roughly 10-fold greater than GR (0.5nM vs. 5nM, 
respectively for corticosterone).  MR also binds aldosterone with a similar affinity as 
corticosterone, but GR is largely insensitive to aldosterone at physiological 
concentrations.   
The DNA binding domains of MR and GR allow them to bind to sequences of 
DNA known as glucocorticoid responsive elements (GRE: GGTACAnnnTGTTCT) 
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found in the promoter regions of corticosteroid responsive genes.  MR and GR are highly 
homologous in the DNA-binding domain, sharing an amino acid identity of 94%, which 
results in their ability to bind to the same GREs.  The N-terminal regions of MR and GR 
are the most divergent, sharing only 15% amino acid identity.  The functional 
implications of the diversity in this region will be further discussed in the Mechanisms of 
Corticosteroid Receptor-Mediated Gene Expression section. 
 When not bound by hormone, MR and GR normally reside in the cytoplasm and 
are part of a multi-protein complex anchored by heat shock protein-90 (HSP90), but also 
comprised of other heat shock proteins and immunophilins that serve to hold the receptor 
in a conformation that facilitates hormone binding (Pratt, Morishima et al. 2006).  Once 
the hormone is bound, a conformational change is induced that allows the chaperone 
complex to dissociate from the receptor, exposing nuclear localization signals that direct 
translocation of the receptors to the nucleus where they exert transcriptional control over 
glucocorticoid responsive genes 
However, it should be noted that evidence exists for a membrane bound 
corticosteroid receptor capable of mediating cellular actions via a non-genomic 
mechanism.  In the roughskin newt (Taricha granulosa), a putative membrane GR was 
isolated in neuronal membranes that has characteristics of a G-protein coupled receptor 
(Orchinik, Murray et al. 1991).  Ligand binding studies have been used to characterize 
putative membrane corticosteroid receptors in the rat liver (Allera and Wildt 1992), rat 
brain (Sze and Towle 1993), and the pituitary cell line AtT-20 (Harrison, 
Balasubramanian et al. 1979), however, the membrane glucocorticoid receptor has not yet 
been cloned or fully characterized.  
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MR and GR exhibit distinct expression profiles in rodents and primates.  GR is 
widely expressed throughout the periphery and the brain, whereas the expression pattern 
of MR is much more limited.  In the periphery, MR is most highly expressed in the 
epithelial target tissues of the kidney and the colon, as well as non-epithelial tissues such 
as cardiomyocytes, the blood vessel wall, and circulating monocytes (Fuller and Young 
2005).  In epithelial target tissues such as the kidney, MR functions as a regulator of 
sodium balance by binding aldosterone that is released from the adrenal in response to 
multiple factors including changes in plasma K+ and Na+ concentrations.  Aldosterone 
concentrations in the plasma are roughly 100-1000 fold lower than corticosterone/cortisol 
concentrations, but aldosterone specificity is maintained in Na+-transporting epithelial 
cells through expression of the enzyme 11 beta-hydroxysteroid dehydrogenase II 
(11βHSD-II) that converts corticosterone/cortisol to the inactive cortisone.  In the central 
nervous system, the expression of 11βHSD-II is restricted to the anterior hypothalamus 
and circumventricular organs; no detectable amounts of 11βHSD-II are found in the 
hippocampus (Roland, Krozowski et al. 1995). 
In the central nervous system of rodents, MR is detected in the prefrontal cortex, 
the medial and central amygdala, lateral septum, various thalamic nuclei and several 
hypothalamic nuclei, but the highest expression levels of MR are found in regions CA1, 
CA2, CA3 and the dentate gyrus of the hippocampus (Herman, Patel et al. 1989; Ahima, 
Krozowski et al. 1991; Han, Ozawa et al. 2005).  Figure 1-3 is an in situ hybridization 
study that depicts the anatomical overlap of MR and GR mRNA in the mouse brain.  It is 
clear from these studies that the highest levels of co-expression of MR and GR are 








Figure 1-3 Coronal sections of mouse forebrain depicting anatomical distribution of 
GR and MR mRNA. 
In situ hybridization with 35S labeled GR and MR specific cRNA probes. 
GR MR
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in the hippocampus, but also in cerebral cortex in humans and squirrel monkeys, 
suggesting additional roles for cortical MR in primates (Patel, Lopez et al. 2000).  
 MR and GR expression are both subject to regulation by glucocorticoids, an effect 
that predominantly occurs through activation of MR.  Adrenalectomy (ADX) results in 
rapid increases in MR protein within 12 hours and is reversed by replacement with MR 
selective but not GR selective agonists (Kalman and Spencer 2002); treatment of ADX 
rats with an MR selective agonist also prevents the ADX-induced increase in GR binding  
(Miller, Spencer et al. 1993).  Similarly, treatment of rats with the MR antagonist 
spironolactone resulted in an up-regulation of GR mRNA and protein in the hippocampus 
(Herman and Spencer 1998).  These results suggest that glucocorticoids may be capable 
of regulating the extent of their own actions, not only through mediating negative 
feedback on the HPA axis, but also through regulation of their own receptors. 
 
Mechanisms of Corticosteroid Receptor-Mediated Gene Regulation: 
Endogenous glucocorticoids are released from the adrenal gland and circulate 
freely in the blood.  Access of corticosteroids to receptors in the periphery is restricted by 
cortisol-binding globulin (CBG), which is thought to occupy as much as 95% of serum 
corticosteroids circulating over a 24-hour period (Dallman, Akana et al. 1994).  However, 
CBG does not appear to be a determinant in corticosteroid access to hippocampal or 
cortical MR or GR, as CBG does not cross the blood-brain-barrier and expression of 
CBG in the brain of both rodents (Mopert 2004) and humans (Herbert, Pollak et al. 2006) 
appears to be restricted to discrete hypothalamic regions. 
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The lipophilic nature of corticosteroids allows them to freely diffuse across the 
plasma membrane and bind to cytoplasmic MR and GR.  The ligand-activated receptors 
then translocate to the nucleus where they can either activate or repress transcription of 
corticosteroid-responsive genes via multiple mechanisms (Figure 1-4).  The first level of 
transcriptional regulation involves binding of ligand-activated MR or GR to specific 
glucocorticoid response elements (GRE) in the promoter regions of corticosteroid 
responsive genes.  MR or GR binding to GREs can result in either induction or repression 
of gene transcription, depending on the make-up of the specific GRE.  GREs from 
positively regulated genes such as tyrosine-amino-transferase (TAT) and the long 
terminal repeat of the mouse mammary tumor virus (MMTV) have been found to contain 
consensus sequences similar to GGTACAnnnTGTTCT (Figure 1-4A).  It is interesting to 
note here that while the DNA binding domain (DBD) of MR is nearly identical to GR, 
the ability of MR to synergistically activate transcription from multiple GREs does not 
equal that of GR.  This is most likely due to limited homology in the N-terminal domains 
of MR and GR.  Indeed, specific amino acid sequences termed synergy control motifs 
have been discovered in the N-terminal domains of multiple members of the steroid 
hormone superfamily and these motifs serve to dampen the more than additive 
transcriptional response of multiple GREs.  While GR was found to contain 2 such 
motifs, MR was found to contain 4, potentially explaining this discrepancy (Iniguez-
Lluhi and Pearce 2000).  Repression of gene transcription through a negative GRE 
(nGRE) (Figure 1-4B) has also been reported, but a highly conserved consensus sequence 
has not been identified (Dostert and Heinzel 2004).  An example of a gene that is 








Figure 1-4 Different mechanisms of transcriptional regulation of corticosteroid 
responsive genes by MR and GR. 
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Additionally, it has been shown that the serotonin receptor 1a is repressed through 
binding of both MR and GR to an nGRE in its promoter (Ou, Storring et al. 2001). 
The transcriptional response of a corticosteroid-responsive gene containing a 
positive or negative GRE can be futher modified by the ability of MR and GR to 
heterodimerize.  In cells expressing only MR or GR, ligand-activated MR or GR 
translocates to the nucleus and binds GRE sites as a homodimer.  In contexts where MR 
is co-expressed with GR, such as in the hippocampus, these two receptors have been 
shown to form heterodimers in addition to homodimers (Trapp, Rupprecht et al. 1994; 
Liu, Wang et al. 1995).  Little is known about the rules that govern heterodimer vs. 
homodimer formation beyond stoichiometric considerations.  It is known, however, that 
the transcriptional outcome of heterodimer formation is dependent on the cellular and/or 
promoter contexts.  For example, in some instances, heterodimer formation appears to 
have synergistic effects on transcriptional activation with respect to either homodimer 
alone (Trapp, Rupprecht et al. 1994), whereas in other contexts the formation of 
heterodimers reduces the transcriptional activity of GR alone (Liu, Wang et al. 1995). 
MR and GR also bind to GRE sequences in close proximity to or overlapping 
with sequences for other transcription factors, termed composite GREs (cGRE) (Figure 1-
4C and D).  When this occurs, the specific promoter sequence and the cellular context 
dictate the transcriptional outcome.  The most prominent example comes from the cGRE 
of the proliferin gene, which has juxtaposed binding sites for GR and AP1 family 
members.  In this example, GR can either activate or repress transcription dependent on 
the composition of the AP1 dimer, with cJUN/cJUN homodimers being activated and 
cFOS/cJUN heterodimers being repressed by GR (Diamond, Miner et al. 1990).  
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Interestingly, the corticosteroid receptor regulation of this cGRE is mediated exclusively 
by GR (Pearce and Yamamoto 1993).  While no specific examples of MR involvement at 
a cGRE have been reported, this does not rule out the possibility that such regulation by 
MR can occur. 
DNA binding-independent mechanisms of transcriptional regulation by MR and 
GR has also been proposed through protein-protein interactions (Figure 1-4 E and F). 
Most well known is the inhibition of the transcription factors NFkB and AP1 by GR 
(Jonat, Rahmsdorf et al. 1990; Almawi and Melemedjian 2002).  Interactions between 
GR and the transcription factor Stat5 have been shown to enhance Stat5 dependent 
transcription (Stoecklin, Wissler et al. 1997), and subsequent data suggest the same may 
be true for interactions between MR and Stat5 (Stoecklin, Wissler et al. 1999). 
The last level at which MR and GR are involved in the regulation of transcription 
involves the capacity of MR and GR to interact with other transcriptional coregulators.  
In general, ligand-bound steroid receptors interact with DNA and a large array of 
coregulators in a sequential and cyclical fashion that allows for the recruitment or 
stabilization of RNA polymerase II at the promoter and subsequent transcription 
initiation.  More specifically, steroid receptor coactivators are thought to modify the 
chromatin around the hormone responsive elements by destabilizing the 
chromatin/histone interactions.  This is hypothesized to “open” the DNA allowing for 
further recruitment of other transcription factors.  Examples of steroid receptor 
coactivators that are capable of modifying chromatin through histone-acetyl-transferase 
(HAT) activity include CBP/p300, and members of a family of related proteins termed 
the p160 coactivators, represented by SRC-1, TIF-2, and pCIP family members.  Other 
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coactivators are capable of destabilizing chromatin through histone-methyl-transferase 
activity (CARM1/PRTM1), or by destabilizing chromatin in an ATP dependent fashion 
(SWI/SNF) (Pascual-Le Tallec and Lombes 2005).   
Conversely, MR and GR can also interact with corepressors that are capable of 
“closing” the DNA through their histone deacetylase (HDAC, eg. NCoR and SMRT) 
activity, or by interacting with proteins that are capable of directly (DAXX (Obradovic, 
Tirard et al. 2004)) or indirectly (PIAS1 (Pascual-Le Tallec, Simone et al. 2005)) 
inhibiting receptor activity.  The interactions of coregulators with steroid receptors have 
been shown to occur in a ligand dependent fashion through binding to a region of the 
ligand binding domain (LBD) termed the activating function domain 2 (AF2) (Freedman 
1999).   
The MR also contains specific regions in its N-terminus that allow it to interact 
with coregulators differentially as compared to other steroid/thyroid hormone receptors.  
The N-terminus of MR is the longest in this superfamily and exhibits less than 15% 
homology when compared to other family members (Evans 1988).  Two activation 
function domains have subsequently been found in the amino terminal region of MR, 
termed AF-1a and AF-1b (Fuse, Kitagawa et al. 2000).   
 Obradovic et. al. isolated three novel transcriptional regulators of MR and GR 
utilizing the AF-1 of MR: DAXX, FLASH, and FAF-1 (Obradovic, Tirard et al. 2004).  
While DAXX and FLASH influenced the transcriptional properties of MR and GR in a 
similar manner, FAF-1 was found to selectively stimulate MR mediated transcription 
while having no effect on GR.  Perhaps the most interesting co-regulator discovered 
recently is ELL.  This protein was shown to act as a selective coactivator of MR in that it 
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can potentiate MR mediated transcription and actually repress GR mediated transcription 
while having no affect on either PR or AR mediated transcription (Pascual-Le Tallec, 
Simone et al. 2005).   
 Hence, an analysis of the molecular mechanisms underlying MR- and GR-
mediated transcriptional regulation suggests that these receptors may regulate 
corticosteroid-responsive genes in both similar and distinct manners.  While a large body 
of work has analyzed the interactions of MR and GR homodimers with coregulators, the 
field is severely lacking in its analysis of MR/GR heterodimer interactions with 
coregulators.  Overall, the data suggest that when MR and GR are co-expressed, the 
transcriptional regulation of corticosteroid responsive genes will be determined by the 
concentration of corticosteroid, the relative levels of MR and GR, and the expression 
profiles of other transcription factors and coregulators.  All of these factors together may 
result in differential regulation of genes relative to the regulation derived from the 
activation of either MR or GR alone.  In support of this notion, a recent study to identify 
glucocorticoid-responsive genes in the rat hippocampus using either low or high doses of 
corticosterone (to activate MR alone or MR and GR together) in ADX rats identified 203 
genes that were regulated by either low or high doses of corticosterone but only 33 that 
were regulated by both doses of corticosterone (Datson, van der Perk et al. 2001).  These 
data suggest that the activation of MR and GR together in the same cell, at varying ligand 
concentrations, may regulate distinct and yet partially overlapping sets of genes. 
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Corticosteroid-Mediated Regulation of HPA axis Activity. 
 As a classical physiological homeostatic system, the HPA axis is under negative 
feedback regulation by corticosteroids, the final product of the pathway.  This negative 
feedback can occur at multiple levels as outlined in Figure 1-5.  Corticosteroids have 
been proposed to directly repress the expression of POMC, the precursor of ACTH, in 
anterior pituitary corticotropes through multiple mechanisms, including a GR-mediated 
antagonism of Nur77 (Philips, Maira et al. 1997), and GR interactions with an nGRE in 
the POMC promoter (Drouin, Trifiro et al. 1989; Riegel, Lu et al. 1991).  In the PVN of 
the hypothalamus, corticosteroids are known to down-regulate the expression of CRH 
and AVP.  While these corticosteroid-mediated actions may include direct regulation of 
the AVP gene, the negative regulation of CRH expression by corticosteroids, however, is 
far more complex with both spatial and temporal domains (Watts 2005). 
Corticosteroid-mediated negative feedback to the HPA axis is also provided by 
other brain regions outside of the hypothalamus.  These are largely forebrain limbic 
regions that encompass the “anticipatory” branch of HPA axis activation and include the 
prefrontal cortex (PFC) and the hippocampus.  As these regions do not project directly to 
the PVN, negative feedback is provided through multi-synaptic pathways that include 
relays through other brain regions (Herman, Figueiredo et al. 2003).  Corticosteroid 
implants in the PFC reduce both the corticosterone and ACTH response to restraint stress 
in rats, however these implants have no effects on either basal AM or PM indices of HPA 
axis activity, suggesting that corticosteroid regulation is restricted to stress induced HPA 
activity (Diorio, Viau et al. 1993).  Implants of corticosterone into the ventral 


















Figure 1-5 Schematic of HPA axis including sites of negative feedback provided by 
GR and MR. 
Reprinted by permission from Macmillan Publishers Ltd: Nature Medicine, 11, 116-118, 
Akil, H., (2005). 
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release (Slusher 1966), and implants of corticosterone into the dorsal hippocampus were 
found to decrease the adrenalectomy induced increase in ACTH (Kovacs and Makara 
1988) suggesting that the hippocampus provides corticosteroid-mediated negative 
feedback to the HPA axis.  In addition to negative feedback provided to the HPA axis by 
the PFC and the hippocampus, positive regulation is provided by the amygdala in a 
corticosteroid-responsive fashion.  Shepard et al. found that implants of corticosterone to 
the amygdala resulted in an enhanced HPA axis response to a behavioral stressor, but had 
no effect on basal a.m. or p.m. corticosteroid levels (Shepard, Barron et al. 2003). 
Interestingly, the glucocorticoid-mediated effects in all of these regions 
correspond with many of the electrical stimulation and lesioning studies discussed in the 
HPA Axis Activity section, highlighting the important role of glucocorticoid-mediated 
information transfer from these limbic regions to the PVN.  All of these regions are 
known to express MR and GR, however, the hippocampus is notable in that it co-
expresses the highest levels of both receptors.  Because of the importance of negative 
feedback regulation and dysregulation in mood disorders, a broad array of techniques 
have been used to elucidate the individual roles of MR and GR in regulating basal and 
stress-induced HPA axis activity and anxiety-related behaviors.  Below, I will review our 
current understanding of corticosteroid/MR/GR actions in these processes based on both 
pharmacological and genetic manipulation studies. 
MR and GR Regulation of HPA Axis Activity: Pharmacological 
Under basal, resting conditions, corticosteroid levels in the plasma oscillate in a 
circadian fashion.  At the trough of the circadian rhythm, corticosteroid levels are low 
and are thought to preferentially occupy MR, while at the peak, the hormone is elevated
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to levels that occupy both MR and GR (Reul and de Kloet 1985).  The differential 
occupancy of MR and GR is consistent with their differential binding characteristics with 
MR exhibiting a roughly 10-fold greater affinity for corticosteroids than GR.  These data 
suggest that because of its high affinity and low capacity, activation of MR is essential 
for maintenance of the basal circadian rhythm, whereas activation of GR with increasing 
corticosterone levels is required for recovery of homeostasis via negative feedback (De 
Kloet and Reul 1987).  Subsequent agonist and antagonist studies from several groups 
demonstrated the importance of MR activity in restraining circadian trough levels of 
corticosteroids (Ratka, Sutanto et al. 1989; Bradbury, Akana et al. 1991; Bradbury, 
Akana et al. 1994).  However, it was also shown that MR activation was necessary, in 
conjunction with GR activation, in restraining peak HPA axis activity as well (Bradbury, 
Akana et al. 1994).  In addition to studies in rats, it was also shown in humans treated 
with canrenoate, a selective MR antagonist, that MR activity affects basal HPA axis 
activity at both the circadian trough and peak (Dodt, Kern et al. 1993).  
In response to stress, corticosteroid levels increase and participate in the classic 
negative feedback loop shown in Figure 1-5.  Due to differences in testing paradigms and 
the types of antagonists used, the relative contributions of MR and GR in this negative 
feedback are not clearly defined.  Two groups have shown that in response to mild 
stressors, such as exposure to a novel environment, blockade of MR in rats resulted in an 
increased or elongated stress response (Ratka, Sutanto et al. 1989; Pace and Spencer 
2005).  Weidenfeld et al. found in rats that administration of a GR antagonist resulted in 
an increased corticosterone response to photic stress, whereas blockade of MR did not, 
suggesting that only GR was necessary for restraining the HPA axis in response to photic 
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stress (Weidenfeld and Feldman 1993).  In response to a more intense stressor, Spencer 
and colleagues showed that while blockade of either MR or GR alone had no effect on 
restraint stress-induced corticosterone levels at either the circadian trough or peak, if both 
receptors were blocked at the same time, stress induced corticosterone levels were 
significantly elevated above vehicle controls at both times of the day, suggesting that 
both receptors are important in negative feedback control in response to restraint stress 
(Spencer, Kim et al. 1998).  In addition to acute stressors such as the ones mentioned, 
Spencer’s group has also shown that blockade of MR, but not GR was sufficient to 
prevent the expression of habituation to repeated restraint in rats (Cole, Kalman et al. 
2000).  In humans, antagonist studies suggest a more prominent role for MR in 
restraining activated HPA activity as blockade of MR alone resulted in elevated cortisol 
levels in response to both exercise (Wellhoener, Born et al. 2004) and CRH challenge 
(Arvat, Maccagno et al. 2001).  Overall, the literature suggests that MR and GR may both 
be important in restraining HPA axis activity to many, but not all types of stressors. 
All of these studies utilized antagonists that were injected either in the periphery 
or in the brain (ie. intracereboventricular, icv) not permitting determination of region-
specific effects of MR and GR blockade.  In order to accomplish this, van Haarst and 
colleagues performed either icv or intra-hippocampal injections of MR and GR 
antagonists (van Haarst, Oitzl et al. 1997).  It was found that while icv delivery of GR 
antagonists resulted in enhanced HPA axis activity, direct intra-hippocampal delivery 
actually resulted in a suppression of HPA axis activity.  In contrast, both icv and intra-
hippocampal delivery of MR antagonists resulted in enhanced HPA axis activity, 
suggesting distinct roles for hippocampal MR and GR in HPA axis regulation.  The 
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amygdala and the PVN are regions that have also been shown to express both MR and 
GR and thus may be additional regions where the actions of MR and GR could provide 
either similar or differential control over HPA axis activity.  Although corticosterone 
implants into the amygdala increase stress induced HPA axis activity and corticosterone 
applied locally to the PVN can inhibit adrenalectomy-induced increases in CRH and AVP 
production (Kovacs, Kiss et al. 1986), receptor-specific blocking studies have not been 
performed in these regions. 
 These studies suggest a rather complex regulation of the HPA axis by 
corticosteroids where the final integration at the level of the PVN can result in either 
enhanced or suppressed HPA axis activity.  Importantly, these outcomes appear to be 
dependent on the levels of activation of both the specific brain region and the receptor 
that is activated. 
 
Corticosteroid and MR/GR Regulation of Anxiety-Related Behaviors: Pharmacological 
It has been known for many years that activity of the HPA axis can modulate 
anxiety-related behaviors, but the actions of corticosterone on anxiety are quite complex.  
A recent review from Korte comprehensively organizes the vast literature in this field and 
finds that the effects of corticosterone on fear and anxiety are heavily dependent on 
whether the stressor is conditioned or unconditioned as well as on the phase of the 
corticosterone response (Korte 2001).  The general effects of corticosterone have been 
studied in animal models of ADX and corticosterone replacement.  ADX was shown to 
increase anxiety (Weiss, McEwen et al. 1970; Joffe, Mulick et al. 1972; File, Vellucci et 
al. 1979) and corticosterone replacement after adrenalectomy had anxiolytic effects (File, 
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Vellucci et al. 1979).  Conversely, it has been reported that fear-induced immobility is 
reduced (decreased anxiety) in ADX animals and the immobility is restored upon 
corticosterone replacement (increased anxiety) (Bohus 1987), suggesting that the actions 
of corticosteroids on anxiety-related behaviors are dependent on context.  
Experimentally, a variety of different testing paradigms have been used to address this 
issue, including short and long-term exposure to corticosterone either systemically or in 
specific brain regions, as well as acute blockade of MR and GR with antagonists in either 
the whole brain (icv) or into specific brain regions.  The effects of corticosteroids on 
measures of anxiety-like behavior not only display brain-region specificity, but there 
appear to be time dependent effects of corticosteroid exposure as well as differential 
effects of MR and GR activation. 
When MR and GR are blocked acutely, the data suggest that they appear to be 
involved in modulating different aspects of fear and anxiety.  For example, 
pharmacological MR inactivation specifically in the hippocampus suggests that it plays a 
permissive role in the expression of unconditioned fear, as blockade of hippocampal MR, 
but not GR, resulted in decreased anxiety-like behavior as measured by multiple tests 
including the elevated plus maze, the defensive burying test, and thigmotaxis in the open 
field (Bitran, Shiekh et al. 1998) as well as the light/dark box (Smythe, Murphy et al. 
1997).  In response to conditioned fear, activation of MR in the brain in general also 
appears to play a permissive role in the mediation of conditioned freezing behavior 
(Korte, de Boer et al. 1995) as well as the extinction of passive avoidance (Bohus and de 
Kloet 1981).  Corticosteroids acting through GR appear to enhance acquisition, 
conditioning, and consolidation of an inescapable stressful experience (Korte 2001).  
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Activation of GR also appears to promote processes underlying fear potentiation, as 
blockade of GR in the brain (icv) prevents the fear potentiated decrease in time spent on 
the open arms of the Elevated Plus Maze (Korte, de Boer et al. 1995).  These data 
coincide with a large number of lesioning studies in the rodent that suggest that the 
learning and memory of conditioned fear is derived from the amygdala but that the 
hippocampus contributes to unconditioned fear responses (McHugh, Deacon et al. 2004; 
Rosen and Donley 2006).  
A number of experiments have been done to address chronic corticosterone 
treatments on anxiety-related behaviors, but differences in testing paradigms, including 
routes of administration, anxiety-tests utilized, and lengths of time of treatment, make it 
difficult to draw conclusions.  For example, Ardayfio et al. found that chronic (17 days) 
but not acute (24 hr) corticosterone in the drinking water of mice increased anxiety-like 
behavior in mice in the light-dark emergence task (Ardayfio and Kim 2006).  Using rats, 
Andreatini et al, found that subcutaneous injections of corticosterone dose dependently 
decreased anxiety-like behavior in the elevated plus maze within 2 hours of injection, but 
chronic injections of 14 days had no effect (Andreatini and Leite 1994; Andreatini and 
Leite 1994).  
Different brain regions contribute to the expression of anxiety-related behaviors.  
Perhaps the best understood relationship between corticosteroids and anxiety occurs in 
the amygdala.  A large body of research suggests that corticosteroids can modulate fear 
and anxiety-related behaviors through stimulation of CRH production in the amygdala 
(Korte 2001; Korte, Koolhaas et al. 2005).  In sheep, stress induced levels of 
corticosteroids increase CRH levels in the amygdala in a manner that is dependent on GR 
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(Cook 2002).  Corticosteroid implants into the amygdala of rats for 7 days increased 
anxiety-like behavior on the Elevated Plus Maze with a concomitant increase in 
amygdalar CRH expression (Shepard, Barron et al. 2000).  In support of this, a recent 
study also found that corticosteroid implants into the amygdala of rats for 5 days 
increased anxiety-like behavior as measured by the Elevated Plus Maze.  Interestingly, 
the corticosteroid effect on anxiety was blocked by co-implantation of both GR and MR 
antagonists (Myers and Greenwood-Van Meerveld 2007).  
Overall, these data suggest that corticosterone can modulate anxiety-related 
behaviors.  The manner in which this occurs, however, is complex.  In the short-term, GR 
and MR activation may have different effects on aspects of consolidation of acquired 
information versus sensory integration underlying the evaluation of environmental 
information.  Long-term elevations of glucocorticoids may have opposite effects on 
anxiety-related behaviors with respect to short-term elevations, but the mechanisms 
underlying this are not completely understood. 
 
Genetic Manipulations of MR and GR: Effects on HPA axis and Anxiety 
 In addition to these pharmacological methods, a large number of studies have 
been done that rely on genetic manipulation of MR and GR to determine their respective 
roles in HPA axis regulation and anxiety-related behaviors.  These studies have been 
summarized in Table 1-3.  For GR, these include transgenic mice with decreased GR 
expression (Pepin, Pothier et al. 1992), and transgenic mice with increased GR 









Table 1-3 HPA system dysregulation and behavioral symptoms in mice with targeted mutations of GR and MR 
Baseline HPA System Challenged HPA System Behavior 
                                      Hypothalamic      Pituitary  Plasma  Plasma      Stress                             Stress dex/CRH     
                                             CRH        POMC/ACTH  ACTH  CORT      ACTH                  CORT  test  Anxiety  Despair  Locomotion  
Human depression  ⇑ n.d. ⇑ ⇑ ⇓ ⇑ ⇑ ⇑ ⇑  
Human panic disorder  ⇔ n.d. ⇔ ⇔ ⇓ ⇔ (⇑) ⇑ ⇑  
(1) Tg mice with ⇓ GR  ⇓ ⇔ ⇔ ⇔ ⇑ ⇓ ⇑ ⇓ ⇓ ⇔ 
(2) GRnull mice  ⇑ ⇑ n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
(3) GRNesCre mice  ⇑ ⇑ ⇓ ⇑ ⇓ ⇔ n.d. ⇓ ⇓ ⇔ 
(4) GRdim mice  ⇔ ⇑ ⇔ ⇑ n.d. n.d. n.d. ⇔ ⇔ ⇔ 
(5) Tg - ⇑ GR (YGR) ⇓ ⇓ ⇑ ⇓ ⇑ ⇓ n.d. n.d. n.d. n.d. 
(6) Tg - ⇑ GR (GRov) ⇔ ⇔ ⇔ ⇔ ⇓ ⇑ (prolonged) n.d. ⇑ ⇑ ⇔ 
(7) GRCaMKII/Cre KO ⇔ - AVP ⇑ ⇔ ⇑ ⇑ ⇑ ⇑ n.d. ⇔ ⇑ ⇑ 
(8) MR / mice  ⇑ ⇑ ⇓ ⇑ n.d. n.d. n.d. ⇑ n.d. n.d. 
(9) MRCaMKII/Cre KO ⇔ n.d. n.d. ⇔ n.d. ⇔ n.d. ⇔ n.d. ⇔ 
(10) Tg - ⇑MR (MRov) ⇔ n.d. n.d. ⇔ n.d. ⇓ (females) n.d. ⇓ n.d. ⇔ 
(11) Tg - ⇑MR (MRtg) n.d. n.d. n.d. ⇔ n.d. ⇔ n.d. ⇓ n.d. ⇔ 
Reprinted with adaptation from Physiology & Behavior 73, Gass, P. et al., Mice with targete mutations of glucocorticoid and 




(Wei, Lu et al. 2004; Wei, Hebda-Bauer et al. 2007).  Mouse models with a disrupted GR 
gene have also been generated either globally (Cole, Blendy et al. 1995), or in a 
forebrain-specific fashion (Tronche, Kellendonk et al. 1999; Boyle, Brewer et al. 2005).  
Transgenic mice have also been generated that contain a mutated DNA-binding domain 
(GRdim) (Reichardt, Kaestner et al. 1998).  These studies demonstrate that GR plays an 
important role in modulating HPA axis activity and affect.  Mice that are total GR 
deficient die shortly after birth demonstrating the importance of GR function in mouse 
development.  It was found, however, that newborn mice homozygous for the GRnull 
allele have enhanced transcription of both CRH in the hypothalamus and 
proopiomelanocortin (POMC) in the anterior lobe of the pituitary, confirming the role of 
GR-mediated negative feedback in the HPA axis (Gass, Kretz et al. 2000).  Knock out or 
knock down of GR specifically in the brain results in elevated levels of corticosterone 
and decreased anxiety-related behaviors.  Mice with a GR deficit specifically in the 
forebrain also show increased corticosterone levels (Boyle, Brewer et al. 2005).  
Behaviorally, these animals demonstrated increased depressive-related behaviors, such as 
anhedonia (defined as a decrease in the sensitivity of brain reward mechanisms), but 
showed increased locomotion without altered anxiety (Boyle, Kolber et al. 2006).   
When GR is overexpressed, many of the opposite phenotypes are seen relative to 
underexpression models.  Mice with two extra copies of the GR gene show reduced 
expression of CRH and ACTH and show a fourfold reduction in the levels of circulating 
corticosterone; behavioral studies for anxiety have yet to be performed (Reichardt, 
Umland et al. 2000).  When GR is overexpressed specifically in the forebrain, transgenic 
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mice show both increased anxiety and depression-related behaviors (Wei, Lu et al. 2004).  
These mice also exhibit a delay in the negative steroid feedback of the HPA axis and a 
mild cognitive deficit, similar to effects observed in aged mice (Wei, Hebda-Bauer et al. 
2007).   
Many fewer relevant mouse models exist for the study of MR in the brain.  Mice 
were generated that lack MR globally (MR-KO), but these mice die within 10 days of 
birth due to renal sodium and water loss (Berger, Bleich et al. 1998).  Although MR-KO 
mice can be rescued with exogenous salt injections, this requires daily handling of pups 
during the early postnatal time period, which can have profound effects on HPA axis 
activity and behavior (Anisman, Zaharia et al. 1998).  With this caveat in mind, the salt-
rescued mice were used to study the loss of MR on hippocampal morphology and 
neurogenesis (Gass, Kretz et al. 2000).  It was found that MR-KO mice exhibit a 
decreased density of granule cells in the dentate gyrus of the hippocampus, indicative of 
neurodegeneration as well as decreased neurogenesis relative to both wildtype controls 
and mice that lack GR in the brain.  These data suggest that MR may play an important 
role in hippocampal neurogenesis and cell survival, although it should be noted that these 
mice also have increased levels of corticosterone in the plasma which may confound the 
results.  In other models, MR has been overexpressed (Ouvrard-Pascaud, Sainte-Marie et 
al. 2005) or underexpressed (Beggah, Escoubet et al. 2002) in the heart.  Le Menuet et al. 
utilized  the human MR promoter to drive expression of MR in the mouse, but only 
studied MR function relative to the kidney and the heart (Le Menuet, Isnard et al. 2001). 
 More recently, mice that lack MR in the forebrain were generated using the Cre-
LoxP recombination system with the CaMKIIα promoter being used to drive expression 
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of Cre recombinase (Berger, Wolfer et al. 2006).  These mice show no changes in HPA 
axis activity either basally or in response to stress.  They also do not exhibit any changes 
in anxiety-related behavior, although they do exhibit a learning deficit in the Morris 
Water Maze (MWM) and the radial maze.  While these mice have a complete loss of MR 
in the forebrain, they also exhibit a compensatory increase in GR expression in the 
hippocampus that may confound interpretations.  Interestingly, a recent study using these 
animals found that MR is required for stress levels of corticosterone to rapidly modulate 
glutamate transmission in region CA1 of the hippocampus (Karst, Berger et al. 2005).  
This suggests that the classic cytoplasmic MR may be capable of mediating fast non-
genomic cellular responses in addition to its role in the traditional genomic pathway, 
perhaps by associating with plasma membrane bound proteins capable of transducing 
traditional intracellular signaling cascades. 
 Concurrent with the published data presented in chapter 2 of this thesis, a similar 
mouse model was published that also overexpresses MR in the forebrain (Lai, Horsburgh 
et al. 2007).  Similar to the transgenic animals generated for this thesis, these transgenic 
animals exhibit a decrease in anxiety-like behavior.  No changes were seen in HPA axis 
activity either basally or in response to stress, although only male animals were used for 
analysis.  These mice also exhibited a mild enhancement in spatial memory retention 
relative to wildtype controls.  Interestingly, these transgenic mice also showed a decrease 
in cell death in region CA1 of the hippocampus in response to ischemic insult, suggesting 
that MR can play a neuroprotective role.  Thus altered levels of brain MR have been 
suggested to affect neurogenesis, learning, and neuroprotection while its roles in HPA 
function and anxiety have not been clearly established. 
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Corticosteroids and Hippocampal Structure and Function 
As mentioned previously, disturbances in HPA axis activity underlie multiple 
mood disorders including major depressive disorder and multiple anxiety disorders, often 
leading to excessive levels of plasma corticosteroids.  The excessive levels of 
corticosteroids are thought to contribute to the decreased structural and functional 
integrity of corticosteroid-responsive brain regions, particularly the hippocampus, but 
also including regions of the cortex.  Recent data have shown that the subtypes of 
depression with the highest rates of hypercortisolism are most often associated with 
atrophy of the hippocampus (Sheline, Sanghavi et al. 1999).  As the hippocampus is 
essential for learning and memory, it is not surprising that both major depression and 
anxiety disorders often include defects in declarative learning and memory (Austin, 
Mitchell et al. 2001; Airaksinen, Larsson et al. 2005).  Corticosteroids are known to have 
potent effects on many aspects of the structure and function of the hippocampus, and thus 
serve as a primary link between hippocampal structure and function and affective 
disorders. 
Repeated stress or repeated exposure to elevated levels of corticosteroids over 
several weeks lead to a retraction of dendrites in region CA3 of the hippocampus 
(Woolley, Gould et al. 1990; Watanabe, Gould et al. 1992; Sousa, Lukoyanov et al. 2000; 
Conrad CD 2007).  Four weeks of chronic unpredictable stress (CUS) resulted in 
impairments in learning and memory in addition to its effects on CA3 dentritic 
morphology (Sousa, Lukoyanov et al. 2000).  The chronic corticosterone treatment 
groups had milder alterations of CA3 dendritic processes than the 4 weeks of CUS, and 
also exhibited milder learning deficits, suggesting that factors other than the 
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corticosterone produced during stress may contribute to morphological and behavioral 
changes.   
New neurons are continually being born in the mammalian dentate gyrus, and this 
process of neurogenesis has also been shown to be highly regulated by corticosterone.  
Rats treated acutely with corticosterone showed a significant decrease in the number of 
newborn neurons, while ADX results in a large increase in neurogenesis (Cameron and 
Gould 1994).  Additionally, physiological alterations in corticosterone levels, such as 
acute and chronic stress are known to suppress hippocampal neurogenesis (Gould and 
Tanapat 1999).  The activation of GR is clearly implicated in the suppression of 
neurogenesis in the dentate gyrus.  High levels of corticosterone given to either 
adrenalectomized (Wong and Herbert 2005) or adrenal-intact rats (Mayer, Klumpers et 
al. 2006) resulted in a suppression of proliferation that was normalized by antagonism of 
GR.  Other evidence suggests that the GR agonist dexamethasone can inhibit 
neurogenesis both in vivo and in vitro (Kim, Ju et al. 2004).  The effects of MR activation 
on neurogenesis are not as clear.  Several groups have shown that MR activation can 
suppress the increased proliferation that accompanies adrenalectomy (Wong and Herbert 
2005; Krugers, van der Linden et al. 2007) in a manner similar to GR.  In contrast, 
however, it has also been shown that aldosterone can further enhance the increased 
proliferation that accompanies adrenalectomy (Fischer, von Rosenstiel et al. 2002).  In 
support of this positive effect of MR activation on neurogenesis, genetic disruption of 
MR leads to impaired neurogenesis in the hippocampus, whereas brain specific disruption 
of GR had no effects on hippocampal neurogenesis (Gass, Kretz et al. 2000).  In a series 
of in vitro experiments, primary hippocampal cultures treated with aldosterone showed 
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enhanced neurogenesis that could be blocked with the MR antagonist spironolactone.  In 
contrast, cultures treated with dexamethasone showed decreased neurogenesis, an effect 
that could be blocked by mifepristone (Fujioka, Fujioka et al. 2006).   
Finally, long-term elevations in corticosteroid levels can have negative effects on 
neuroplasticity and cell survival, a phenomenon that has been referred to as 
glucocorticoid endangerment (Sapolsky 1985).  Region CA1 of the hippocampus is 
particularly sensitive to glutamate toxicity induced by neurological insult and excess 
corticosteroids make this region more vulnerable to damage (Sapolsky 1985; Sapolsky 
and Pulsinelli 1985).  While there is some evidence that corticosteroids can be directly 
toxic to neurons, a number of other glucocorticoid actions have been identified that may 
contribute to the ability of corticosteroids to exacerbate neuronal death.  These include 
increasing the basal free intracellular cytosolic calcium concentrations (Elliott and 
Sapolsky 1992; Elliott and Sapolsky 1993) and inhibiting glucose transport (Tombaugh 
and Sapolsky 1992; Lawrence and Sapolsky 1994), outlining a general scheme where the 
glucocorticoid-mediated disturbance of energy homeostasis in the cell makes it more 
vulnerable to toxic insults such as excess glutamate.   
As the hippocampus is richly endowed with both GR and MR, it is of major 
importance to understand the relative contributions of each receptor to this process of 
glucocorticoid endangerment.  There is substantial evidence that the glucocorticoid 
endangerment effect is mediated by GR (Herman and Seroogy 2006).  Interestingly, 
while extensive GR activation appears responsible for many of the deleterious 
consequences of glucocorticoids, MR activation appears to provide a neuroprotective 
role.  Overexpression of MR in the hippocampus provides protection from ischemic 
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insult relative to wildtype controls (Lai, Horsburgh et al. 2007).  Overexpression of MR 
in the neuronal cell line PC12 also provides protection from various neurological insults 
(Lai, Seckl et al. 2005).  Crochemore and coworkers found that MR activation with 
aldosterone can prevent the dexamethasone induced apoptosis of primary hippocampal 
cell cultures (Crochemore, Lu et al. 2005).  Similarly, McCullers and collegues, found 
that rats treated with an MR antagonist showed substantial exacerbation of kainite-
induced neurotoxicity in subfield CA3 of the hippocampus, whereas in contrast, GR 
blockade did not affect cell loss (McCullers and Herman 2001).  Additionally, the 
increased neurodegeneration after MR antagonism was associated with a decrease in 
expression of Bcl-2, an anti-apoptotic protein, in this same subregion (McCullers and 
Herman 1998).  Hence, numerous studies suggest that MR may provide neuroprotective 
effects in response to insult through modulation of anti-apoptotic mechanisms. 
The activity of MR also appears to play a supportive role in cell survival.  
Removal of corticosteroids by adrenalectomy results in a large amount of cell death in the 
dentate gyrus.  Very low levels of corticosteroids or administration of an MR agonist is 
sufficient to prevent this neurodegeneration, suggesting that there are trophic actions of 
corticosteroids that are mediated by MR (Woolley, Gould et al. 1991; Sloviter, Sollas et 
al. 1993). 
On a cellular level, glucocorticoids are intimately involved in modulating multiple 
properties relevant to learning and memory and information transfer out of the 
hippocampus.  Levels of glucocorticoids equivalent to a stressor decrease long-term 
potentiation (LTP) whereas low levels of corticosteroids enhance LTP (McEwen and 
Sapolsky 1995).  Similarly, low levels of corticosterone can enhance excitability of 
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pyramidal neurons in the hippocampus and higher levels of hormone result in decreased 
neuronal excitability (Joels and de Kloet 1991; Joels and de Kloet 1992).  Interestingly, 
under conditions of ADX, when no corticosteroids are present, a similar cellular 
phenotype is observed as under high levels of corticosteroids.  These inverted U shaped 
patterns can be explained by the relative occupations of the two corticosteroid receptors 
present in the hippocampus.  Studies using specific agonists and antagonists for MR 
suggest that the activity of this receptor is responsible for increased LTP and increased 
neuronal excitability.  Conversely, higher levels of corticosteroids, activating both MR 
and GR, and specific agonists for GR decrease LTP and neuronal excitability (Joels and 
de Kloet 1991; De Kloet, Vreugdenhil et al. 1998).  
As one would predict from the LTP data, lower levels of glucocorticoids 
commensurate with low to moderate stress have been shown to enhance cognition in 
several learning and memory paradigms, whereas more severe stressors and higher levels 
of glucocorticoids disrupt it (Luine, Villegas et al. 1994; Bodnoff, Humphreys et al. 
1995; McLay, Freeman et al. 1998).  It should be stressed here, however, that these 
effects of corticosteroids on learning and memory are time dependent, as acute 
glucocorticoid treatment in close relation to training has been shown to potentiate 
memory in a dose-dependent fashion (De Kloet, Vreugdenhil et al. 1998).  These findings 
highlight that corticosteroids modulate information processing in a time- and context-
dependent fashion. 
Many studies have been performed to determine the individual roles of MR and 
GR in learning and memory.  While these studies clearly implicate MR and GR in 
cognitive function, an overall conclusion is difficult to ascertain as a wide range of 
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testing paradigms and conditions have been used.  Acute blockade of MR and GR during 
different phases of morris water maze (MWM) training has implicated MR activity in 
search escape strategies, whereas GR activity was implicated in the consolidation of 
spatial memories (Oitzl and de Kloet 1992).  However, here too, there seems to be a time 
dependent effect of receptor blockade.  For example, chronic blockade of MR for 12 days 
impaired spatial learning in the MWM (Yau, Noble et al. 1999).  Similarly, repeated 
blockade of MR, but not GR resulted in impaired food-rewarded spatial learning in the 
hole-board task (Douma, Korte et al. 1998).  
Overall, glucocorticoids have been shown to heavily influence the structure and 
function of the hippocampus.  Research suggests that the actions of MR and GR in these 
processes may be separable, mediating differential effects on cellular properties such as 




This introduction has described how corticosteroids, acting through MR and GR, 
are critical to the maintenance of homeostasis in mammals.  The similarities and 
differences in MR and GR properties, including differential ligand sensitivities, 
expression patterns, and modes of transcriptional activation/repression suggest they have 
both independent and overlapping roles in regulating allostatic mechanisms that comprise 
the “stress response”.  The HPA axis is a highly dynamic system and corticosteroid 
actions are not strictly coincidental with the level of hormone; levels of the individual 
receptors also contribute to the final biological output.  MR and GR can function as 
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monomers, homodimers, or heterodimers when co-expressed, with very different 
outcomes based on the concentration of hormone and the level of each receptor.  Thus, 
the balance in MR and GR levels and activation is hypothesized to be a significant factor 
in proper cellular, physiological and behavioral responses to corticosteroids.  Several 
endogenous systems of altered MR activity suggest that this is indeed the case.  For 
example, the Lewis rat exhibits higher levels of hippocampal MR relative to the Wistar 
rat from which it is derived and shows lower evening basal and stress-induced HPA axis 
activity (Oitzl, van Haarst et al. 1995).  Different strains of aged rats have decreased MR 
in the hippocampus relative to GR, and these rats show increased basal and/or stress 
induced HPA axis activity (Morano, Vazquez et al. 1994; Van Eekelen, Oitzl et al. 1995).  
Interestingly, in both rats that have received chronic unpredictable stress and in suicide 
victims with a history of depression, the expression levels of MR has been shown to be 
decreased, leading overall to an imbalance in the MR/GR ratio (Lopez, Chalmers et al. 
1998).  These data support the hypothesis that a balance in the activation of MR and GR 
in forebrain regions such as the hippocampus is an important process in the maintenance 
of proper homeostasis. 
Previous studies attempting to elucidate the role of MR in anxiety-related 
behaviors and in the regulation of HPA axis have focused on acute blockade of MR with 
receptor specific antagonists.  While this method has provided invaluable information 
regarding short-term signaling consequences, it does not provide information regarding 
long-term alterations in MR signaling.  Thus, chapter II of this thesis addresses long-term 
alterations in MR signaling through the generation of transgenic mice that specifically 
overexpress MR in the forebrain.  We hypothesized that overexpression of MR in the 
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forebrain would decrease basal and stress induced HPA axis activity.  We also 
hypothesized that overexpression of MR would alter anxiety-related behaviors.  
These studies were published in the manuscript “Mineralocorticoid receptor 
overexpression in forebrain decreases anxiety-like behavior and alters the stress response 
in mice” PNAS (2007) 104(11):4688-4693.   
Corticosteroids are also known to influence learning and memory and 
neurogenesis in the hippocampus but the role of MR in this process is currently unclear.  
As such, we were interested in determining the effects of overexpression of MR in the 
hippocampus on learning and memory and neurogenesis.  We hypothesized that 
overexpression of MR in the hippocampus would enhance hippocampal-dependent 
learning and memory and increase proliferation of dentate gyrus granule cells.  
These studies are presented as appendices following chapter 2. 
High levels of corticosteroids can have deleterious effects on the structure and 
function of the hippocampus.  The mouse hippocampal cell line HT-22 has been used as a 
model system to study glucocorticoid endangerment of neurons.  This cell line expresses 
GR but not MR, and glucocorticoid pre-exposure of these cells has been shown to 
exacerbate glutamate toxicity.  Recent studies suggest that MR activation may play a 
neuroprotective role, promoting cell survival in response to various insults.  To address 
this neuroprotective role, we generated stable clones of HT-22 cells that express varying 
levels of MR in addition to the GR already present in the cell.  We hypothesized that the 
expression of MR in HT-22 cells could attenuate the ability of corticosterone to 
exacerbate glutamate toxicity.  Data suggesting a potential neuroprotective role for MR 
is presented in chapter 3.   
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MR and GR function in large part as ligand-activated transcription factors that 
control the expression of gene networks.  The relative levels of these receptors within the 
same cell have been shown to influence transcriptional regulation of corticosteroid-
responsive genes in manners that are distinct from when either MR or GR is present 
alone.  Thus, HT-22 cells and a stable clone of HT-22 cells that expresses MR in addition 
to GR have been used for microarray analysis to determine the effects of MR and GR 
activation together on global corticosteroid-responsive gene transcription relative to when 
GR alone is activated.  We hypothesized that the activation of MR and GR together 
in the same cell would significantly alter the expression patterns of both similar and 
different corticosteroid-responsive genes relative to GR activation alone.  Data 
summarizing these findings are presented in chapter 4. 
Overall, disturbances in the structure and function of the hippocampus are 
hypothesized to underlie some depressive and anxiety disorders.  Glucocorticoids have 
been shown to heavily influence cellular properties that may affect the structure of the 
hipppocampus, as well as physiological and behavioral processes that are dependent on 
the hippocampus.  As much less is known about the function of MR in mediating the 
effects of glucocorticoids in the central nervous system, the goal in this thesis has been to 
address the role of MR in these processes using both in vivo techniques to understand 
physiological and behavioral consequences of MR action, and in vitro techniques to 
understand cellular consequences of MR action. 
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Chapter 2 
Mineralocorticoid Receptor Overexpression in Forebrain Decreases Anxiety-Like 
Behavior and Alters the Stress Response in Mice 
 
Introduction: 
The hypothalamic-pituitary-adrenal (HPA) axis controls the production and 
release of adrenal glucocorticoids (GC) across the daily circadian rhythm and in response 
to stress. The major functions of GC within the HPA axis are twofold: 1) alter metabolic 
processes in a manner that provides the energy needed to combat the stressful stimuli; 2) 
recover homeostasis. These functions are essential to the well-being of the organism and 
dysregulation of the axis can result in potentially deleterious consequences. Indeed, 
evidence suggests that multiple mood disorders, including anxiety conditions and major 
depression, are associated with chronic alterations in the circulating levels and circadian 
rhythm of GC (Chrousos and Gold 1992; De Kloet, Vreugdenhil et al. 1998; Akil 2005). 
Furthermore, clinically efficacious antidepressant treatment is often accompanied by 
normalization of the HPA axis, underscoring the importance of HPA axis function in 
control of affect (Lopez, Chalmers et al. 1998). 
The actions of GC are mediated by two corticosteroid receptors, the 
glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR). MR and GR 
function as ligand-activated transcription factors that reside in the cytoplasm, dimerize 
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upon ligand binding, translocate to the nucleus and exert transcriptional control, either 
positive or negative, over glucocorticoid responsive genes. MR and GR have different 
affinities for corticosterone (Kd = 0.5nM for MR and 5nM for GR), and thus are 
differentially activated throughout the circadian rhythm and during times of stress. GR is 
widely expressed throughout the brain, whereas MR expression, although present in 
various brain regions, is found predominantly in the hippocampus in rodents. 
Interestingly, MR is highly expressed in cerebral cortex of squirrel monkeys and humans, 
suggesting additional roles for cortical MR in primates (Patel, Lopez et al. 2000; Watzka, 
Bidlingmaier et al. 2000). In brain regions where MR and GR are co-expressed, they can 
heterodimerize, further increasing the complexity by which the receptors can signal 
(Trapp and Holsboer 1996). While numerous studies have shown that MR and GR act 
synergistically in HPA axis inhibition, other work has suggested that the actions of MR 
and GR can be antagonistic. For example, MR and GR mediate opposite effects on ion 
conductances in hippocampal pyramidal neurons (Joels and de Kloet 1990) and can 
interact with co-activators in distinct manners (Meijer 2002). These differential 
mechanisms of action allow for a diverse response to corticosterone even within the same 
cell. Because of the importance of corticosteroid-mediated activity in anxiety and 
depressive disorders, it is critical to understand the individual roles of forebrain MR and 
GR in HPA axis regulation and control of affect. 
The traditional view posits that, because of its high affinity and low capacity, 
activation of MR is essential for maintenance of the basal circadian rhythm, whereas 
activation of GR is required for the stress response and the subsequent recovery of 
homeostasis via negative feedback (De Kloet and Reul 1987). However, more recent 
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studies suggest that MR activity is required in conjunction with GR at the peak of the 
circadian rhythm and during times of stress (Bradbury, Akana et al. 1994) or that MR 
alone can mediate negative feedback in response to various challenges (Reul, Probst et al. 
1997; Arvat, Maccagno et al. 2001; Wellhoener, Born et al. 2004). These results are 
consistent with MR antagonist studies in humans that demonstrate a clear role for MR in 
HPA regulation and increased MR function in depression (Young, Lopez et al. 1998; 
Young, Lopez et al. 2003). In contrast, recent findings in forebrain specific MR-deficient 
mice show no alterations in HPA axis activity under basal or stress activated conditions 
(Berger, Wolfer et al. 2006). Clearly, additional studies are required to elucidate the role 
of MR both in HPA function and in the modulation of affective responses.  
In addition to the roles of MR and GR in HPA axis regulation, research over the 
last decade has suggested a potential role of these molecules in modulation of anxiety. 
The evidence is clearest for GR, as genetic manipulation has shown that decreased GR 
signaling in the brain results in decreased anxiety-like behavior (Montkowski, Barden et 
al. 1995; Tronche, Kellendonk et al. 1999), whereas overexpression of GR in the 
forebrain results in increased anxiety-like behavior (Wei, Lu et al. 2004). MR antagonist 
application directly into the hippocampus (Smythe, Murphy et al. 1997; Bitran, Shiekh et 
al. 1998) or brain in general (Korte, de Boer et al. 1995) suggest a similar anxiogenic role 
for MR either exclusively or in conjunction with GR. However, these effects are transient 
and do not address whether sustained alterations of MR would be anxiogenic or 
anxiolytic.  
To specifically examine the role of MR in corticosteroid-mediated basal and 
stress induced feedback regulation of the HPA axis and/or anxiety-like behaviors, we 
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generated transgenic mice that overexpress forebrain MR (MRov). In this system, the 
calcium-dependent calmodulin kinase IIα (CaMKIIα) promoter is used to direct 
expression of MR specifically to forebrain regions. This promoter is not expressed 
prenatally, preventing overexpression of MR during development. In contrast to the 
forebrain specific MR-deficient mice, we find that overexpression of MR in the forebrain 
does impact stress-induced regulation of the HPA axis in female mice, and results in a 
reduction in anxiety-like behavior in both male and female mice. These data highlight the 
differential roles for MR and GR in the modulation of anxiety-related behaviors and 
suggest a more prominent role for MR in HPA axis regulation. 
 
Materials and Methods: 
Complementary DNA (cDNA) Cloning.  To isolate a mouse brain MR cDNA, a 700 bp 
StuI/XbaI fragment from the rat MR cDNA (provided by Paresh Patel, University of MI) 
was used to screen a UniZAP XR mouse brain cDNA library (Stratagene, La Jolla, CA). 
Approximately 850,000 phage were screened under conditions previously described 
(Cortright, Nicoletti et al. 1995).  In vivo excision of the pBluescript phagemids 
containing the hybridization-positive cDNA clones was performed according to the 
manufacturer’s protocol.  Eight clones were isolated and characterized by restriction 
digests and DNA sequence analysis. The University of Wisconsin Genetics Computer 
Group (Madison, WI) Sequence Analysis Software Package was utilized for sequence 
alignments.  The resulting full -length cDNA clone pMR-2A was used for subsequent 
experiments.   
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Generation of 3XFlag-Tagged MR and Transgenic Mice.  The endogenous MR 
translation start codon was replaced with a Kozak sequence and an N-terminal 3XFlag-
tag sequence  (ACCATGGACTACAAAGACCATGACGGTGATTATAAAGAT 
CATGACATCGATTACAAGGATCATGATGGT) using a PCR based cloning strategy.  
A BsgI/PshAI fragment containing the 3XFlag-tag N-terminus was used to replace the 
unmodified BsgI/PshAI site of pMR-2A to generate pMR2AFlag. The MR2AFlag coding 
sequence was cloned into the EcoRV site of pNN265, which flanks the insert with a 
5’UTR+intron and a 3’ UTR+polyadenylation signal sequence, to create pNN265-
MR2AFlag. The full-length non flag-tagged MR cDNA was also cloned into pNN265, 
which allows for the expression of the inserts from a minimal CMV promoter.   The NotI 
fragment of pNN265-MR2AFlag containing the MR2AFlag coding sequence plus 
surrounding 5’ and 3’ regulatory sequences was cloned into the NotI site of pMM403, 
which places the fragment under the control of the CaMKIIα promoter (Mayford, Bach et 
al. 1996), to generate pMM403-MR2AFlag. pMM403-MR2A-Flag was digested with Sfi 
I and the 14.5kb insert was purified and injected into (C57Bl/6J x SJL) F2 mouse eggs by 
the University of Michigan Transgenic Animal Core.  Ten transgenic founders were bred 
to C57BL6J mice, and 7 lines were established. Transgenic mice were maintained as 
hemizygotes and wildtype littermates were used as controls in all experiments.  Genomic 
DNA prepared from tail biopsies was screened for the presence of the transgene by PCR.  
The transgene primers for genotyping are: 5’-GTT CTT CTC TTG GAC CTG CAG-3’ 
and 5’-CCG CCA GTC CAG CGG TAA G-3’.  The β−globin primers are 5’-CCA ATC 
TGC TCA CAC AGG ATA GAG AGG GCA GG-3’ and 5’-CCT TGA GGC TGT CCA 
AGT GAT TCA GGC CAT CG-3’.  PCR reactions contained both sets of primers (30 
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cycles of 1min @ 94, 1.5 min @65, and 1.5 min @72 C, followed by a terminal 10 min 
extension @72 C).  PCR products are 727 bp for the MR transgene and 450 bp for β-
globin internal control. 
 
Animal Husbandry:  Mice were maintained on a 14:10 light/dark schedule with lights 
on between 6:00 and 20:00.  Mice were given food (5008 mouse chow, 9% fat content; 
Purina Mills, Inc., St. Louis, MO) and water ad libitum.  C57BL/6J (The Jackson 
Laboratory, Bar Harbor, ME) mice were bred at the University of Michigan.  All 
procedures using mice were approved by the University of Michigan Committee on Use 
and Care of Animals.  All experiments were conducted in accordance with the principles 
and procedures outlined in the National Institutes of Health guidelines for the Care and 
Use of Animals. 
 
Cell Culture and Transfection.  CV-1 and Cos-1 cells were maintained in DMEM 
Invitrogen) containing 10% heat-inactivated FCS (Hyclone, Logan, UT) at 37C and 5% 
CO2.   To examine the possible effects of the addition of the 3X Flag tag to the N-
terminus of MR, both transactivation and binding assays were performed.  Twenty-four 
hours prior to experiments, 2.5x105 or 3-5x105 cells were plated in media containing 10% 
charcoal-stripped serum on 6 cm plates (for transactivation assays) or 10 cm plates (for 
binding assays), respectively.  For the transactivation assays, CV-1 cells were transfected 
with 5μg of 5GRE-Luc reporter plasmid, 1μg CMV β-galactosidase, and 1μg of either 
pNN265-MR2aFlag or pNN265-MR2a using Fugene-6 Transfection Reagent (Roche 
Diagnostics, Basel, Switzerland) according to the manufacturer’s protocol.  The 
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CMVβgal expression vector was included for normalization purposes.  Twenty-four 
hours post transfection cells were either left untreated or treated with either 10nM 
aldosterone or 100nM corticosterone (Sigma-Aldrich, St. Louis, MO.  Cells were 
harvested 24 h later in cold 1X PBS, pelleted, and lysed in 100μl lysis buffer [0.25 M 
Tris (pH 8.0), 0.1 mM EDTA, 15 mM MgSO4, 1 mM dithiothreitol (DTT), and 1% 
Triton X-100] and incubated on ice 10 min.  Lysates were centrifuged at 10,000 rpm for 
10 min at 4 C, and 10μl of each supernatant was added to 100μl of luciferase assay buffer 
(20 mM Tris (pH 8.0), 1.07 mM magnesium carbonate, 2.67 mM magnesium sulfate, 0.1 
mM EDTA, 33.3 mM DTT, 0.27 mM Coenzyme A (Calbiochem, San Diego, CA), 0.53 
mM ATP, and 0.47 mM luciferin (Analytical Luminescence, Ann Arbor, MI)) and 
assayed for 10 sec in a Turner 20/20 (Promega, Madison, WI) luminometer.  β−gal 
activity was determined as previously described (Seasholtz, Thompson et al. 1988) For 
the binding assays, Cos-1 cells were transfected with 5μg of either the pMM403-
MR2AFlag or pMM403-MR2A expression constructs.  40 hours later, cells were 
harvested and resuspended in TEMDG (20 mM Tris/1 mM EDTA/20 mM sodium 
molybdate/5 mM DTT/10% glycerol/10% Sigma Protease Inhibitor Cocktail, pH 7.6 at 
4°C) binding buffer.  After a brief sonication (setting 4 for 5 seconds with a Branson 
Sonifier 150), samples were centrifuged at 4°C at 16,100Xg for 30 min.  Lysates were 
incubated, in triplicate, for 20 hours at 4°C with 7 serial 1:2 dilutions of 3H corticosterone 
plus or minus an excess of unlabeled corticosterone for determination of nonspecific 
binding.  Bound and free [3H]corticosterone levels were separated by addition of an ice-
cold dextran/charcoal suspension in TEMDG (0.05/0.5%).  The tubes were incubated 10 
min at 0-2°C and centrifuged.  The supernatants were removed and counted in a Packard 
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scintillation counter at 45% efficiency.  Protein content was measured by method of 
Bradford (Bradford 1976) using BSA as a standard, and the receptor densities were 
expressed as fmol/mg protein.  The dissociation constant (Kd) of MR was calculated by 
Scatchard analysis. 
 
Immunoprecipitations and Western Blots. To analyze whole-cell MR2A-Flag protein 
levels, tissues were homogenized in TEMS buffer (50mM Tris, 1mM EDTA, 6mM 
MgCl2, 10% sucrose, pH 7.2 @ 4C) in a glass dounce homogenizer on ice and then 
sonicated briefly (5 sec setting 4 of Branson sonifier 150). Lysates were centrifuged at 
4°C at 16,100Xg for 30 min to remove cellular debris; supernatants were assayed for 
protein concentration.  One hundred μg of protein/sample (exceptions: pituitary, 40μg, 
and hypothalamus, 80μg) was immunoprecipitated with 1 μg of a polyclonal anti-flag 
antibody (Sigma) in a total volume of 200μl for 2 hours at 4°C on a rocking platform.  
Twenty μl of re-suspended protein G coated beads (Santa Cruz, Santa Cruz, CA) was 
then added to each sample and incubated overnight as above.  Samples were centrifuged 
at 1000Xg at 4°C.  The tissue lysate was removed and saved for loading control 
immunoblot analysis, and the protein G coated beads were washed with cold PBS 
(repeated 2x).  Samples were then resuspended in PBS and brought to a final volume of 
20μl with 5x SDS loading dye, boiled 5 minutes, and iced 5 minutes.  Resuspended 
immunoprecipitates were separated on a 10% SDS-PAGE gel and transferred onto PVDF 
membranes with a Bio-Rad Trans-Blot SD semi-dry transfer system.  For immunoblots, 
membranes were blocked in a buffer containing 20mM Tris pH 7.5, 150mM NaCl, and 
0.1% Tween 20 (TBST) + 5% non-fat dry milk (NFDM), for 1hr at room temperature, 
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then incubated for 1hr at room temperature with an HRP-linked anti-Flag antibody 
(Sigma) at 1:6000.  For control immunoblot analysis, 10 μl of the tissue lysates were used 
for Western blotting with a monoclonal anti-β-tubulin antibody (Sigma) and an HRP 
linked donkey-anti mouse secondary antibody as described above.  Immunoblots were 
visualized with ECL Plus (Amersham Biosciences, GE Healthcare) according to the 
manufacturer’s protocol.  Control immunoblot analysis revealed comparable levels of β-
tubulin signal in similar brain regions from the different transgenic lines and wildtype 
control (data not shown). 
 
In Situ Hybridization. In situ hybridization was performed as previously described 
(Herman, Wiegand et al. 1990).  The high-stringency wash for all probes was done in 
0.1x SSC at 65°C.  Riboprobes for MR were synthesized from pGem11zASMR, which 
contains a 277bp StuI/NcoI fragment of the mouse MR N-terminal region containing 
nucleotides 940-1217 from accession number XM_983321.  pGem11zASMR was 
linearized with EcoRI and antisense riboprobes synthesized with SP6.  Riboprobes for 
CRH were synthesized from pGem4zPST578 (Seasholtz 1991) that contains a 578 bp 
PstI fragment of the mouse CRH exon II.  PGem4zPST578 was linearized with HindIII 
and antisense riboprobes synthesized with SP6 RNA polymerase.  Antisense riboprobes 
for hnCRH were synthesized from pGem4zKpn/PvuII442, containing CRH intronic 
sequences (nucleotides 569 to 1011 from accession number AY128673), using SP6 RNA 
polymerase and plasmid that was linearized with HindIII.  Riboprobes for mouse GR 
were synthesized from mGR600, which contains a 596 bp Bst217I/XbaI mouse cDNA 
fragment containing nucleotides 1-596 from NM_008173.  EcoRI was used to linearize 
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mGR600 and antisense probes were synthesized with T3 RNA polymerase.  r5HTr1a 
riboprobes were synthesized from a 905 bp MscI/PvuII rat cDNA fragment containing 
nucleotides 212-1117 from NM_012585.  The plasmid was linearized with EcoRI and 
antisense probes were generated with SP6 RNA polymerase.  The probe used to 
specifically detect expression of the transgene (tg probe) was generated by PCR using 
primers 5’-GGT GTC CAC TCC CAG GTC CAA CTG C-3’ and 5’-CAT TCA GAA 
AAC TGA ATT AAA TCT A-3’ and pMM403-MR2A-Flag as DNA template.  This 
190bp PCR product encompasses the vector-encoded 5’ UTR region that will be specific 
to the transgene mRNA only and will not hybridize to any region of MR. This plasmid 
was linearized with EcoRV and SP6 RNA polymerease was used to generate antisense 
probes.  All riboprobes were double labeled with [35S]UTP and [35S]CTP (Perkin Elmer) 
using standard transcription reaction conditions.  Radiolabeled cRNA robes were purified 
from free nucleotides using Bio-Rad Micro Bio-Spin 6 columns. Semi-quantitative 
analysis of autoradiogram images was performed using the MCID image analyses system 
and Image J (NIH). Optical density measures were corrected for background to yield 
mean grey levels which were multiplied by the area sampled to produce an integrated 
density measurement.   
 
In Vitro Receptor Autoradiography. [3H]-8-Hydroxy-2-(N,N-di-N-propylamino-
tetralin) ([3H]-8-OH-DPAT) binding to detect 5HT-1a receptors was performed as 
previously described (Lopez, Chalmers et al. 1998). Sections were apposed to tritium 
sensitive film (Amersham) and exposed at room temperature for 13 days. Semi-
quantitative analysis of autoradiogram images was performed using Image J. 
 
    57
Behavioral Testing. All behavioral tests were performed with an n = 14-20 
animals/genotype/sex and all tests were repeated with a second cohort of mice. Male and 
female mice were individually housed for at least 7 days before the beginning of 
behavioral testing.  All testing was performed between 6:30 and 13:00. The following 
testing order was used: open field (three consecutive days) and elevated plus maze 3 days 
later. All behavior was scored manually by investigators blinded to the phenotype of the 
animal. Open Field Test:  General locomotor activity was measured in a 42 × 42 cm 
cage using the Digiscan Activity Monitor (Accuscan Instruments).  Activity was 
measured for 15 min for 3 consecutive days.  Total distance traveled and time in the 
center of the open field were measured automatically by the Digiscan Software Program 
(Accuscan Instruments). Elevated Plus Maze:  The EPM consisted of four arms (27 × 6 
cm) arranged in a plus form, and elevated 50 cm above the floor. Two opposing arms 
were surrounded on three sides with 15-cm-high clear Plexiglas walls (closed arms) and 
the other arms were left open (open arms).  Mice were placed in the center of the maze 
facing an open arm and behavior was monitored for 5 minutes.  
 
Blood Collection, RIA, Basal and Acute Stress Analysis. Plasma was isolated as 
previously described (Burrows, Nakajima et al. 1998) and plasma corticosterone and 
ACTH levels were determined with MP Biomedicals kits (Orangeburg, N.Y.). For basal 
A.M. and P.M. hormone levels, blood was collected within 1-2 hours of lights on and 30-
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Statistical Analysis. All statistical analyses were performed by t tests and ANOVA.  
Two-factor ANOVA was performed on in situ assays for MR and 5HT-1a (genotype x 




Generation of forebrain specific MR overexpressing mice.  To generate transgenic 
mice that overexpress MR specifically in the forebrain (MRov), we used the previously 
described CaMKIIα promoter (Mayford, Bach et al. 1996) to direct expression of a 3X 
Flag-tagged MR cDNA. The 3X Flag epitope tag was added at the N-terminus of MR to 
allow detection of transgene-directed MR (Figure 2-1A). The addition of the 3X Flag 
epitope did not significantly alter the transcriptional activation properties of MR (Figure 
2-1B), and MR and Flag-MR showed similar transactivation profiles across 
corticosterone concentrations from 10 pM to 100 nM (data not shown).  The binding 
properties of MR and Flag-MR expressed in vitro were also not significantly different 
(Figure 2-1C). The transgene construct was then utilized for production of transgenic 
mice. 
In situ hybridization (ISH) analysis using both MR and transgene specific probes 
(delineated in Figure 2-2A) was used to determine the sites of transgene expression in 10 
different founder lines. Of these 10 lines, only 7 expressed the transgene. Transgene-
directed MR expression was localized largely to the hippocampus and cortex, with 
varying intensities of expression in these regions seen between the different lines (data 
not shown). As expression patterns were similar in most lines, lines 743 and 709 were  
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Figure 2-1 Transgene construct and properties of Flag-MR. 
(A) Schematic of transgene construct. The CaMKIIα promoter directs expression of a 3X 
Flag-tagged mouse MR cDNA. Arrows represent the location of the primer pair used for 
PCR genotyping. The two bars represent the locations of the two probes used for in situ 
hybridization analysis (TG = transgene specific, MR = endogenous MR + transgene 
directed MR). NTD = N-terminal domain, DBD = DNA binding domain, and LBD = 
ligand binding domain. (B) Transactivation of GRE-Luciferase by MR vs. Flag-MR. CV-
1 cells were transfected with MR, Flag-MR or vector alone, GRE-Luciferase, and CMV-
βgal. 24 hours later cells were treated with drugs for an additional 24 hours 
(corticosterone = 100nM, aldosterone = 10nM). Normalized luciferase activity (luciferase 
activity/βgal activity) for samples was divided by their respective no drug control to 
result in fold induction of reporter gene activity. The data are presented as the mean ± 
S.E.M. and represent 3-5 independent experiments done in duplicate. (C) Ligand binding 
properties of MR vs. Flag-MR. Cos-1 cells were transfected with MR or Flag-MR. Cells 
were harvested after 40 hours and 3H corticosterone was used to determine dissociation 
constants (Kd) for MR and Flag-MR in 5 independent Scatchard analyses. Data represent 
mean ± S.E.M.  
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selected for further analysis. ISH with sagittal sections demonstrated that MR transgene 
mRNA was detected specifically in forebrain regions (Figure 2-2A). RT-PCR 
experiments using RNA from brain and peripheral tissues revealed no transgene 
expression outside of the forebrain (data not shown). While transgene mRNA was widely 
expressed in cortex and all subfields of the hippocampus, ISH experiments with a 
transgene specific probe showed no expression of the transgene in either the PVN (Figure 
2-3) or the amygdala of MRov mice, additional sites of endogenous MR expression 
(Arriza, Simerly et al. 1988; Ahima, Krozowski et al. 1991; Han, Ozawa et al. 2005). 
Western analysis using tissue prepared from different brain regions and a transgene 
specific anti-Flag antibody confirmed the presence of transgene directed Flag-MR protein 
in hippocampal and cortical regions for both lines (Figure 2-2B) consistent with in situ 
hybridization results. The very low levels of Flag-MR protein seen in the hypothalamus 
and hindbrain/cerebellum (HB) lanes for line 743 females were not observed in additional 
analyses, consistent with the lack of transgene specific mRNA in these regions. 
To determine whether transgene expression in the hippocampus of MRov mice 
resulted in overexpression of total MR mRNA relative to wildtype littermates, ISH 
experiments using an MR specific probe that detects both endogenous and transgene 
directed MR were performed using both wildtype and transgenic male and female mice 
(Figure 2-2C, line 743). ANOVA analysis reveals a significant effect of genotype (p < 
0.05) in all sub-regions of the hippocampus (CA1, CA2, CA3 and Dentate Gyrus (DG)) 
with MRov mice exhibiting greater levels of expression, and no gender effects in any of 
the sub-regions. If the data are analyzed separately to compare either male or female 
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Figure 2-2 Forebrain specific transgene expression in MRov mice. 
(A) ISH with MR and transgene-specific (TG) probes on sagittal sections from WT and 
two different MRov founder lines reveals forebrain specificity of transgene expression. 
(B) Western blot analysis with anti-Flag antibody confirms expression of transgene in 
forebrain regions of both male and female mice.  Regions include hippocampus (Hip), 
hypothalamus (Hyp), cortex (Ctx), hindbrain/cerebellum (HB), and pituitary (Pit). (C) 
Representative pseudo-colored ISH images with an MR specific cRNA probe show 
overexpression of MR mRNA in sub-regions of the hippocampus (blue = low expression 
and red = high expression). Quantitation represents Integrated Optical Density (IOD) 
analysis of 4-5 animals/genotype/sex and 9-14 sections/animal. Data are presented as 
mean ± S.E.M. and * = P < 0.05 by t-test. 
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Figure 2-3 Transgene expression is not found in the hypothalamus of MRov mice. 
ISH analyses with a transgene specific cRNA probe show clear expression of the 
transgene in the hippocampus (slides 34 and 35) and cortex, with no detectable 
expression of the transgene mRNA in the PVN.  Cresyl violet stains of boxed regions 
indicate that slides 7, 5 and 10 contain the PVN (arrows). 
 
    63
transgenics with their respective wildtype littermates, a significantly higher expression of 
total MR mRNA in CA1, CA2, and CA3 (p < 0.05 for each sub-region) in female MRov 
mice was seen. In male transgenic mice, a significant increase in MR mRNA was seen 
only in CA2 (p < 0.05), with a trend towards increased MR mRNA in CA3 (p = 0.06). In 
a second set of ISH studies, where males and females were analyzed in separate 
experiments, similar results were obtained. The mean grey levels from this experiment 
(not corrected for area) (Figure 2-4) show that MR mRNA levels for transgenic and 
wildtype mice are greatest in CA2 and DG. 
Together, these data demonstrate that transgenic MRov mice overexpress 
hippocampal MR mRNA by approximately 20-25% relative to wildtype littermate 
controls, representing a physiologically relevant increase in expression in vivo.  
Moreover, female mice tend to show more areas of hippocampal overexpression than 
males. As shown above, the MRov mice also express significant levels of MR in the 
cerebral cortex, a site of increased MR expression in primates, allowing potential 
functional interactions of MR alone or with GR in additional cortical sites.  
 
Normal basal HPA axis activity, but sexually dimorphic corticosterone release in 
response to restraint stress in MRov mice. The traditional view of MR function in 
HPA axis control suggests a primary involvement in the maintenance of basal tone with 
little to no role in the response to stress. To assess the effects of forebrain MR 
overexpression on basal HPA axis activity, circadian trough and peak corticosterone 
levels were determined. Plasma samples from transgenic line 743 and wildtype 
littermates were collected 1-2 hours after lights on or 30-60 minutes before lights off.
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Figure 2-4 Increased expression of MR mRNA in hippocampus of MRov mice. 
ISH analyses of a second cohort of female (A) and male (B) MRov mice from line 743 
with an MR specific cRNA probe reveals increased levels of MR in a subregion-specific 
manner.  Quantitation represents analyses of mean gray levels (instead of IOD) of 4-5 
animals/genotype/sex and 6-12 sections/animal for females and 11-15 sections/animal for 
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There were no differences between transgenics and wildtype littermate controls for either 
sex at the nadir of the circadian rhythm (Figure 2-5A). In two independent experiments, 
corticosterone levels were 20-27% lower in both male and female transgenic mice at the 
peak of the circadian rhythm, however this did not reach significance (Figure 2-5B, 
experiment 1 shown, 20 and 22% reductions, respectively). Because all anxiety-like 
behavior tests constitute mild stressors, we also assessed corticosterone levels in MRov 
mice under mild stress conditions. Plasma samples were collected 10 minutes after a 5-
minute exposure to the elevated plus maze; no significant differences between 
transgenics and wildtypes were observed for either sex (data not shown). To assess HPA 
axis function in response to more intense stressor, male and female transgenic and 
wildtype mice were subjected to 30 min. of restraint stress. Plasma samples were 
collected at 0, 20, 40, and 60 minutes (Figure 2-5C). There was no significant difference 
in corticosterone levels between male transgenic and wildtype mice. Female transgenic 
mice, however, exhibited a moderate suppression of the corticosterone response to stress 
throughout the stress and recovery timepoints compared to wild-type littermates (p < 
0.05); no significant differences were observed in ACTH levels.  These results 
demonstrate a sexually dimorphic corticosterone response to restraint stress in the MRov 
mice. 
 
MRov mice exhibit decreased anxiety-like behavior. Previous studies using icv MR 
antagonist administration in rats suggest that temporary blockade of MR in the brain 
results in decreased anxiety (Korte, de Boer et al. 1995; Smythe, Murphy et al. 1997), 
suggesting that increased MR signaling would be anxiogenic. To further address the role
 




are needed to see this picture.
 
Figure 2-5 Normal basal HPA axis activity but sexually dimorphic suppression of 
corticosterone release in response to restraint stress. 
Basal A.M. corticosterone levels (n = 4-5/genotype/sex). (B) basal P.M. 
corticosterone levels (n = 5-6/genotype/sex). (C) Restraint stress-induced 
corticosterone release in male and female MRov and wildtype mice in the A.M. 
Female MRov mice exhibit a moderate suppression of the corticosterone response to 
stress over the stress and recovery time course. ANOVA analysis reveals a significant 
difference due to genotype, p = 0.029  (n = 4-10/genotype/timepoint). 
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of constitutive forebrain MR overexpression in anxiety-like behavior, MRov mice were 
analyzed in a series of behavioral paradigms. These include general locomotor activity 
and time in the center of the open field, in addition to the elevated plus maze (EPM). 
Transgenic and wildtype mice of both sexes were initially tested for general locomotor 
activity for 15 minutes in the open field for 3 consecutive days. These data were collected 
in five 3-minute bins per day. As subsequent behavioral tests are 5 minute tests, only the 
first 2 bins (6 minutes) are presented. For line 743, the results show that MRov and 
wildtype mice both habituate normally to the open field and do not reveal any changes in 
general locomotor activity over the testing period (Figure 2-6A). Thus, forebrain MR 
overexpression does not result in any generalized locomotor alterations that could 
obscure further behavioral analyses. 
To determine the consequences of forebrain overexpression of MR on anxiety-
like behaviors, the time spent in the center of the open field was determined for male and 
female MRov and wildtype mice. MRov mice of both sexes exhibited increased time in 
center on days two and/or three of testing, an indicator of decreased anxiety-like behavior 
(Figure 2-6B). Male and female MRov mice and wildtype controls were also tested on 
the EPM, a widely used test of anxiety-like behavior. Male MRov mice spent a signi-
ficantly greater percentage of time in open arms of the EPM compared to wild-type 
controls (p < 0.05, Figure 2-6C). The latency to first entry on the open arm was signifi-
cantly less in male MRov mice compared to wt (p < 0.05). In an independent group of 
animals, significant differences were observed in these two measures in addition to show-
ing a significant increase in percent open arm entries (data not shown). Over two rounds 
of testing, female MRov mice spent a significantly greater percentage of time in open
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Figure 2-6 Reduced anxiety-like behavior in forebrain MRov mice. 
(A) Three days of open field exposure show normal habituation and no changes in 
locomotor activity in either male or female line 743 MRov mice (first 6 minutes of 
activity shown). (B-C) Anxiety-like behavior measures in male and female MRov mice. 
(B) Open field activity reveals increased center time on days 2 and/or 3. (C) MRov mice 
show decreases in measures of anxiety-like behavior on the EPM, with significant 
changes in % Open Arm Time, % Open Arm Entries (females only), and Open Arm 
Latency.  Data represent mean +/- S.E.M. of 19-40 animals/genotype/sex and * = p < 
0.05. 
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arms of the EPM compared to wildtype controls (p < 0.05, Figure 2-6C). They also 
showed a significant increase in the percent of open arm entries (p < 0.05) and a 
significant decrease in the latency to the first entry on an open arm (p = 0.05).  
To rule out the possibility of insertion site effects, most of these behavioral 
experiments were repeated in another line of MRov mice (line 709). While the phenotype 
was not as pronounced in line 709 as it was in line 743, there were many similarities, 
suggesting that the decreased anxiety-like behavior is not due to an insertion site effect 
(Figure 2-7). 
 
Basal expression of genes associated with HPA axis activity. We hypothesized that the 
constitutive overexpression of MR in forebrain regions might result in altered expression 
of genes associated with HPA axis activity and anxiety-like behaviors. To address this 
hypothesis, the basal or stress-induced expression patterns of CRH and hnCRH in PVN, 
GR in hippocampus and PVN, and 5HT-1a in hippocampus were analyzed by in situ 
hybridization in MRov mice.  Region CA1 of the hippocampus showed a significant 
decrease in the expression of GR mRNA in male MRov mice (p < 0.05), while in female 
MRov mice, this same region showed a non-significant trend towards decreased GR 
mRNA (p = 0.11, Figure 2-8A).  This effect was selective to the hippocampus as no 
significant changes in GR mRNA levels were observed in the PVN (Table 2-1). There 
were also no significant changes in the expression of steady-state CRH mRNA levels in 
the PVN of male and female transgenic mice and no changes in hnCRH in the PVN of 
transgenic mice after 20 minutes of restraint stress for either sex (Table 2-1). 
Interestingly, both male and female MRov mice showed a significant increase in 
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Figure 2-7 Assessment of anxiety-like behavior on EPM in line 709 MRov female 
and male mice. 
Whereas line 709 expressed increased levels of Flag-MR compared to line 743 on 
immunoblot analaysis, in situ hybridization studies showed that total hippocampal MR 
mRNA in line 709 was increased over wild type (wt), but similar to or less than 
hippocampal MR mRNA levels in line 743.  Endogenous MR expression was likely 
decreased in line 709 in response to increased Flag-MR as part of a compensatory 
mechanism, consistent with autologous regulation of MR expression (38). The modest 
increase in total MR mRNA in line 709 may explain why the behavioral changes are less 
dramatic in this line than in line 743.  (A) Decreased anxiety-like behavior in line 709 
female MRov mice with decreased open arm latency, and a trend towards increased % 
open arm time on the EPM.  (B) Line 709 male MRov mice show nonsignificant changes 
in the same directions as line 709 female MRov mice.  Data represent mean +/- S.E.M. of 
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Figure 2-8 Altered expression of GR and 5HT1a in MRov mice. 
(A) ISH analyses with a GR specific probe show a decrease in GR mRNA in region CA1 of the hippocampus of male MRov mice and 
a trend towards decreased GR in region CA1 of female MRov mice with n = 5 animals/genotype/sex, and 12-16 sections/animal for 
males and 7-9 sections/animal for females. (B) ISH with a 5HT-1a specific probe shows significantly increased levels of the receptor 
mRNA in the CA1 of male and female MRov mice with n = 4-5 animals/genotype/sex, and 9-12 sections/animal. * = p < 0.05, = = p = 
0.11.  (C) 5HT-1a receptor binding with [3H]-8-OH-DPAT shows significantly increased levels of binding (** = p = 0.0004) with n = 








Table 2-1 HPA axis gene expression profiles 
  
Male   
PVN WT MRov 
basal GR 15,779 ± 2070 11,208 ± 1,470    
basal CRH 24,921 ± 5,471 21,183 ± 4,274 
hnCRH 38,157 ± 2,932 40,314 ± 1,279 
Female   
PVN   
basal GR 23,048 ± 2,872 24,757 ± 1,683 
basal CRH 27,911 ± 3,319 26,277 ± 2,108 
hnCRH 38,591 ± 3,749 34,900 ± 4,095 
 
GR, CRH, and stress induced hnCRH RNA expression in PVN of male and female MRov 
mice.  Quantitation was performed as described in Materials and Methods.  Data are 
presented as the mean ± S.E.M. in integrated optical density units obtained from ISH 
analyses.   Male and female ISH results were obtained in independent experiments. 
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the expression of 5HT-1a mRNA in region CA1 of the hippocampus (Figure 2-8B, p < 
0.05). The transgenic mice also showed an increase in [3H]-8-OH-DPAT binding in CA1 
(Figure 2-8C, WT = 0.71 and TG = 0.76, p = 0.0004), consistent with elevated levels of 
5HT-1a protein. The relative change in 5HT-1a receptor binding was less than the change 
in mRNA levels, consistent with previous studies (Korte, Meijer et al. 1996). Together, 
these results suggest that overexpression of MR in the forebrain alters the basal mRNA 




In this study, we characterize anxiety-like behaviors and the HPA axis of 
transgenic mice with chronic forebrain-specific overexpression of MR. We show that 
chronic elevations of forebrain MR result in decreased anxiety-like behaviors in both 
male and female transgenic mice. We also demonstrate that increased levels of forebrain 
MR result in a moderate suppression of the stress response in female transgenic mice, 
suggesting that, at least in females, MR contributes to negative feedback information 
during a stressful event. Furthermore, MR overexpression alters mRNA levels of two 
genes associated with stress and anxiety, increasing hippocampal 5HT-1A and decreasing 
hippocampal GR expression. This latter change results in a significantly altered MR:GR 
ratio in certain areas of the hippocampus. Our findings suggest that the functions of 
forebrain MR overlap with GR in HPA axis regulation but counterbalance GR in 
modulation of anxiety related behaviors. 
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Anxiety-like behavior.   
Both male and female MRov mice exhibit a decreased anxiety-like behavior 
phenotype. These data are at odds with a series of antagonist studies that suggest that MR 
activation plays an anxiogenic role either alone or in combination with GR. There are, 
however, two prominent changes at the molecular level in the MRov mice that may 
account for this result. First, forebrain GR plays an anxiogenic role in several genetic 
models of altered GR levels (Montkowski, Barden et al. 1995; Tronche, Kellendonk et al. 
1999; Wei, Lu et al. 2004) and it is downregulated in certain hippocampal areas of the 
MRov mice, consistent with MR-mediated downregulation of GR (Herman and Spencer 
1998). Thus, it is possible that overexpression of MR in the forebrain of MRov mice 
reduces anxiety behavior through a decrease in GR function, or through alterations of the 
GR/MR ratio which has been proposed to have functional import (De Kloet, Vreugdenhil 
et al. 1998). Second, decreased anxiety-like behavior in the MRov transgenic mice may 
result from the increased expression of 5HT-1a in CA1 of both male and female MRov 
mice. Multiple genetic manipulation studies of 5HT-1a suggest that this receptor plays an 
anxiolytic role, and that post-synaptic sites of 5HT-1a, such as the hippocampus, mediate 
the anxiolytic effects (Gordon and Hen 2004).  
The increased expression of 5HT-1a receptor in the hippocampus of MRov mice 
was not predicted as 5HT-1a receptors are under tonic inhibition by corticosterone in vivo 
(Chalmers, Kwak et al. 1993), and studies by de Kloet (De Kloet, Sybesma et al. 1986) 
suggest that MR is the primary inhibitor of 5HT-1a expression. In addition, in vitro 
studies show direct repression of 5HT-1a promoter activity by binding of MR and GR as 
both homo- and heterodimers to a novel negative glucocorticoid responsive element 
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(nGRE) in the rat 5HT-1a promoter (Ou, Storring et al. 2001). Multiple hypotheses can 
be proposed to explain the observed increase in hippocampal 5HT-1a in MRov mice. 
First, while adrenalectomy studies are short term, MRov mice experience chronically 
elevated levels of MR for most of their lives. Hence, while the decrease in corticosterone 
levels seen at the PM time point in male and female MRov mice is not statistically 
significant, it may, over the course of the lives of the animals, represent a significant 
biological decrease in glucocorticoid signaling that allows for enhanced 5HT-1a 
expression in the hippocampus. There may, in addition, be a critical developmental time 
window during which MR overexpression may result in lifelong changes in serotonin 
receptor expression.  Moreover, the change in hippocampal MR/GR ratio in MRov mice 
may affect the expression pattern of 5HT-1a through altered signaling on the 5HT-1a 
promoter directly or through an indirect mechanism such as changes in expression of 
other transcription factors. While the mechanism remains to be elucidated, it is evident 
that chronic MR overexpression results in downstream changes that have different 
molecular and behavioral outcomes from short-term alterations in MR signaling. Of note 
is that the change in MR expression is relatively subtle and may well occur in the context 
of normal variability in gene expression. That such a modest and localized change in 
gene expression can result in lifelong changes in responsiveness to affective stimuli 
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HPA axis regulation: 
Several extra-hypothalamic sites have been shown to inhibit HPA axis activity in 
a corticosterone-dependent manner including the hippocampus (Kovacs and Makara 
1988; van Haarst, Oitzl et al. 1997) and the cingulate cortex (Diorio, Viau et al. 1993), 
both of which express MR and GR. While it is clear that GR in these forebrain sites is 
important for HPA axis inhibition (Boyle, Brewer et al. 2005), the contribution of MR to 
HPA axis feedback post-stress or at the peak of the circadian rhythm is currently under 
debate. Female MRov mice, which have increased levels of MR compared to wt controls 
in cortex and in all sub-regions of the hippocampus do not exhibit significant alterations 
in basal corticosterone levels, or an altered endocrine response to mild stress. However, 
they do show a small but significant attenuation in their response to restraint stress. 
These data suggest that as MR becomes progressively more occupied in female 
MRov mice, it is capable of inhibiting the stress response and to a lesser degree, the pm 
corticosterone levels. Recent data from Kalman et. al. (Kalman and Spencer 2002) 
support the potential biological relevance of this overexpression model. They find that 
MR occupation at the nadir of the circadian rhythm is closer to 50% rather than the 
previously thought 90%, suggesting a more dynamic capability of MR signaling in 
response to stress (Kalman and Spencer 2002). 
The in situ hybridization data show that, relative to wildtype mice, female 
transgenic mice show a greater percent increase in MR mRNA than the male mice. This 
result suggests that a threshold mechanism may be in place, where the percent change in 
MR may be important for its relative contribution towards negative feedback during a 
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stressful event.  This may account, in part, for the sexually dimorphic alteration in stress 
response observed in the MRov model.   
 
Comparison with MR knock-out models: 
In 1998, mice were generated that lack MR globally, but these mice die of 
dehydration by postnatal day 10 due to renal sodium and water loss, not allowing for 
behavioral analyses (Berger, Bleich et al. 1998). Very recently, a forebrain-specific MR-
deficient mouse was created using the CaMKIIα promoter to direct cre recombinase 
activity only in forebrain regions (MRCamKCre) (Berger, Wolfer et al. 2006). No alterations 
in corticosterone levels were seen either under basal AM or PM conditions or after 40 
minutes of restraint stress. Also, contrary to the findings in MRov mice, no differences 
were seen in anxiety-like behaviors. There are, however, several significant differences 
between these two genetic models of increased or decreased forebrain MR. First, the 
respective mice are on slightly different genetic backgrounds. Second, while behavioral 
testing in MRov mice was performed during the nadir of the circadian rhythm (in the 
light period), all of the behavioral testing for the MRCamKCre mice was performed during 
the dark cycle when corticosterone levels are higher. This may result in a greater 
proportion of activated GR, while the testing in MRov mice is under predominant MR 
activation. Third, the loss of MR in MRCamKCre mice appears to be more extensive than 
the overexpression of MR in MRov mice. For example, MR is lost in the amygdala in 
MRCamKCre mice, but MR is not overexpressed in the amygdala of MRov mice. Fourth, the 
MRov mice exhibit increased expression of MR in cortical regions that normally express 
low or non-detectable levels of MR in mice.  Combined, these differences may result in a 
 
    78
differential expression of compensatory mechanisms leading, overall, to altered patterns 
of behavior or HPA axis function in the MRCamKCre and MRov mice. 
In conclusion, we have created a transgenic mouse with physiologically relevant 
increases in MR expression in the forebrain to assess the role of MR in anxiety-like 
behavior and HPA function. The data demonstrate a significant role for MR in the 
reduction of anxiety-related behaviors and suggest important roles for MR signaling in 
HPA axis activity beyond maintenance of basal tone. These data also highlight the 
complex nature of MR and GR signaling which may work together in the regulation of 
some pathways, but exhibit distinct activities in the modulation of others.  
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Appendix 1 
The Effects of Forebrain Overexpression of MR on Neurogenesis 
 
Introduction: 
Corticosteroid production is tightly controlled by the Hypothalamic Pituitary 
Adrenal (HPA) axis.  Throughout the circadian rhythm and in response to stress, 
corticosteroids are released into the blood stream and serve to alter metabolic processes 
in a manner that allows the organism to adapt.  While short-term activation of the 
pathway is adaptive, long-term elevations in corticosteroid levels have been shown to 
result in deleterious consequences, such as loss of hippocampal volume, dendritic tree 
retraction (Woolley, Gould et al. 1990), and decreased neurogenesis in the dentate gyrus 
of the hippocampus.  Hypersecretion of corticosterone has been linked to multiple mood 
disorders including major depression and anxiety, and it is hypothesized that the 
structural remodeling of the hippocampus accompanying glucocorticoid hypersecretion 
may contribute to or exacerbate these pathophysiologies (McEwen 2005).   
Corticosteroid action is mediated via two types of receptors, the high affinity 
mineralocorticoid receptor (MR) (Kd corticosterone = 0.5nM) and the lower affinity 
glucocorticoid receptor (GR) (Kd corticosterone = 5nM).  MR and GR are both members 
of the steroid/thyroid hormone receptor superfamily that function as ligand-activated 
transcription factors.  MR and GR normally reside in the cytoplasm, dimerize upon 
ligand binding and translocate to the nucleus where they are capable of regulating the 
transcription of genes whose promoters contain a glucocorticoid responsive element 
(GRE).  Their different affinities for corticosterone suggest that they are activated 
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differentially over the course of the circadian rhythm and during times of stress.  GR 
expression is widely distributed throughout the brain, whereas MR, while present in 
multiple regions, is most highly expressed in the hippocampus.  In regions where MR and 
GR are coexpressed, such as the hippocampus, they can homodimerize as well as 
heterodimerize, allowing for increased complexity in corticosteroid signaling.   
While MR and GR are both activated by corticosterone, the cellular consequences 
of their activation can often oppose each other, even in the same cell.  For example, MR 
activation results in increased long-term potentiation (LTP) while GR activation 
decreases LTP (Pavlides, Watanabe et al. 1995).  Similarly, MR activation can prevent 
the adrenalectomy-induced apoptosis in the dentate gyrus, whereas GR activation has 
been shown to have no effect or increase this apoptosis (Hornsby, Grootendorst et al. 
1996).  Because of the significant role that corticosteroids play in the structural 
remodeling of the hippocampus, and the potential importance of this remodeling in 
depression and anxiety, it is important to understand the individual roles of MR and GR 
in hippocampal remodeling events such as neurogenesis.  
New neurons are continually being born in the mammalian dentate gyrus.  The 
process of neurogenesis has been shown to be highly regulated by corticosterone.  Rats 
treated acutely with corticosterone showed a significant decrease in the number of 
newborn neurons, while ADX results in a large increase in neurogenesis (Cameron and 
Gould 1994).  Additionally, physiological alterations in corticosterone levels, such as 
acute and chronic stress are known to suppress hippocampal neurogenesis (Gould and 
Tanapat 1999).  The activation of GR is clearly implicated in the suppression of 
neurogenesis in the dentate gyrus.  High levels of corticosterone treatment given to either 
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adrenalectomized (Wong and Herbert 2005) or adrenal intact (Mayer, Klumpers et al. 
2006) rats resulted in a suppression of proliferation that was normalized by antagonism of 
GR.  Other evidence suggests that the GR agonist dexamethasone can inhibit 
neurogenesis both in vivo and in vitro (Kim, Ju et al. 2004).  The effects of MR activation 
on neurogenesis are not as clear.  Several groups have shown that MR activation can 
suppress the increased proliferation that accompanies adrenalectomy (Wong and Herbert 
2005; Krugers, van der Linden et al. 2007) in a manner similar to GR.  In contrast, 
however, it has also been shown that aldosterone can further enhance the increased 
proliferation that accompanies adrenalectomy (Fischer, von Rosenstiel et al. 2002).  In 
support of this positive effect of MR activation on neurogenesis, genetic disruption of 
MR leads to impaired neurogenesis in the hippocampus, whereas brain specific disruption 
of GR had no effects on hippocampal neurogenesis (Gass, Kretz et al. 2000).  In a series 
of in vitro experiments, primary hippocampal cultures treated with aldosterone showed 
enhanced neurogenesis that could be blocked with the MR antagonist spironolactone.  In 
contrast, cultures treated with dexamethasone showed decreased neurogenesis, an effect 
that could be blocked by mifepristone (Fujioka, Fujioka et al. 2006).   
In this study we sought to further address the role of MR in neurogenesis in a 
mouse model of forebrain MR overexpression previously characterized in our laboratory.  
These animals have been shown to overexpress MR in the hippocampus by 20-25%.  
Under basal conditions, MRov mice do not have any overt alterations in plasma 
corticosterone concentrations allowing for the analysis of basal levels of neurogenesis 
under a primary increase in MR signaling.  Two well-described methods were used to 
detect newborn cells in the dentate gyrus:  1) BrdU incorporation into actively dividing 
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precursor cells; and 2) Ki67 staining that serves as a marker for cells in all stages of the 
cell cycle except G0 (Wojtowicz and Kee 2006; Mandyam, Harburg et al. 2007). 
 
Materials and Methods: 
Generation of MRov mice and Animal Husbandry.  A detailed description of the 
generation of the MRov mice is provided in a previous publication (Rozeboom, Akil et 
al. 2007).  Mice were maintained on a 14:10 light/dark schedule with lights on between 
6:00 and 20:00. Mice were given food (5008 mouse chow, 9% fat content; Purina Mills, 
Inc., St. Louis, MO) and water ad libitum. C57BL/6J (The Jackson Laboratory, Bar 
Harbor, ME) mice were bred at the University of Michigan.  All mice in this study were 
4–5 months of age.  All procedures using mice were approved by the University of 
Michigan Committee on Use and Care of Animals. All experiments were conducted in 
accordance with the principles and procedures outlined in the National Institutes of 
Health guidelines for the Care and Use of Animals. 
 
Bromodeoxyuridine Administration. Bromodeoxyuridine (BrdU, Sigma) was dissolved 
in normal saline (0.9% NaCl, .007M NaOH) at a concentration of 20mg/ml and filtered at 
0.2μm.  To label dividing cells, mice received 3 i.p. injections of BrdU (100 μg/g of body 
weight) spaced 4 hours apart (8am, 12pm, and 4pm).  Mice were sacrificed 24 hours 
following the last injection (4pm). 
 
Tissue Processing. Under anesthesia with sodium pentobarbital (50mg/kg), mice were 
transcardially perfused with 0.9% cold saline followed by cold 4% paraformaldehyde in 
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0.1M sodium phosphate buffer.  Brains were removed from the animals and post-fixed 
for 1-2 hours at 4oC in the same fixative.  Brains were then cryoprotected in a 20% 
sucrose/PBS solution overnight at 4oC.  Brains were then frozen at -50oC in 2-methyl-
butane and stored at -80oC until use.  Cryostat sections through the dorsal hippocampus 
were cut at 30μm in the coronal plane.  Five 1-in-5 series were collected in PBS for 
immediate use or transferred to a cryprotectant solution (30% ethylene glycol, 20% 
glycerol, and 50mM sodium phosphate buffer, pH 7.4) and stored at -20°C until use.  
 
Immunohistochemistry. Detection of the proliferation marker Ki67 was performed as 
follows.  Free-floating sections were mounted onto Superfrost plus (Fisher Scientific) 
slides and allowed to dry for several hours at room temperature.  Sections were then 
washed in Tris-buffered saline (TBS) + 0.05% triton X-100 (TBST) on a shaker.  Antigen 
retrieval was accomplished by heating the sections in 10% NaCitrate buffer for 40 
minutes at 90oC.  Sections were then allowed to cool to room temperature in the same 
buffer for 20 minutes and then endogenous peroxidase activity was quenched by 
incubating sections for 30 minutes in TBS + 0.001% H202.  Sections were subsequently 
washed in TBST, and blocked for 1 hour in BSA diluent (0.15M NaCl, 25mM K2HPO4, 
17mM KH2PO4, 1% BSA, 1% normal goat serum, 0.4% Triton X-100).  Sections were 
incubated with Ki67 antibody (provided by S.J. Watson laboratory) at 1:20,000 in BSA 
diluent overnight at room temperature (RT) with shaking.  Sections were then washed in 
TBST, incubated for 1 hour at RT with a biotinylated goat anti-rabbit antibody at 1:1000 
(Sigma, St. Louis, MO).  Sections were washed in TBST and incubated for 80 minutes in 
Ready To Use (R.T.U.) (Vector).  Sections were washed in TBST and incubated for 12 
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minutes in 3-3’ diaminobenzidine (DAB) Tabs (Sigma) dissolved in water.  Sections 
were rinsed in water, counterstained with cresyl violet, dehydrated through alcohols (50-
100%), incubated in xylene 2-3 minutes and cover-slipped with Permount.   
Immunohistochemistry for BrdU was performed as follows.  Free-floating 
sections were transferred from cryoprotectant solution to TBS (0.5M NaCl, 0.1M Tris pH 
7.5) and washed in several rinses for at least 3 hours.  Endogenous peroxidase activity 
was quenched by incubation of sections in 0.1% H2O2 for 10 min.  Antigen retrieval was 
achieved by incubation of sections for 2 hours at 65°C in 50% formamide/2X SSC, 
followed by 30 minutes in 2N HCl at 37°C and a 10 min. incubation in 100mM Na 
Borate, pH 8.5.  Sections were blocked in BSA diluent as above, followed by overnight 
incubation of sections with 1:500 rat anti-BrdU (Accurate Chemical, Westbury, NY) at 
room temperature. Sections were washed in TBST and incubated for 1 hour at RT with a 
biotinylated goat anti-rat antibody at 1:1000 (Sigma).  Sections were washed in TBST 
and incubated for 60 minutes in avidin-biotin complex (ABC) reagent (Vector) diluted 
1:1000 in BSA diluent.  Sections were then washed in TBST, incubated for 6 minutes in 
DAB (DAB tablets, Sigma), and washed in DI water. Sections were mounted onto slides, 
air dried, counterstained with cresyl violet, dehydrated through alcohols (50-100%), and 
coverslipped as above. 
 
Cell Counting and Dentate Gyrus Volume Estimates. Cell counts were performed by 
an observer blinded to the genotype of the animal.  A complete 1-in-5 series of sections 
through the dorsal dentate gyrus was analyzed for each animal.  BrdU and Ki67 positive 
cells were counted in the subgranular layer of the dentate gyrus using a light microscope 
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at 63x magnification.  Labelled cells in the subgranular layer (SGL), or ± 2 cell diameters 
of the SGL, and in all focal planes through the 30μm section were counted.  The total 
number of BrdU and Ki67 positive cells was estimated by multiplying the number of 
labeled cells counted by 5.  The volume of the granule cell layer was estimated for each 
animal in the same series of sections (analyzed at 10x magnification) by the method of 
Cavaliere using Stereo Investigator software (Williston, VT).  The average labeled cell 
counts and volumes were determined for each group and subjected to unpaired t-test 
using Statview software. 
 
Results: 
The proliferation of dentate gyrus granule cells in wildtype and MRov mice was 
determined by immunohistochemical analysis for the incorporation of BrdU and the cell 
cycle marker Ki67.  BrdU labeling was visible throughout the rostral-caudal extent of the 
dorsal dentate gyrus.  Morphologically, labeled cells were irregularly shaped with DAB 
staining appearing as both multipunctate and densely uniform throughout the nucleus 
(Figure 2-9A).  BrdU-labeled cells were most commonly found in clusters of 2 or more.  
Under basal conditions, there was no difference in the number of BrdU labeled cells 
between MRov and wildtype mice (Figure 2-9B).   
Ki67 staining was also visible throughout the rostral-caudal extent of the dorsal 
hippocampus. Overall, the number of cells labeled for Ki67 was greater than BrdU 
labeled cells.  This is most likely due to the fact that, while BrdU is only incorporated 
during S-phase, Ki67 is expressed during all stages of the cell cycle except G0, suggesting 
that a larger population of cells may be available for labeling at any given time. 
 
    86
 
Figure 2-9 Immunohistochemistry for BrdU in the dentate gyrus of the 
hippocampus. 
(A) The 10x magnification reveals BrdU positively stained cells (arrows denote examples 
of some of these cells) throughout the SGL of the upper and lower blades of the dentate 
gyrus.  The 63x magnification reveals both densely (arrows) and diffusely (double 
arrowhead) stained clumps of cells in the SGL of the upper blade of the dentate gyrus.  
Dashed boxes denote area of enlargement.  (B) Quantitation of BrdU labeled profiles 
throughout the rostral-caudal extent of the dorsal hippocampus of both wildtype (WT) 
and MRov (TG) mice. 
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Consistent with the BrdU data, there was no statistically significant difference in the 
number of Ki67 labeled cells between MRov and wildtype mice (Figure 2-10). 
Any alterations in either proliferation or survival of newborn neurons in the 
dentate gyrus may result in differences in the size of this structure.  To determine if the 
relative sizes of the dentate gyrus differed between MRov transgenic and wildtype mice, 
the Cavaliere method was used to estimate volumes in the same series of sections used to 
analyze Ki67 expression.  Consistent with the neurogenesis data, there was no difference 




 Glucocorticoids have powerful effects on the proliferation and survival of 
newborn cells in the dentate gyrus.  While the preponderance of data suggests that GR 
negatively regulates neurogenesis in the dentate gyrus, the role of MR in this process is 
not well understood.  The goal of this study was to further delineate the role of MR in the 
regulation of proliferation in the dentate gyrus under basal conditions.  To do this, we 
assessed the levels of neurogenesis in the previously characterized forebrain specific MR 
overexpressing mouse (Rozeboom, Akil et al. 2007) using two common methods for the 
determination of proliferation in the dentate gyrus: 1) BrdU incorporation by actively 
dividing precursor cells and 2) Ki67 staining that serves as a marker for cells in all stages 
of the cell cycle except G0.  Under baseline conditions, at 4-5 months of age, there were 
no differences in the levels of neurogenesis in the dorsal dentate gyrus between MRov 
and wildtype mice.  Correspondingly, there were also no differences in the estimated 
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Figure 2-10 Immunohistochemistry for Ki67 labeled cells in the dentate gyrus of the 
hippocampus. 
(A)The 10x magnification reveals Ki67 positively stained cells (arrows denote examples 
of some of these cells) throughout the SGL of the upper and lower blades of the dentate 
gyrus.  The 63x magnification reveals both densely (arrows) and multipunctate (double 
arrowheads) stained clumps of cells in the SGL of the upper blade of the dentate gyrus.  
Dashed boxes denote area of enlargement.  (B) Quantitation of Ki67 labeled profiles 
throughout the rostral-caudal extent of the dorsal hippocampus of both wildtype (WT) 
and MRov (TG) mice.
 










Mean Dentate Gyrus Volumes (mm3)
WT                         TG
0.086 +/- 0.004      0.087 +/- 0.003





Figure 2-11 Estimated volumes of the dorsal hippocampus. 
The Cavaliere method was used to estimate the volumes of the dentate gyrus in wildtype 
(WT) and MRov (TG) mice.  The graph depicts the range of volume estimates for both 
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volumes of the dorsal dentate gyrus.   
While previous data suggest that MR signaling is involved in the process of 
neurogenesis, there is currently no consensus concerning its exact role.  Some studies 
suggest that MR activation can downregulate neurogenesis in a manner similar to GR 
(Wong and Herbert 2005; Krugers, van der Linden et al. 2007), while others suggest that 
MR activation can increase neurogenesis (Gass, Kretz et al. 2000; Fischer, von Rosenstiel 
et al. 2002).  These experiments must be compared carefully, as there are both 
fundamental differences between paradigms used as well as differences in the manner in 
which studies are conducted within paradigms.  For example, adrenalectomy and 
hormone replacement (Fischer, von Rosenstiel et al. 2002; Wong and Herbert 2005; 
Krugers, van der Linden et al. 2007) is useful for targeting MR activation directly.  
However, this paradigm only provides the opportunity to address short-term alterations in 
MR signaling and does not allow for the assessment of long-term alterations in signaling 
that may accompany a disease state.  Additionally, methodological differences between 
studies such as the ligand used (aldosterone vs. corticosterone), dose of the ligand, and 
the route of ligand administration (injections vs. in the drinking water) make it difficult to 
directly compare the different studies and may help explain the variable results.  
Conversely, while genetic manipulation studies allow for assessment of long-term 
changes in gene expression, genetically modified animals often exhibit compensatory 
changes in the system that could obfuscate the ability to study the specific pathway of 
interest.  For example, MR knockout mice (MRKO) showed a decrease in neurogenesis 
in the dentate gyrus of the hippocampus (Gass, Kretz et al. 2000).  A simultaneous 
comparison with mice containing a disruption of brain specific GR showed no changes in 
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neurogenesis, suggesting that the decreased neurogenesis in MR knockout mice is 
specific to the loss of MR.  A complication in this interpretation arises when considering 
the compensatory changes that accompany the complete loss of MR in the organism.  
These mice normally die within a week of birth due to sodium imbalance, pointing to the 
important role of MR in sodium homeostasis through its activation by aldosterone in the 
kidney.  MRKO mice can be rescued, however, through daily exogenous salt 
supplementation.  While this allows the mice to survive to adulthood, it was found that 
the MRKO mice have elevated levels of corticosterone, perhaps due to the combination 
of the daily handling required for salt supplementation as well as loss of negative 
feedback provided to the HPA axis from MR.  The increased levels of plasma 
corticosterone may therefore be responsible for the decreased neurogenesis through 
increased signaling at GR rather than a specific effect of decreased MR on neurogenesis.   
In the forebrain of the MRov mice used in this study, there is a 20% elevation in 
hippocampal MR levels for most of the animals’ lives.  There are also no overt changes 
in baseline corticosteroid levels and no changes in the expression levels of GR in the 
dentate gyrus, allowing for the assessment of basal levels of neurogenesis under a 
primary increase in MR signaling without the complication of increased corticosterone 
levels or altered GR signaling.  The fact that there are no changes in basal levels of 
neurogenesis in MRov mice may be explained by multiple possibilities.  First, the ratio of 
hippocampal MR to GR expression is thought to have functional importance (De Kloet, 
Vreugdenhil et al. 1998).  Thus, while the level of MR overexpression in these mice 
alters anxiety related behavior (Rozeboom, Akil et al. 2007), it may not be large enough 
to significantly alter neurogenesis.  Alternatively, only a small proportion of progenitor 
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cells actually express GR, and none express MR (Garcia, Steiner et al. 2004) suggesting 
that the effects of corticosterone on proliferation are via an indirect mechanism that 
involves cell to cell communication.  There are multiple cell types in the hippocampus 
that express MR and GR, including both neurons and glia, but it is currently unclear 
which populations of cells may be involved in this signaling (Bohn, Howard et al. 1991).  
In MRov mice, the CamKIIα promoter is used to drive expression of MR.  This promoter 
is known to be neuron specific and largely glutamatergic (Liu and Jones 1996); hence it 
is possible that the overexpression of MR is limited to cell types not involved in the 
majority of signaling to precursor cells of the dentate gyrus. 
 The analysis of neurogenesis in this experiment was in young animals (4-5 
months) under baseline conditions.  There is evidence supporting the idea that under 
conditions of sustained increase in corticosteroids, such as chronic treatment with 
corticosterone, there is a decrease in the level of neurogenesis in the dentate gyrus that 
can be brought back to baseline levels through the blockade of GR alone (Mayer, 
Klumpers et al. 2006).  Basal levels of corticosteroids are also elevated in aged rodents 
(Sapolsky 1985) and this correlates with a decrease in neurogenesis in old rats (Kuhn, 
Dickinson-Anson et al. 1996; Cameron and McKay 1999).  Consistent with the idea that 
corticosteroids are involved in this decreased neurogenesis, removal of endogenous 
corticosteroids by adrenalectomy in young and aged rats increased the rate of cell 
proliferation to similar levels (Cameron and McKay 1999).  Interestingly, studies have 
shown that MR levels are decreased under conditions of chronic stress and during the 
aging process in rats (Lopez, Chalmers et al. 1998; Hibberd, Yau et al. 2000).  If the level 
of MR overexpression is too low to affect neurogenesis in young mice under baseline 
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conditions, it may be possible that the sustained increase in MR levels in MRov mice 
may prevent or attenuate the decreases in neurogenesis that accompanies chronic stress or 
aging.  Future experiments will address these possibilities.  
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Appendix 2 
The effects of overexpressionof MR in the forebrain on learning and memory 
 
Introduction: 
Glucocorticoid hormones are known to affect processes underlying learning and 
memory.  On a cellular level, concentrations of glucocorticoids equivalent to a stressor 
decrease long-term potentiation (LTP), whereas low levels of glucocorticoids enhance 
LTP.  Behaviorally, lower levels of glucocorticoids commensurate with low to moderate 
stress have been shown to enhance cognition in several learning and memory paradigms, 
whereas more severe stressors and higher levels of glucocorticoids disrupt it.  While 
previous studies suggest that activation of MR and GR is clearly involved in cognitive 
function, differences in testing paradigms has made it difficult to draw overall 
conclusions concerning the exact roles of MR and GR.  Short-term blockade of MR and 
GR suggests differential roles for MR and GR, affecting search escape strategies and 
processes underlying consolidation respectively.  Long-term blockade of MR resulted in 
impaired learning and memory, whereas long-term blockade of GR, in contrast to acute 
effects, was shown to enhance learning and memory (Oitzl, Fluttert et al. 1998). 
 Recent studies addressing the affects of long-term alterations in GR and MR 
signaling through genetic modifications suggest that overexpression of GR in the 
forebrain results in mild cognitive impairments (Wei, Hebda-Bauer et al. 2007) and 
forebrain removal of MR results in impairments in learning and memory (Berger, Wolfer 
et al. 2006).  Concurrent with studies in this thesis, a recent paper addressed the effects of 
overexpression of MR in the forebrain on learning and memory and observed mild 
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cognitive improvements (Lai, Horsburgh et al. 2007).  As MRov mice also overexpress 
MR in the hippocampus, we were interested in determining the effects of increased MR 
in hippocampal-dependent learning and memory as well as retrieval of long-term 
memory through the use of long-term probe trials in the Morris Water Maze (MWM).  
 
Materials and Methods: 
Animals. MRov mice were bred and housed as previously described (Rozeboom, Akil et 
al. 2007).  Four to 5 month old, gender matched, male and female MRov and wildtype 
mice were used in the Morris Water Maze. 
 
Morris Water Maze. The Morris water maze (MWM) used in these experiments 
consisted of a 1.2-meter diameter pool filled with water that was made opaque with white 
nontoxic paint.  Water temperature was maintained at 24 ±1 C° throughout the 
experiment.  Every training trial began with the mouse on the platform for 15 sec.  The 
mouse was then placed into the water facing the wall of the pool and allowed to search 
for the platform, with the starting position chosen pseudorandomly among six start 
positions.  The trial ended either when the mouse climbed onto the platform or when 60 
sec had elapsed. At the end of each trial, the mouse was allowed to rest on the platform 
for 15 sec.  Mice were given 4 trials per day in blocks of 2 trials with inter-block times of 
approximately 90 minutes.  Mice were trained for a total of 9 days.  Probe trials were 
conducted 24 hours after every third day of training to monitor whether the mice were 
learning the task differentially.  During the probe trial, the escape platform was removed 
and mice were placed in the pool at the start location directly opposite of the platform and 
 
    96
allowed to swim for 60 sec.  If more training was to occur (days 4, 7, and 10), then the 
training took place directly after the probe trial.  Long-term memory was assessed with 
probe trials performed 2.5 and 5 weeks after the final probe trial, with no further training 
between probe trials. 
 
Data Analysis. Data were analysed by two-way repeated measures ANOVA with a 
repeated measure for training day. 
 
Results: 
Both MRov and wildtype (WT) mice were trained for 4 trials a day for 9 days on 
the hidden platform version of the Morris Water Maze. Acquisition data are shown in 
Figure 2-12.  In both groups, the latency to reach the platform decreased as training 
progressed. There was a strong main effect of training day on the escape latencies for 
both groups (F(8,152) = 15.92, p < 0.0001), however, there was no main effect of genotype 
on latency (F(1,19) = 0.229, p = 0.64) and no interaction between training day and 
genotype (F(8,152) = 0..44, p = 0.9). These data suggest that MRov and WT mice acquire 
the hidden platform equally well. In addition to measuring latency to the platform during 
training, probe trials were conducted 24 hours after the completion of training on days 3, 
6, and 9. During probe trial 1, 24 hours after the third day of training, the amount of time 
each group spent in the Target quadrant (where the platform used to be) was not 
significantly greater than chance (25%) (Figure 2-13). During probe trial 2, 24 hours after 
the sixth day of training, while the WT mice spent significantly more time in the Target 
quadrant (40.4% ± 5.1%, p < 0.05, single group t-test compared to 25%), the MRov mice 
did not spend more time in the Target quadrant (29.0% ± 5.3%, p = 0.47). However, there 
 
















1 2 3 4 5 6 7 8 9 training day
 
Figure 2-12 MRov mice are not impaired in the acquisition phase of the Morris 
water maze. 
Mice were trained for 4 trials a day for 9 days.  Time to reach the hidden platform 
(escape latency) was not significantly different for MRov (TG) mice when compared 













    98
was no significant difference in the amount of time that the MRov mice spent in the 
Target quadrant compared to their WT littermates (p > 0.05, unpaired t-test) (Figure 2-
13). During probe trial 3, 24 hours after the final day of training, both MRov and WT 
mice spent significantly more time in the Target quadrant (MRov, 45.4% ± 5.9%, p < 
0.05, and WT, 46.9% ± 4.7%, p < 0.05 single group t-test compared to 25%), and there 
was no difference between MRov and WT mice (p > 0.05, unpaired t-test). 
To determine if overexpression of MR had an effect on long-term memory, probe 
trials were conducted 2.5 and 5 weeks following the final probe trial (Figure 2-14).  
During the first long-term probe trial, 2.5 weeks following the final probe trial, both 
MRov and WT mice spent significantly more time in the Target quadrant relative to 
chance (MRov, 42.7% ± 4.7%, p < 0.05, and WT, 36.7% ±4.5%, p < 0.05 single group t-
test compared to 25%), and there was no difference between MRov and WT mice in the 
amount of time they spent in the Target quadrant (p > 0.05, unpaired t-test).  During the 
second long-term probe trial, 5 weeks after the last probe trial, MRov mice spent 
significantly more time in the Target quadrant (47.9% ± 4.6%, p < 0.05 single group t-
test compared to 25%), but WT mice did not (34.3% ± 5.0%, p > 0.05 single group t-test 
compared to 25%).  While there was no significant difference between the MRov and 
WT mice in the amount of time that they each spent in the Target quadrant, there was a 





































Figure 2-13 Spatial memory is not altered in MRov mice 
A 60-second probe trial was completed 24 hours after every third day of training.  During 
probe trial 1, neither group spent significantly more time in the quadrant where the 
platform used to be (Target).  During probe trial 2, while WT mice spent more time in the 
Target quadrant and MRov (TG) mice did not, there was no significant difference 
between the groups.  By the probe trial 3, both groups spent significantly more time in the 
Target quadrant.  The dashed line (25%) represents random, or “chance” performance.  
(OP) Opposite; (AL) adjacent left; and (AR) adjacent right quadrants. *= p < 0.05 


























































Figure 2-14 There are no significant changes in long-term memory in MRov mice 
A 60-second probe trial was completed 2.5 weeks and 5 weeks after the last day of 
training.  During long-term probe trial 1, both groups spent significantly more time in the 
quadrant where the platform used to be (Target).  During long-term probe trial 2, MRov 
(TG) mice spent more time in the Target quadrant and WT mice did not, however there 
was a strong trend towards a difference between the groups (p = 0.06).  The dashed line 
(25%) represents random, or “chance” performance.  (OP) Opposite; (AL) adjacent left; 
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Discussion: 
 There are no significant differences between MRov and WT mice in the hidden 
platform version of the MWM.  It should be noted, however, that MRov mice did exhibit 
a trend towards increased long-term memory at the 5 week probe trial as compared to the 
WT mice.  These results are similar to another model of forebrain specific 
overexpressionof MR, where a mild, but significant, cognitive improvement was 
observed with transgenic (MT-tg) mice spending more time in the target quadrant relative 
to WT mice during the probe trial 24 hours after the final day of training (Lai, Horsburgh 
et al. 2007).  There are, however, two main differences between our MRov mice and MR-
tg mice that may account for the differences in results.  First, MRov mice display a 
roughly 20-25% increase in MR mRNA expression in the hippocampus relative to WT 
littermates.  In contrast, MR-tg mice were reported to exhibit a 474% increase in MR 
mRNA expression averaged over regions CA1-CA3 relative to its WT littermate controls.  
While both sets of transgenic mice displayed decreased anxiety-related behaviors, the 
lack of a change in learning and memory in MRov mice may be due to a dose dependent 
effect, with the level of overexpression of MR in the hippocampus not reaching a critical 
threshold to observe a similar cognitive improvement as MR-tg mice.  Second, MRov 
mice are different from MR-tg mice in that GR mRNA in region CA1 of the 
hippocampus is significantly decreased relative to WT mice in MRov mice, but there is 
no difference in hippocampal GR between MR-tg mice and their respective WT controls.  
GR activity is also known to contribute to processes underlying learning and memory and 
it may be this long-term decrease in GR in CA1 of MRov mice, combined with the 
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increase in MR, may represent a compensatory mechanism that leads to relatively normal 
learning and memory processes in the MWM in MRov mice. 
Berger and colleagues found that mice with a forebrain specific deletion of MR 
exhibited decreased performance during the acquisition phase of the MWM, but no 
differences in the recall phase during the probe trials (Berger, Wolfer et al. 2006).  Given 
that the loss of MR in these animals is complete in the hippocampus, as well as other 
brain regions such as the amygdala, the forebrain-specific MR-KO mice represent a 
model with a more drastic change in glucocorticoid signaling than the MRov mice.  Thus, 
the altered learning and memory in forebrain MR-KO but not in MRov mice may also be 
due to dose dependent effects. 
 The analysis of learning and memory in this experiment was in young animals (4-
5 months) under baseline conditions.  Under conditions of sustained increase in 
corticosteroids, such as chronic stress, there are significant impairments in learning and 
memory (Sousa, Lukoyanov et al. 2000), and studies have shown that MR levels are 
decreased under conditions of chronic stress (Lopez, Chalmers et al. 1998).  While the 
level of MR overexpression may be too low to affect learning and memory in young 
MRov mice under baseline conditions, it remains possible that the sustained increase in 
MR levels in MRov mice may prevent or attenuate the cognitive deficits that accompany 
chronic stress. Similarly, aging has been shown to impair learning and memory and the 
effects of sustained increases in MR may be more readily assessed in aged MRov and 
WT mice.  Finally, MR activity has also been shown to be involved in processes 
underlying contextual fear-conditioning, a different type of hippocampal dependent task, 
and it may be possible that MR overexpression in MRov mice could affect aspects of 
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learning and memory in this context.  These hypotheses will be further tested in future 
studies.
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Chapter 3 
Role of mineralocorticoid receptor in protection from glucocorticoid endangerment 
of HT-22 hippocampal cells 
 
Introduction: 
Hippocampal neurons are extremely sensitive to excitotoxic and oxidative insults 
such as hypoxia/ischemia, seizure, and hypoglycemia.  Glucocorticoid hormones released 
during stress have been shown to exacerbate the toxic effects of these types of 
neurological insults (Lee, Ogle et al. 2002).  This concept of “glucocorticoid 
endangerment” is particularly relevant to the hippocampus, a major site of corticosteroid 
receptor expression.  Chronic elevations in plasma cortisol are observed in multiple 
affective disorders including major depression, and it is has been proposed that this 
increase in glucocorticoids may contribute to the decreased structural and functional 
integrity of the hippocampus that accompanies these diseases (Lee, Ogle et al. 2002; 
Csernansky, Dong et al. 2006).  Indeed, recent data have shown that the subtypes of 
depression with the highest rates of hypercortisolism are most often associated with 
atrophy of the hippocampus (Sheline, Sanghavi et al. 1999).  However, the mechanisms 
by which glucocorticoids alter the vulnerability of hippocampal neurons to neurological 
insults remains poorly understood.   
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The actions of glucocorticoids are mediated by two types of receptors, the 
mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR).  MR and GR are 
members of the steroid/thyroid hormone receptor superfamily and they function as 
ligand-activated transcription factors. Both MR and GR bind the rodent glucocorticoid 
hormone corticosterone (cortisol in humans), but they do so with very different affinities 
(0.5nM for MR and 5nM for GR), leading to different activation profiles throughout the 
circadian rhythm and during times of stress.  These varied activation patterns often result 
in differential cellular responses to varying corticosteroid concentrations.  As MR and 
GR are co-expressed in numerous hippocampal subfields, understanding their 
independent and overlapping roles in hippocampal function is critical.   
Recent observations suggest that differential activation of MR and GR can have 
profoundly different effects on neuronal survival.  While high dose glucocorticoid 
treatment or stress increases vulnerability to neuronal damage, there is substantial 
evidence that this glucocorticoid endangerment is mediated by GR, but not MR (Herman 
and Seroogy 2006).  For example, in vitro studies indicate that glucocorticoid 
enhancement of neurotoxicity is inhibited by the GR antagonist RU486 but not by MR 
antagonists (Talmi, Carlier et al. 1995).  In addition, administration of GR (but not MR) 
agonists is sufficient to enhance neurotoxic damage in the hippocampus (Goodman, 
Bruce et al. 1996). 
In contrast, a number of studies suggest that the low levels of corticosteroid that 
activate MR may play a trophic or protective role (Woolley, Gould et al. 1991).  
Overexpression of MR in the hippocampus of transgenic mice provides protection from 
ischemic insult relative to wildtype controls (Lai, Horsburgh et al. 2007).  Similarly, 
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overexpression of MR in the neuronal cell line PC12 provides protection from various 
neurological insults (Lai, Horsburgh et al. 2007).  Interestingly, in both rats that have 
received chronic unpredictable stress and in suicide victims with a history of depression, 
the expression levels of MR have been shown to be decreased, leading overall to an 
imbalance in the MR/GR ratio (Lopez, Chalmers et al. 1998).  These data support the 
hypothesis that a balance in the activation of MR and GR in forebrain regions such as the 
hippocampus is important in the maintenance of proper physiological and cellular 
homeostasis (De Kloet, Vreugdenhil et al. 1998), including neuronal survival. 
 Neurological insults such as ischemia and hypoglycemia are thought to be 
injurious to cells through a mechanism that involves an over-accumulation of the 
excitatory amino acid glutamate.  Glutamate has been shown to be toxic to neuronal cells 
via two different mechanisms.  In the first mechanism, excessive binding of glutamate to 
specific glutamate receptors produces excitotoxic effects through a rise in cytosolic 
calcium and the production of oxygen radicals (Lipton 1999).  Alternatively, glutamate 
toxicity can also occur when excessive levels of the amino acid compete with cystine at 
the cystine/glutamate transporter, resulting in an antioxidant imbalance in the cell 
(Murphy, Miyamoto et al. 1989).  Decreased cystine transport results in the decreased 
production of glutathione, leading to an increase in reactive oxygen species and increased 
calcium influx, ultimately leading to cell death through both apoptotic and necrotic 
mechanisms (Tan, Wood et al. 1998).   
The immortalized mouse hippocampal cell line HT-22 has been shown to be 
sensitive to glutamate-induced oxidative stress via competition at the cystine/glutamate 
transporter.  Activation of GR in the HT-22 hippocampal cell line exacerbates 
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glutatmate- induced cell death (Behl, Lezoualc'h et al. 1997), and this effect is blocked by 
a GR antagonist.  However, the role of MR in the corticosteroid-mediated increase in 
glutamate-induced cell death has not been previously examined.  In this study, we 
demonstrate that HT-22 cells express GR, but not MR.  To study the potential 
neuroprotective actions of MR in corticosteroid-mediated effects on glutamate toxicity, 
we therefore stably transfected HT-22 cells with a CMV-MR construct to generate clones 
that co-express MR and GR at varying levels.  These clonal cell lines were characterized 
for MR/GR levels, transactivation properties, and their sensitivity to corticosteroid-
mediated exacerbation of glutamate-induced cell death.  Additionally, the potential role 
of apoptotic mechanisms in the glucocorticoid-mediated effects was also examined. 
 
Materials and Methods: 
Cell culture. HT-22 cells were obtained from Dr. David Schubert (Salk Institute, San 
Diego).   This immortalized mouse hippocampal cell line was selected from HT-4 cells 
based on glutamate sensitivity (Maher and Davis 1996).  HT-22 cells were maintained in 
DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum (FCS, 
Hyclone, Logan, UT), and gentamicin (50μg/ml, Invitrogen) at 37°C in 5% CO2. 
 
Generation of HT22/MR Stable Expression Clones. The cloning of the full-length MR 
cDNA (MR2A) was previously described (Rozeboom, Akil et al., 2007).  MR2A was 
subcloned into a CMVneo expression construct (kindly provided by Mike Uhler) to 
generate CMV-MR.  To generate clones of HT-22 that stably express MR, cells were 
cotransfected with CMV-MR and a plasmid that expresses the puromycin resistance gene 
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using Lipofectamine (Invitrogen) according to the manufacturer’s protocol.  Twenty-four 
hours later, media was replaced with media containing 2.5 μg/ml puromycin.  This media 
was replaced every 3-4 days for 10 days.  Individual clones were isolated and grown 
individually for another 10-14 days in puromycin-containing media. 
 
Transfections. HT-22 Parent, HT-22/MR24 and HT-22/MR16 cells were plated at 1.5-
2.5Z104 cells/well in 24 well plates in media containing 10% FCS.  Twenty-four hours 
later, transient transfections were performed using Lipofectamine.  Briefly, 250 μg of a 
glucocorticoid responsive reporter plasmid (5GRE-Luc or MMTV-Luc) and 50ng of 
CMV-β-gal were transfected per well in serum free media.  After 12 hours, the 
transfection media was replaced with media containing 10% charcoal-stripped FCS and 
the drugs indicated (or vehicle alone) for an additional 20 hours.  Forty-eight hours after 
transfection, cells were rinsed with ice cold PBS-D and lysed in the well with buffer 
containing 0.25M Tris pH 8.0, 0.1 mM EDTA, 5mM MgSO4, 1mM DTT, and 1% Triton.  
Lysates were centrifuged at 10,000 rpm for 10min at 4°C and supernatants were assayed 
for luciferase activity as previously described (Rozeboom, Akil et al., 2007) using a 
Promega 20/20n luminometer.  RLU values were normalized to β-gal activity to correct 
for transfection efficiency as previously described (Seasholtz, Thompson et al. 1988).  
Data for all treatment groups are expressed as fold induction over vehicle alone.  
Experiments were performed in triplicate and repeated 2-5 times. 
 
Corticosterone Binding assays. For single receptor binding capacity determinations, 
3X105 cells were plated in 10% charcoal-stripped FCS.  Twenty-four hours later, cells 
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were harvested and resuspended in TEMDG (20 mM Tris/1 mM EDTA/20 mM sodium 
molybdate/5 mM DTT/10% glycerol/10x Sigma Protease Inhibitor Cocktail, pH 7.6 at 
4°C) binding buffer.  After a brief sonication (setting 4 for 5 seconds with a Branson 
Sonifier 150), samples were centrifuged at 4 C at 16,100 x g for 30 min (Pearce and 
Yamamoto 1993).  Supernatants were removed and used for the binding assays.  For each 
sample, three sets of lysates were incubated, in triplicate, for 20 hours at 4°C under the 
following 3 conditions: 1) 20nM [1,2,6,7-3H] corticosterone (67μCi/nmol, Amersham, 
Arlington Heights IL) (total binding), 2) 20nM [3H]corticosterone + plus 100 nM 
mifepristone to displace GR binding, and 3) 20nM [3H]corticosterone + 10μM unlabeled 
corticosterone for determination of nonspecific binding.  Bound and free 
[3H]corticosterone were separated by addition of an ice-cold dextran/charcoal suspension 
in TEMDG (0.05/0.5%).  The tubes were incubated 10 min at 0-2°C and centrifuged.  
The supernatants were removed and counted in a Packard scintillation counter at 45% 
efficiency.  Protein content was measured by Bradford assay using BSA as a standard, 
and the apparent maximal binding capacity (Bmax) was expressed as fmol/mg protein. GR 
binding (RU486 displaceable) was calculated from the difference between conditions 1 
and 2 above.  MR binding was calculated from the difference between condition 2 (3H-
corticosterone binding not displaced with RU486) minus background (condition 3). 
 
Cell Survival Assay. The MTT (3-(4,5,dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium 
bromide) assay (Hansen, Nielsen et al. 1989) was used to measure cell death.  This assay 
relies on the conversion of the MTT tetrazolium salt to a purple formazan crystal by 
mitochondrial enzymes.  HT-22 Parent and HT-22/MR16 cells were plated at 8-15X103 
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cells/well in 24 well plates in low glucose DMEM + 10% charcoal-stripped FCS media.  
The next day, cells were pre-treated with the drugs indicated or vehicle alone for 24 
hours.  Cells were then treated with varying concentrations of glutamate for an additional 
16-22 hours.  MTT (Sigma, 5mg/ml stock in PBS) was added to 0.05mg/ml final 
concentration for 4 hours.  Finally, 500μl of solubilization buffer (50% 
dimethylformamide and 20% SDS, pH 4.8) was added.  After overnight incubation at 
37°C, absorbance readings were measured at 590nm.  Data are expressed as % survival 
relative to vehicle treated control cells.  All experiments were performed in triplicate and 
repeated multiple times. 
 
Western Blots. HT-22 Parent and HT-22/MR16 cells were plated on 10 cm plates at a 
density of 22.5X104 cells/plate.  Thirty-six hours later, cells were pre-treated with 1μM 
corticosterone or ethanol vehicle alone for 24 hours.  Six mM glutamate was added (or 
vehicle control) and cells were harvested at 2-hour intervals for 12 hours.  Cells were 
harvested in 1ml cold PBS, centrifuged at 4°C at 3000 rpm for 8 minutes, and cell pellets 
were re-suspended in 100 μl RIPA buffer (0.05M Tris pH 7.5, 0.15M NaCl, 1% 
IGEPAL, 0.1% SDS, 1% deoxycholic acid) plus 1:50 dilution of protease inhibitor 
cocktail (Sigma).  Lysates were centrifuged at 10,000 rpm for 10 minutes at 4°C and 
supernatants were used for western analysis.  Equal amounts of protein (12 μg) were 
loaded and separated on discontinuous 10% (bottom 1/3), 7% (top 2/3) SDS-
polyacrylamide gels.  Proteins were tank transferred to PVDF membranes (Millipore, 
Billerica MA) in transfer buffer (25mM Tris, 150mM glycine, and 20% methanol) + 
0.02%SDS for 2 hours at 200V.  For immunoblots, membranes were blocked in a buffer 
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containing 20mM Tris pH 7.5, 150mM NaCl, 0.1% Tween 20 (TBST) + 5% non-fat dry 
milk (NFDM) for 1hr at room temperature and then incubated with a 1:2000 dilution of 
α-Fodrin antibody (Biomol-Affinity Research Products, Plymouth Meeting, PA) 
overnight at 4°C in TBST.  After washing, immunoblots were incubated with a 1:50,000 
dilution of HRP linked donkey anti-mouse antibody (Jackson, West Grove, PA) for 1-2 
hours at room temperature in TBST.  Immunoblots were visualized with Lumi-Light 
(Roche, Indianapolis, IN) according to the manufacturer’s suggestions. 
 
Results: 
Generation of HT-22 MR expressing clones: 
The HT-22 hippocampal cell line has previously been shown to exhibit 
corticosterone-mediated transactivation of MMTV-luciferase activity that is blocked by 
RU486 (Schmidt, Holsboer et al. 2001), consistent with the presence of GR in these cells 
as shown by western blot (Wang, Pongrac et al. 2002).  However, previous studies had 
not tested for the presence of MR in HT-22 cells.  Therefore, [3H]-corticosterone binding 
assays were performed with the HT-22 Parent cell line.  RU486 blocked > 99% of [3H]-
corticosterone binding, demonstrating a lack of detectable corticosterone binding by MR 
in the HT-22 cells (Figure 3-1A).  Therefore, to address the effects of corticosteroid 
signaling in a cellular context that contains both MR and GR, more closely resembling 
the endogenous hippocampal setting, HT-22 cells were stably transfected with a CMV- 
MR expression construct.  [3H]-corticosterone binding assays were used to characterize 
the apparent maximal binding (Bmax) of MR and GR in the independently selected clonal  
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Figure 3-1 HT-22 Parent and HT-22/MR clones express either GR alone or MR and 
GR in different ratios. 
A) Lysates from HT-22 Parent or HT-22/MR clones were incubated with 
[3H]corticosterone plus or minus RU486 to specifically block GR binding, or unlabeled 
corticosterone to determine non-specific binding as described in the Materials and 
Methods.  B) Binding data from (A) expressed as ratios of MR:GR.  GR binding was 
derived from the RU486 displacement of the [3H]corticosterone binding and MR binding 
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cell lines.  While the Bmax for GR in HT-22 Parent cells was approximately 250fmol/mg 
protein, there was no detectable binding for MR (Figure 3-1A).  Analyses of four stably 
transfected clonal cell lines reveals a range of Bmax values for MR binding, with Bmax 
values ranging from 10-110 fmol/mg protein.  In all of these clones, Bmax values for GR 
are decreased relative to the parent cell line, consistent with the MR mediated down-
regulation of GR (Herman and Spencer 1998).  Figure 3-1B depicts the binding data as a 
ratio of [3H]-corticosterone binding by MR relative to GR, revealing ratios that range 
from 0 in the parent cell line to an MR binding at 80% that of GR in clone HT-22/MR16.  
 
Transactivation properties of HT-22 cells and HT-22/MR stable clones: 
To further characterize the HT-22 Parent and clones, reporter gene transactivation 
assays were performed with two different promoters driving the expression of luciferase.  
The 5GRE-Luc construct contains 5 tandem repeats of the tyrosine amino transferase 
GRE in combination with the TATA region of the Adenovirus 2 major late promoter and 
the MMTV-Luc construct contains the well characterized glucocorticoid responsive 
MMTV-LTR promoter.  Using a wide range of corticosterone doses, inductions of 
reporter gene activity with the 5GRE promoter were not detectable in the HT-22 parent 
cells until 100nM corticosterone (Figure 3-2A), similar to what has been previously 
reported (Schmidt, Holsboer et al. 2001); in clone HT-22/MR16, inductions in GRE-
luciferase reporter gene activity were detected as low as 0.01 nM corticosterone.  The 
HT-22/MR24 clone showed intermediate levels of induction over the dose response 
curve, relative to HT-22/Parent and HT-22/MR16, with statistically significant inductions 
at 0.05nM corticosterone. Results using the MMTV-luciferase construct were similar to 
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Figure 3-2 HT-22 Parent, HT-22/MR16, and HT-22/MR24 clones exhibit different 
transactivation profiles in response to different doses of corticosterone. 
(A) The different cell lines were transiently transfected with the 5GRE-Luc and CMV β-
gal for 12 hours and exposed to varying concentrations of corticosterone for an additional 
20 hours. Normalized luciferase activity (luciferase activity/ gal activity) for samples was 
divided by their respective no drug control to result in fold induction in luciferase 
activity. The data are presented as mean ± SEM and represent three independent 
experiments done in duplicate.  B) Experiment performed identically to (A) except with 
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the 5GRE-luciferase construct (Figure 3-2B).  Inductions in reporter gene activity did not 
rise above background until 100nM corticosterone in the HT-22 parent cells; significant 
inductions in luciferase activity were observed at less than or equal to 1nM corticosterone 
in both HT-22/MR16 and HT-22/MR24  (Figure 3-2B).  As seen above, clone HT-
22/MR24 which contains about 3-4 fold less MR than clone HT-22/MR16, exhibited an 
increase in reporter gene activity at similarly low levels of corticosterone as MR16, albeit 
the fold induction in luciferase activity was less.  As the Kd of MR for corticosterone is 
0.5nM, luciferase activity at this concentration of drug most likely reflects the activation 
of MR, consistent with the lack of induction in reporter gene activity until much higher 
concentrations in the parent HT22 cell line.  The differences in profiles of GRE-luc and 
MMTV-luc most likely reflects other contextual differences of the promoters in terms of 
both the number and positioning of GREs, as well as the possible presence of other cis-
acting elements that may result in differential interactions of MR and GR with other co-
regulators and transcription factors. 
To demonstrate the receptor specificity of these transactivation properties, the GR 
and MR specific ligands, dexamethasone and aldosterone, and the GR-specific and MR-
specific antagonists, RU486 and eplerenone were also used.  In the HT-22 parent cell 
line, 7 and 15 fold inductions of luciferase activity from the 5GRE-luc-reporter plasmid 
were seen with 1μM corticosterone and dexamethasone, respectively.  These inductions 
were blocked 100% by the co-incubation of 1μΜ RU486 (Figure 3-3A), but are not 
blocked at all by the co-incubation of the MR-specific antagonist eplerenone (data not 
shown).  Aldosterone (10 nM) had no effect on the HT22 parent clone (Figure 3-3A).  In 
clone HT-22/MR24 and HT-22/MR16, however, aldosterone significantly increased 
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Figure 3-3 Receptor specificity of corticosteroid transactivation properties. 
A) Parent HT-22 cells are transiently transfected with 5GRE-Luc and CMV β-gal as in 
Figure 2, and treated with vehicle alone, dexamethasone (D), corticosterone (C), or 
aldosterone (A) plus or minus RU486 as indicated.  The data represent the mean ± SEM 
of three experiments performed in duplicate.  B) Clone HT22/MR24 and C) HT22/MR16 
treated with corticosterone or aldosterone as indicated.  The data represent the mean ± 
SEM of three experiments performed in duplicate. * = p < 0.05 from vehicle treated cells, 
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luciferase activity (Figure 3-3B and Figure 3-3C).  Interestingly, eplerenone effectively 
blocks 100% of the corticosterone-mediated inductions in luciferase activity in HT-
22/MR16 at 1nM corticosterone, but neither eplerenone alone, nor RU486 alone, blocks 
the inductions in luciferase activity at 1 μM (data not shown).  When RU486 and 
eplerenone were used together, they produced a significant 35% drop in reporter gene 
activity but this induction was still significantly above control (data not shown).  These 
data suggest that at concentrations of corticosterone sufficient to activate both receptors, 
the transactivation properties of MR and GR on this promoter are more complex than 
with activation of either MR or GR alone.  As heterodimers are likely to be forming at the 
high corticosterone concentrations, these results also suggest that the antagonists may not 
effectively block transactivation of GR/MR heterodimers. 
 
Glutamate-induced neurotoxicity and corticosteroid endangerment and protection: 
HT-22 cells are sensitive to glutamate through a non-excitotoxic pathway, as 
these cells do not express ionotropic glutamate receptors.  Instead, excess glutamate is 
thought to compete for cystine, preventing its import into the cell, thus leading to a 
reduction in glutathione levels, the accumulation of reactive oxygen species and eventual 
cell death through an apoptotic pathway.  Previous studies in HT22 cells have shown that 
pre-exposure with corticosterone can exacerbate glutamate toxicity (Behl, Lezoualc'h et 
al. 1997).  HT-22 cells were pre-exposed for 24 hours to different doses of corticosterone 
before the addition of 6mM glutamate for an additional 16 hours.  As predicted, 
corticosterone treatment of HT-22 cells decreases, in a dose dependent manner, cell 
survival relative to glutamate treatment alone as measured by the MTT assay  
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(Figure 3-4A).  To address the consequences of the activation of MR along with GR, HT-
22/MR16 cells were also pre-exposed to the same doses of corticosterone before the 
addition of 6mM glutamate.  In contrast to HT-22 Parent cells, corticosterone dose 
dependently increased cell survival relative to glutamate treatment alone in HT-22/MR16 
cells (Figure 3-4A).  To determine if corticosterone exacerbation of glutamate toxicity is 
dependent on the dose of glutamate, HT-22 Parent and HT-22/MR16 cells were pre-
exposed with 1μM corticosterone for 24 hours before the addition of increasing levels of 
glutamate for an additional 22 hours.  While corticosterone pre-exposure further 
decreased cell survival in the HT-22 Parent cell line at all 3 doses of glutamate (Figure 3-
4B), corticosterone did not exacerbate cell death relative to glutamate alone in clone 
HT22/MR16 (Figure 3-4B), suggesting a potential neuroprotective role for MR.   
Previous data suggest the involvement of apoptotic mechanisms in glutamate-
induced cell death of HT-22 cells, as inhibitors of the apoptotic enzyme calpain can block 
glutamate-induced cell death in this cell line (Zhang and Bhavnani 2006).  Preliminary 
experiments have been performed to address the possible role of apoptotic mechanisms in 
the corticosterone-mediated exacerbation of glutamate-induced cell death.  HT-22 Parent 
and HT-22/MR16 cells were analyzed by western blots for the calpain and caspase-3 
dependent cleavage of the cytoskeletal protein α-Fodrin. Cleavage of the 240KDa α-
Fodrin by calpain and caspase-3 results in 145KDa and 120KDa products, respectively.  
HT-22 Parent cells were pre-incubated with corticosterone or ethanol vehicle alone for 24 
hours before the addition of 6mM glutamate.  Western blot analysis for α-Fodrin in cells 
harvested in two-hour intervals for 12 hours after addition of glutamate suggests that pre-
incubation with corticosterone may enhance the accumulation of cleavage products 
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Figure 3-4 Glucocorticoid exacerbation of glutamate toxicity is attenuated in Clone 
HT-22/MR16. 
A) HT-22 Parent and Clone HT-22/MR16 are pre-incubated for 24 hours with varying 
doses of corticosterone or vehicle alone before the addition of 6 mM glutamate for and 
additional 16 hours as described in the Materials and Methods.  B)  HT-22 Parent and 
Clone HT-22/MR16 cells are pre-incubated with 1μM corticosterone or vehicle alone for 
24 hours before the addition of different doses of glutamate for an additional 22 hours.  
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specific to both caspase-3 and calpain activation (Figure 3-5).  Similar analysis with HT-
22/MR16 cells suggests no differences in the accumulation of cleavage products between 
cells that were pre-exposed to corticosterone and those that were exposed to vehicle.  
 
Discussion: 
 While there is some evidence that corticosteroids can be directly toxic to neurons, 
the primary actions of glucocorticoids are thought to place neurons in a state of metabolic 
distress that subsequently exacerbates any further insults, such as enhancement of 
glutamate toxicity.  Glutamate levels are increased during insults such as ischemia and 
hypoglycemia and excessive levels of corticosteroids during such insults increases 
neuronal cell death in hippocampus (Sapolsky and Pulsinelli 1985).  The HT-22 mouse 
hippocampal cell line is quite sensitive to glutamate toxicity, and it has been shown that 
corticosterone pre-exposure of these cells exacerbates glutamate toxicity.  Hence, these 
cells provide a model system in which to examine the role of corticosteroid receptors in 
corticosterone-induced endangerment to glutamate-induced cell death.  However, the 
parent HT-22 cells express only GR, suggesting that glucocorticoid endangerment is 
mediated entirely by GR in this cell line.  As GR is co-expressed with MR in most 
regions of the hippocampus, the parent HT-22 cells do not recapitulate the normal 
corticosteroid-signaling environment of the hippocampus.  The goal of our study was to 
test the hypothesis that expression and activation of MR in HT-22 cells may attenuate or 
block the endangering effects of GR signaling alone. 
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Figure 3-5 Corticosterone pre-treatment enhances α-Fodrin cleavage in HT-22 
Parent but not HT-22/MR16 cells. 
HT-22 Parent and HT-22/MR16 cells were pre-treated with either 1μM corticosterone or 
vehicle alone (- corticosterone) for 24 hours before the addition of 6mM glutamate.  Cells 
were harvested after the indicated amount of time.  Cell extracts were separated by SDS-
PAGE and used for western blot analysis with an anti- α-Fodrin antibody.  The 240 KDa 
band represents the uncleaved protein, whereas the 145 KDa and 120 KDa bands 
represent α-Fodrin cleaved by activated calpain and caspase-3, respectively. 
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 We report here the generation of stably-transfected HT-22 clones with varying 
levels of MR, and hence different MR/GR ratios, as evidenced by [3H]corticosterone 
binding.  Previous transactivation studies have shown that, depending on the cellular and 
promoter context, MR activation can have synergistic effects with GR when both are 
activated (Trapp, Rupprecht et al. 1994), or it can have antagonistic effects, repressing 
the transactivation activity of GR alone (Liu, Wang et al. 1995).  In the context of HT-22 
cells, as the ratio of MR to GR increased from 0 in the Parent cell line to 0.2 and 0.8 in 
clones HT-22/MR24 and HT-22/MR16 respectively, the level of 5GRE-luciferase and 
MMTV-luciferase reporter gene activity is increased over the entire corticosterone dose 
response curve.  These data suggest that at low concentrations of corticosterone, MR is 
capable of mediating positive transcriptional effects on these two promoters; similarly at 
high levels of corticosterone, sufficient to bind both MR and GR, the activity of MR does 
not inhibit GR function from the two promoters analyzed, but significantly increases the 
transcriptional response.   
HT-22 cells are very sensitive to glutamate and Behl et al. showed that pre-
incubating HT-22 cells with corticosterone leads to an exacerbation of the glutamate 
toxicity that is dependent on GR activation alone (Behl, Lezoualc’h et al. 1997).  Here we 
confirm that finding, showing that corticosterone enhances glutamate-induced cell death 
in the HT-22 Parent cell line.  However, in HT-22/MR16, pre-incubating the cells with 
1μM corticosterone no longer enhances glutamate-induced toxicity at any glutamate 
concentration tested, suggesting that the activation of MR along with GR is capable of 
diminishing the glucocorticoid endangerment effect.   
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Extensive efforts have been made to determine the molecular mechanisms 
underlying glutamate mediated cell death in HT22 cells.  These mechanisms are complex 
and are thought to involve the initial depletion of GST, followed by activation of 12-
lipoxygenase, and subsequent accumulation of ROS and intracellular Ca2+ (Li, Maher et 
al. 1997).  Ultimately, morphological features of both apoptosis and necrosis have been 
described in the cell death pathway (Tan, Wood et al. 1998).  In addition, molecular 
features of apoptosis have also been described in the glutatmate-induced cell death 
pathway.  This is exemplified by DNA fragmentation as well as involvement of apoptotic 
proteases, as inhibitors of calpain can prevent glutamate-mediated features of apoptosis in 
HT-22s (Zhang and Bhavnani 2006).  The mechanisms by which glucocorticoids 
exacerbate glutamate toxicity in HT-22s are not fully understood, but evidence suggests 
that metabolic constraints may be involved as increasing the concentration of glucose in 
the media can attenuate the glucocorticoid endangerment effect (Behl, Lezoualc’h et al. 
1997).  Preliminary studies suggest that pre-incubation of HT-22 Parent cells with 
corticosterone may increase cell death in response to glutamate via apoptotic 
mechanisms, as the presence of α-Fodrin cleavage products is increased throughout the 
time-course of glutamate treatment relative to cells not treated with corticosterone.  
Interestingly, the accumulation of α-Fodrin cleavage products in HT-22/MR16 cells is 
not increased in cells pre-treated with corticosterone relative to vehicle treated cells.  MR 
activation has been previously implicated in neuronal protection from toxic insults (Lai, 
Seckl et al. 2005; Lai, Horsburgh et al. 2007).  MR activity has also been implicated in 
the regulation of select cell survival and cell death related genes in the hippocampus 
(McCullers and Herman 1998).  These data suggest that the activation of MR along with 
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GR may normalize processes that would otherwise lead to increased apoptosis if only GR 
were activated during a toxic insult.  Indeed, using serial analysis of gene expression 
(SAGE) in the rat hippocampus, a previous study found that when MR and GR are 
activated at the same time, different but partially overlapping sets of genes were regulated 
by corticosterone relative to when MR was activated alone (Datson, van der Perk et al. 
2001). 
 Currently, evidence suggests that prolonged exposure to high levels of 
corticosteroids may be involved in the decline of the structural and functional integrity of 
the hippocampus and that these alterations may be an important component in the 
etiology of mood disorders.  It is hypothesized that subtle alterations in the ratio of MR to 
GR expression and activation in the hippocampus may underlie some of these deleterious 
effects.  Experiments with HT-22 cells have shown them to be a good model system to 
study the endangering effects of corticosteroids and their ability to exacerbate subsequent 
toxic insults.  Evidence provided here suggests that when MR is stably expressed in HT-
22 cells, the ability of corticosteroids to exacerbate glutamate toxicity is attenuated.  
These data support the hypothesis that a proper balance in the activation of MR and GR 
in hippocampal cells has important cellular consequences and that the declines in the 
ratio of MR to GR observed in models of depression and anxiety, such as chronic 
unpredictable stress, may serve to enhance the phenomenon of glucocorticoid 
endangerment. 
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Chapter 4 
Comparison of corticosteroid-responsive genes in mouse hippocampal cell lines that 





 Glucocorticoid hormones influence the structure and function of the 
hippocampus, a brain region intimately involved in learning and memory and the 
modulation of anxiety-related behaviors.  The high sensitivity of the hippocampus to 
glucocorticoids is not surprising as the hippocampus exhibits the highest levels of co-
expression of the two receptors that bind glucocorticoid hormones, the mineralocorticoid 
receptor (MR) and the glucocorticoid receptor (GR).  MR and GR are two of the most 
closely related members of the steroid/thyroid hormone receptor superfamily and they 
function as ligand-activated transcription factors. These two corticosteroid receptors 
normally reside in the cytoplasm, dimerize upon ligand binding, and translocate to the 
nucleus where they can enhance or repress transcription of glucocorticoid-responsive 
genes.   
While both MR and GR bind glucocorticoid hormones, they do so with very 
different affinities (MR: Kd~0.5nM for corticosterone; GR: Kd~5nm for corticosterone), 
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suggesting that they have different activation profiles throughout the circadian rhythm 
and during times of stress.  In addition to differences in ligand binding properties, MR 
and GR are also significantly different in their N-terminal domains (only 15% amino acid 
identity), regions that contain activating function (AF) sequences that allow for 
interactions with other transcription factors and co-regulators.  These distinct AF regions 
allow similar interactions for MR and GR with some co-regulators, while other co-
regulators have been found to only interact with one receptor (Kitagawa, Yanagisawa et 
al. 2002), or to act as a coactivator of one but a corepressor of the other (Pascual-Le 
Tallec, Simone et al. 2005). Hence, these differences in ligand affinity and interactions 
with co-regulators define mechanisms by which MR and GR can differentially affect 
transcription of glucocorticoid-responsive genes when expressed individually or together. 
Finally, MR and GR have been shown to form heterodimers, in addition to 
homodimers, in contexts where they are coexpressed such as the hippocampus.  Little is 
known about the rules that govern heterodimerization beyond stoichiometric 
considerations.  It is known, however, that the transcriptional outcome of heterodimer 
formation for transcriptional activation or repression is dependent on the cellular and/or 
promoter contexts and corticosterone concentrations.  In some cases, heterodimers work 
more efficiently than either GR or MR homodimers (Trapp, Rupprecht et al. 1994) and in 
other cases, the heterodimer is less efficient than the homodimers (Liu, Wang et al. 
1995).  Overall, the data suggest that when MR and GR are co-expressed, the 
transcriptional regulation of corticosteroid-responsive genes will be determined by 
multiple factors including the concentration of corticosteroid, the relative levels of MR 
and GR, and the expression profiles of other transcription factors and coregulators.  All of 
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these factors together may result in the differential regulation of genes when MR and GR 
are both activated relative to the regulation derived from the activation of either MR or 
GR alone. 
Functionally, a shift in the balance of MR and GR activation can have significant 
effects on several features of cellular function and survival.  On a cellular level, 
glucocorticoids can modulate multiple properties relevant to learning and memory and 
information transfer out of the hippocampus.  Levels of corticosteroids equivalent to a 
stressor decrease long-term potentiation (LTP) whereas low levels of corticosteroids 
enhance LTP (McEwen and Sapolsky 1995).  Similarly, low levels of corticosterone can 
enhance excitability of pyramidal neurons in the hippocampus while higher levels of 
hormone result in decreased neuronal excitability (Joels and de Kloet 1991; Joels and de 
Kloet 1992).  Interestingly, under conditions of ADX, when no corticosteroids are 
present, a similar cellular phenotype is observed as under high levels of corticosteroids.  
These inverted U shaped patterns can be explained, at least in part, by the relative 
occupation of the two corticosteroid receptors present in the hippocampus.  Studies with 
low levels of corticosteroids, which preferentially bind to MR, as well as specific 
agonists for MR suggest that the activity of this receptor is responsible for increased LTP 
and increased neuronal excitability.  Conversely, higher levels of corticosteroids, 
activating both MR and GR, and specific agonists for GR decrease LTP and neuronal 
excitability (Joels and de Kloet 1991; De Kloet, Vreugdenhil et al. 1998).  With respect to 
cell survival, high levels of glucocorticoids can enhance the likelihood that a neuron will 
die with a subsequent toxic insult.  Multiple lines of evidence suggest that this 
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“glucocorticoid endangerment” is propagated through predominant activation of GR, 
whereas MR activation can provide a neuroprotective effect (Herman and Seroogy 2006) 
Clearly, an understanding of glucocorticoid actions on hippocampal structure and 
function requires an understanding of the combined actions of MR and GR.  As 
mentioned previously, the transcriptional output of MR and GR activity may be affected 
not only by absolute glucocorticoid concentrations, but also by the levels and ratio of MR 
to GR present in the cell.  The study of MR/GR heterodimer-mediated transcriptional 
regulation has been limited to only a few individual genes (Trapp, Rupprecht et al. 1994; 
Liu, Wang et al. 1995; Ou, Storring et al. 2001), and little is known at the transcriptome 
level about genes that are regulated exclusively by the individual receptors and/or the 
extent of overlap of the transcriptional effects of activated MR and GR. 
A recent study from Datson et al. aimed to identify corticosteroid-responsive 
genes in the rat hippocampus using either low or high doses of corticosterone (to activate 
MR alone or MR and GR together) in adrenalectomized (ADX) rats.  Using SAGE 
analysis, they identified 203 genes that were regulated by either low or high doses of 
corticosterone, but only 33 genes that were regulated by both doses of corticosterone 
(Datson, van der Perk et al. 2001), suggesting that the activation of MR alone or GR and 
MR together in the same cell may regulate both distinct and partially overlapping sets of 
genes. A drawback to this analysis is that it does not allow the identification of genes 
responsive specifically to activated GR, as it is not possible to distinguish between GR 
homodimer and GR/MR heterodimer activities at high corticosterone concentrations. This 
system also does not allow for the assessment of gene expression at a constant dose of 
corticosterone under conditions of altered MR and GR levels. These questions can be 
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more easily addressed in an in vitro system such as a mouse hippocampal cell line. 
 The mouse hippocampal cell line HT-22 was originally generated to study 
mechanisms of glutamate toxicity.  It was subsequently demonstrated that this cell line 
expresses GR, and it has been used to study GR-mediated glucocorticoid endangerment 
as well as GR interactions with other signaling pathways.  We previously determined that 
HT-22 cells do not express MR.  To address the global transcriptional effects of MR and 
GR signaling, we generated clones of HT-22 cells that co-express MR and GR in varying 
levels for use in a microarray analysis.  By examining the gene expression profile of the 
HT-22/Parent and HT-22/MR clonal cells with low and high doses of corticosterone, this 
system can overcome drawbacks of the endogenous system, allowing us to identify genes 
responsive to GR activation (HT-22/Parent at high dose corticosterone), genes responsive 
to MR activation (HT-22/MR clones at low dose corticosterone) and genes regulated by 
the activation of both MR and GR (HT-22/MR clones at high dose corticosterone). 
 
Materials and Methods: 
Cell culture. HT-22 cells were obtained from Dr. David Schubert (Salk Institute, San 
Diego).  This immortalized mouse hippocampal cell line was selected from HT-4 cells 
based on glutamate sensitivity (Maher and Davis 1996).  HT-22 cells were maintained in 
DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum (FCS, 
Hyclone, Logan, UT), and gentamicin (50μg/ml, Invitrogen) at 37°C in 5% CO2. 
 
Generation of HT-22 clones containing MR. The generation and characterization of 
clone HT-22/MR16 is described in detail in Chapter 3.  HT-22 Parent cells express GR 
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but do not express MR.  HT-22/MR16 clonal cells were shown by [3H]corticosterone 
binding assays to express GR and MR at a ratio of 1:0.8. 
 
Isolation of RNA. Cultures of HT-22 Parent and HT-22/MR16 cells were plated on 10 
cm plates in DMEM + 10% charcoal-stripped FCS + 50 μg/ml gentamicin and grown to 
~60-70% confluency.  Triplicate plates of cells were treated with vehicle (ethanol, 0.1% 
final concentration) or corticosterone (1nM or 100nM, Sigma, St. Louis, MO) 24 h before 
harvest, and total cellular RNA was isolated using Trizol (Invitrogen) according to the 
manufacturer’s protocol.  Thirty μg of total RNA was further purified using the RNeasy 
spin columns according to the manufacturer’s protocol (Qiagen, Inc., Valencia, CA). 
 
RNA Probes for Microarray. Total RNA (175 ng) was amplified using the Illumina 
Totalprep RNA Amplification Kit (Ambion, Inc.) to generate biotinylated amplified RNA 
(aRNA).  Two micrograms of biotinylated aRNA was used for hybridization to Illumina 
Sentrix Bead Chips (Illumina Mouse 6_V1) according to manufacturer’s 
recommendations. Following scanning, array data processing, normalization (Rank 
Invariant), and analysis was performed with Illumina BeadStudio software. ). Array 
values shown on the Tables are the mean of the 3 replicates for each sample. 
 
Quantitative RT-PCR. Ten micrograms of total RNA from each sample were treated 
with RNase-free DNase according to the manufacturer’s protocol (Ambion, Austin TX).  
First-strand DNA synthesis was synthesized using 4μg of DNA-free RNA with Oligo-dT 
primers and Superscript II reverse transcriptase according to the manufacturer’s 
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recommendations (Invitrogen).  PCR reactions (25μl) contained 1μl of cDNA template, 
12.5μl 2x SYBR Green I Master Mix (Bio-Rad, Hercules, CA) and 250nM forward and 
reverse primer.  Reactions were carried out in a Bio-Rad iCycler.  The cycling conditions 
were as follows:  polymerase activation 10 minutes at 95°C and 40 cycles at 95°C for 20 
sec, 60°C for 20 sec, and 72°C for 20 sec followed by melt curve analysis.  All reactions 
were performed in biological triplicates and experiments contained –RT reactions for 
each sample and a no template control for each primer set.  PCR efficiencies for all 
primer pairs were determined by performing a standard curve of 3 serial 1:4 dilutions of 
HT-22 cDNA.  The expression of the gene of interest was normalized in parallel 
reactions with TATA binding protein (TBP).  This gene was not regulated by 
corticosterone treatment in HT-22 cells.  Primer pairs for housekeeping gene (TBP) and 
Dbp were obtained from Primer Bank (Wang and Seed 2003).  Primer pairs for all the 
other genes used were designed using Primer3 platform.  Changes in gene expression 
levels were quantitated with efficiency correction using the following mathematical 
formula, ratio=(Etarget) ΔCPtarget/(Eref) ΔCPref (Abbreviations: E, efficiency; CP, threshold 
crossing point; target, target gene; ref, reference gene (Pfaffl, Lange et al. 2003) which 
accounts for differences in primer efficiencies.  Data represent the average of three 
biological replicates.   
 
Real-Time RT-PCR primers: 
Gene     Forward Primer        Reverse Primer    Amplicon size          Melt Temp (Tm) 
 
Per2             gtgcgatgatgattcgtgag              aaaagacacaagcagtcacacaa           106bp      60/60 C 
Per3     gtacaccggcaatctctgct           caacacacacttttcttaccaattc           137bp      60/59 C 
NR1D1     gggctctggtgctgaaga             gtccacccggaaggacag                  125bp      60/61 C 
TEF     aaagaggccaggagaaaagc          cccaacttccctccataaca                 143bp       60/60 
 
    132
Dbp     cctgatcccgctgatctcg          caggcacctggactttcctt                  133bp       62/62 
TBP     agaacaatccagactagcagca             gggaacttcacatcacagctc             120bp      59/60 C 
 
Identification of Differentially Expressed Genes. Differentially expressed genes were 
identified by comparing corticosterone-treated values to vehicle-treated values within 
each cell line using the following criteria: 1) differential expression required a Diff. score 
of ± 17 (p-value = 0.02) and 2) differential expression required at least a ± 1.5 fold (or 
greater) change in expression.  We found that genes with average intensity values of less 
than 100 were highly variable within the triplicate samples for that group due to their 
very low expression.  Therefore, genes were only included in the analysis if their average 
expression intensity values were greater than 100 in at least one of the comparison 
groups. 
 
Gene Ontology Classification of Differentially Expressed Genes. The Gene Ontology 
Tree Machine website (http://bioinfo.vanderbilt.edu/gotm) was used assign gene ontology 
(GO) terms to each gene and to determine which categories of genes are overrepresented 
in the data.  The GoMiner website (http://discover.nci.nih.gov/gominer/) was used in 
combination with VennMaster software (http://www.informatik.uni-
ulm.de/ni/staff/HKestler/vennm/doc.html) to also assign GO terms to the differentially 
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Results: 
Microarray Data: 
 Biological replicates (n=3) were used to generate triplicate RNA samples and 
biotinylated aRNA probe sets for each condition: HT-22 Parent cells treated with vehicle 
alone (P0), 1nM corticosterone (P1), or 100nm corticosterone (P100), and HT-22/MR16 
cells treated as above (M0, M1, and M100).  Each Illumina BeadChip array contained 
~42,000 genes and each gene was represented with, on average, a 30 fold redundancy to 
provide a measure of internal variability.  Signal intensity values are reported in arbitrary 
units and ranged from -50 to ~80,000 for all the genes on the array.  As expected, most of 
the highly expressed genes (signal intensity values of =/> 10,000 on the array) were 
involved in general cellular biosynthetic processes, including many ribosomal and 
structural genes.  As a measure of array integrity, scatter plots were generated from all 
the genes on the arrays comparing the vehicle-treated control groups to the 
corticosterone-treated groups within each cell line.  Figure 4-1 depicts the scatter plots of 
P0 vs. P1, P0 vs. P100, M0 vs. M1, and M0 vs. M100.  A visual inspection of the data 
reveals that the average signal intensity values for most of the genes are equivalent 
between each treatment group suggesting that there were no significant abnormalities in 
the RNA or probe integrity between groups.  The points above or below the main line 
indicate genes whose expression is altered by the treatment; as predicted, the majority of 
genes with altered expression are present in the P0 to P100 and M0 to M100 
comparisons. 
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Figure 4-1 Array integrity is equivalent between samples. 
Scatter plots containing the average intensity values of all the genes on the array are 
compared between vehicle treated control cells on the x-axis and the respective treatment 
groups on the y-axis.  Visual inspection of the graphs suggests that there are no major 
differences in sample integrity between groups.  P0=HT-22 Parent vehicle control, 
P1=HT-22 Parent 1nM corticosterone, P100=HT-22 Parent 100nM corticosterone, 
M0=HT-22 MR16 vehicle control, M1= HT-22 MR16 1nM cortiocsterone, and 
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Corticosterone-responsive genes activated or repressed by GR occupation: 
 Using the criteria outlined in the Materials and Methods section (Diff. score>17 
and change >1.5 fold), differentially expressed genes were identified in the HT-22 Parent 
cell line in response to treatment with 1nM or 100nM corticosterone when compared to 
vehicle alone.  In response to 1nM corticosterone, only 4 genes were differentially 
regulated, all of which were repressed.  These included two unknown genes, 
2600005O03Rik (-1.9 fold change in expression, Diff. score -39.04) and LOC234640 
(1.5 fold, Diff. score -22.94), and two known genes, the ubiquitin specific protease Usp1 
(-1.5 fold, Diff. score -22.79), and the Arf-like GTPase Arl10b (-1.5 fold, Diff. score 
27.29).  As HT-22 cells do not express MR, we did not expect to see many genes whose 
expression was altered at 1nM corticosterone, significantly below the Kd for GR.   
 However, as predicted, 252 genes were up or down-regulated in the HT-22 Parent 
cell line in response to 100nM corticosterone.  Of the 252 regulated genes, 193 were 
identified as known genes and the other 59 are largely represented by cDNAs from the 
RIKEN Mouse Encyclopedia Project.  Seventy-nine percent of these genes were down-
regulated and 21% were up-regulated.  Table 4-1 lists the 252 genes that were present at 
significantly different levels in the P100 group with respect to the vehicle-treated P0 
group, and Table 4-2 lists the 10 genes that are induced or repressed to the greatest 
extent.  As this cell line only expresses GR, the regulation of these genes can be said to 
be GR-specific.  
To identify classes of regulated genes and place them into functional categories, 
gene ontology (GO) terms are assigned to each gene. Classes of genes that are 
overrepresented in the data can be identified by generating ratios of the observed number 
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Table 4-1 Corticosterone responsive genes of HT-22 Parent cells activated or 








Score Accession Gene Symbol 
388.1 258.5 -1.5 -25.798 NM_021446 0610007P14Rik 
307.2 206.7 -1.5 -27.882 NM_026746.1 1110014D18Rik 
646.1 394.4 -1.6 -41.631 NM_025391 1110017C15Rik 
462.1 286.5 -1.6 -41.205  1110048P06Rik 
1019.8 655.9 -1.6 -21.52 XM_147036.4 1190002N15Rik 
163.4 248.5 1.5 23.38 AK078433 1200008A14Rik 
248.3 169.4 -1.5 -17.951 NM_026424.2 1500041J02Rik 
93.4 141.8 1.5 17.124  1600002O04Rik 
123.9 194.1 1.6 27.959 NM_138581.1 1700088E04Rik 
216.5 112.7 -1.9 -24.604 NM_029682.2 1700095N21Rik 
510.3 328.9 -1.6 -34.933 AK008437 2010204K13Rik 
241.5 162.4 -1.5 -20.265 NM_133839.1 2010311D03Rik 
431.3 278.7 -1.5 -17.408 NM_025917.1 2010315L10Rik 
105.7 205.9 1.9 48.629 XM_489155 2310001H17Rik 
244.6 167.6 -1.5 -22.329 XM_128102.2 2410187C16Rik 
186.3 103.5 -1.8 -27.27 NM_026453.1 2600016B03Rik 
362.5 232.3 -1.6 -37.803 NM_019836 2610024G14Rik 
493 296.7 -1.7 -38.809 NM_146130 2610510D13Rik 
264.2 179.5 -1.5 -25.262 NM_026528.1 2700060E02Rik 
132.8 241 1.8 22.326  2900042O04Rik 
249.4 144 -1.7 -28.921 XM_126172 3110040D16Rik 
1938.9 1286.9 -1.5 -22.067 XM_203376.1 3732413I11Rik 
614.3 934.7 1.5 21.292 AK029315 4832420L08Rik 
251.7 161.6 -1.6 -19.327 NM_172499.1 4931419K03Rik 
113.5 63.1 -1.8 -17.266 BC018281 6030411K04Rik 
170.8 97.3 -1.8 -25.307  9930009M05Rik 
329.5 225.6 -1.5 -28.09  9930105H17Rik 
233.1 151.7 -1.5 -18.063 AK044233 A930002H24Rik 
280.2 176.5 -1.6 -31.041 NM_133237.1 AB023957 
199.9 126.5 -1.6 -20.132 NM_013853.1 Abcf2 
231.9 146.4 -1.6 -28.239 NM_013853.1 Abcf2 
148.7 251.2 1.7 45.732 NM_019811.2 Acas2 
248.1 145.1 -1.7 -22.782 NM_013777.1 Akr1c12 
252.2 164.1 -1.5 -28.35 NM_019705.2 AL033326 
282.8 161.9 -1.7 -44.334 NM_021505.1 Anapc5 
1727.4 892.8 -1.9 -53.585 NM_013468.2 Ankrd1 
362.8 532.9 1.5 27.902 NM_013471 Anxa4 
120.2 72.7 -1.7 -17.235 NM_025545.2 Aptx 
134.6 37.6 -3.6 -50.369 NM_009701.1 Aqp5 
784.4 490.2 -1.6 -36.53 NM_007480.1 Arf5 
284 444.6 1.6 26.43 NM_007489.1 Arntl 
1295.7 836.5 -1.5 -35.709 NM_019767.1 Arpc1a 
266.3 136.6 -1.9 -54.083 NM_012055.1 Asns 
1964.3 1200.1 -1.6 -33.035 NM_009716 Atf4 
336 219.3 -1.5 -22.264 NM_026195.1 Atic 
308.1 207.7 -1.5 -28.831 NM_027439 Atp6ap2 
 








Score Accession Gene Symbol 
159.4 93.7 -1.7 -21.542 NM_027439.2 Atp6ap2 
119.2 66.3 -1.8 -20.705 NM_027439.2 Atp6ap2 
166.2 102.8 -1.6 -18.127 NM_007517.1 Aup1 
395 254.4 -1.6 -37.161 NM_198609 BC003885 
454.8 294 -1.5 -19.795 NM_033562.2 BC005682 
243.5 426.6 1.8 31.344 NM_146237 BC024537 
251.9 164.6 -1.5 -23.6 NM_172149 Bnip1 
232.1 148.4 -1.6 -23.227 NM_012047.1 Brd7 
553.7 254.4 -2.2 -85.486 NM_007569.1 Btg1 
512.9 235.4 -2.2 -81.036 NM_007569.1 Btg1 
4057.8 2608.5 -1.6 -29.063 NM_007573.1 C1qbp 
244.6 165.8 -1.5 -20.496 NM_026561.2 C330027I04Rik 
1041.2 2139.1 2.1 21.008  C920004C08Rik 
246.4 169.6 -1.5 -20.588 NM_133926.1 Camk1 
133.5 76.5 -1.7 -17.575 NM_007664.1 Cdh2 
2850.7 1776.9 -1.6 -41.887 NM_009870.2 Cdk4 
1211.9 743.2 -1.6 -60.444 NM_009870.2 Cdk4 
136.2 239.7 1.8 34.553 NM_009893.1 Chrd 
212.7 102.8 -2.1 -49.03 NM_023850.1 Chst1 
1049.1 523.6 -2.0 -24.487 NM_007739.1 Col8a1 
164.2 343.2 2.1 37.381 NM_007752 Cp 
1924.8 2835 1.5 46.425 NM_009964.1 Cryab 
132.8 73.3 -1.8 -23.735 NM_009968.1 Cryz 
215.3 144.4 -1.5 -21.003 NM_139117 Csda 
115.3 236.5 2.1 18.856 NM_019389.1 Cspg2 
491.6 306.5 -1.6 -47.889 NM_016748.1 Ctps 
128.8 46.8 -2.8 -27.293 NM_010516.1 Cyr61 
54.9 258.4 4.7 138.754  D15Bwg0759e 
807.9 1270.4 1.6 40.612  D15Mit260 
5968.1 10897.8 1.8 101.066 NM_033075.2 D17H6S56E-5 
1218.4 2062 1.7 72.231 NM_033075.2 D17H6S56E-5 
189.9 122.8 -1.5 -19.54 NM_175514.1 D430039N05Rik 
411.4 41.9 -9.8 244.639 NM_016974.1 Dbp 
504.7 319.4 -1.6 -24.64 NM_201408 Dhps 
274.2 162.7 -1.7 -34.503 NM_019448.2 Dnmt3l 
461.4 795.9 1.7 36.447 NM_013642.1 Dusp1 
353.1 177.3 -2.0 -23.252 NM_176933 Dusp4 
256.8 151.9 -1.7 -29.111 NM_008748.1 Dusp8 
207.5 348.6 1.7 49.271 NM_021469 Dysf 
901.8 510 -1.8 -37.108 NM_007907.1 Eef2 
332.4 229.1 -1.5 -18.39 NM_145371.1 Eif2b1 
422.7 249.7 -1.7 -34.705 NM_146200 Eif3s8 
572.4 386.4 -1.5 -25.419 NM_133916.1 Eif3s9 
158.8 94.7 -1.7 -22.075 XM_147230.1 Eif4a2 
1676 960.1 -1.7 -65.302 NM_181582.2 Eif5a 
1725.1 896.6 -1.9 -78.533  Eif5a 
133.5 58.9 -2.3 -27.305 NM_010139.2 Epha2 
208 103.5 -2.0 -28.677 NM_007945.1 Eps8 
2818.9 1717.9 -1.6 -32.925 NM_016903.2 Esd 
499.4 315.2 -1.6 -36.703 NM_145615.2 Etfa 
 








Score Accession Gene Symbol 
187 87.1 -2.1 -35.862 NM_025923.2 Fancl 
135.8 218 1.6 17.907 NM_134469 Fdps 
1364 2441.1 1.8 18.274 NM_010216.1 Figf 
365.3 713.9 2.0 63.229 NM_010220.2 Fkbp5 
271.3 178.4 -1.5 -19.4 XM_127565.4 Flnb 
400.6 250.5 -1.6 -42.449 XM_129845.3 Fn1 
980 590.4 -1.7 -58.549 XM_129845.3 Fn1 
815 441.8 -1.8 -17.208 NM_008037.3 Fosl2 
120 64 -1.9 -22.662 NM_011814.1 Fxr2h 
132.8 79.1 -1.7 -19.628 NM_013716.1 G3bp 
145 93.7 -1.5 -17.1 NM_175935.2 G6pc3 
2373.8 1540.8 -1.5 -28.244 NM_007836.1 Gadd45a 
67.6 115.6 1.7 17.106 NM_053108 Glrx1 
263.2 162.6 -1.6 -32.527 NM_010301.1 Gna11 
125.8 73.3 -1.7 -19.212 NM_010309.1 Gnas 
389.7 211.9 -1.8 -38.752 NM_010309.1 Gnas 
431.6 266.7 -1.6 -17.981 NM_016739.2 Gpiap1 
311.7 201.9 -1.5 -33.32 NM_153419.1 Grwd1 
675.9 463.7 -1.5 -22.729 NM_025652.1 Gtf3a 
233.5 147.8 -1.6 -29.081 NM_022331.1 Herpud1 
946.1 622.1 -1.5 -33.103 NM_182650.2 Hnrpa2b1 
284.7 176.5 -1.6 -35.939 NM_025279.1 Hnrpk 
770.7 497.3 -1.5 -49.771 XM_355338.1 Hoxd8 
630.2 939.8 1.5 39.221 NM_178162.2 Hrbl 
196.5 110.1 -1.8 -28.883 XM_147286.1 Hs6st1 
1110.6 624 -1.8 -19.358 NM_010480 Hspca 
6170.1 3545.1 -1.7 -38.64 NM_008302.2 Hspcb 
3337.8 1865.8 -1.8 -69.914 NM_008302.2 Hspcb 
417.1 237.7 -1.8 -31.09 NM_010477.2 Hspd1 
141.2 280.4 2.0 60.755 AK013239 Idb2 
1110.6 741.5 -1.5 -24.718 NM_008323.1 Idh3g 
347.7 104.8 -3.3 -109.15 NM_010743.1 Il1rl1 
156.2 89.1 -1.8 -17.996 NM_008363.1 Irak1 
207.6 111.9 -1.9 -24.455 NM_013566.1 Itgb7 
311.7 193 -1.6 -21.8 NM_010591.1 Jun 
296.2 199.5 -1.5 -23.935 NM_011317.2 Khdrbs1 
376.2 250.6 -1.5 -22.796 NM_010637.1 Klf4 
174.2 76.8 -2.3 -18.7 NM_010637 Klf4 
1550.3 875.6 -1.8 -21.593 XM_111684.3 LOC195357 
315.7 179.6 -1.8 -36.17 XM_137003.2 LOC212399 
198 123 -1.6 -18.419 XM_123387.2 LOC226036 
312.5 125.8 -2.5 -32.234 XM_205287.3 LOC279653 
859.1 520.1 -1.7 -45.775 XM_203701.3 LOC280487 
250 105.1 -2.4 -67.084 XM_207856.3 LOC280487 
1759.5 1109.6 -1.6 -61.062 XM_147224.2 LOC328703 
4299.2 2713 -1.6 -37.554 XM_287286.2 LOC329750 
826.4 566.9 -1.5 -24.216 XM_354540.1 LOC380634 
1316.4 860.3 -1.5 -25.907 XM_354663.1 LOC380749 
1226.8 801.1 -1.5 -26.87 XM_354669.1 LOC380756 
256.6 171.3 -1.5 -20.839 XM_355597.1 LOC381632 
 








Score Accession Gene Symbol 
184.4 109.7 -1.7 -22.199 XM_359170.1 LOC386324 
1429.9 772 -1.9 -27.105 XM_359287.1 LOC386463 
1894.3 3437.7 1.8 52.546 NM_010741 Ly6c 
265.8 388 1.5 35.692 NM_011838.2 Lynx1 
1047.2 613.2 -1.7 -20.546 NM_008549.1 Man2a1 
133.2 251.1 1.9 40.296 NM_016693 Map3k6 
785.9 509.8 -1.5 -22.78 NM_015806.2 Mapk6 
121.5 51.6 -2.4 -22.599 NM_145569 Mat2a 
514.1 312.5 -1.6 -41.701 NM_013595.1 Mbd3 
342 221.1 -1.5 -17.535 NM_019709.3 Mbtps1 
57.4 175.6 3.1 66.251 NM_008597.2 Mglap 
1158.2 2187.7 1.9 374.344 NM_021462.2 Mknk2 
70.6 118.8 1.7 19.386 NM_021462 Mknk2 
398.6 267.1 -1.5 -30.247 NM_053159.2 Mrpl3 
850.5 568.3 -1.5 -19.893 NM_026971.2 Mrpl48 
420.1 273.9 -1.5 -27.89 NM_026971.2 Mrpl48 
1297.5 300.2 -4.3 -128.38 NM_011954.2 Mrpplf3 
245.8 432.3 1.8 23.474 NM_018857.1 Msln 
149.3 90.7 -1.6 -19.374 NM_010833.1 Msn 
1591.3 4368 2.7 32.135 NM_008630.1 Mt2 
577.4 381.6 -1.5 -37.151 NM_019880.2 Mtch1 
230.5 131.4 -1.8 -27.138 NM_016776.2 Mybbp1a 
139.5 78.5 -1.8 -21.423 NM_010849.2 Myc 
137.6 66.4 -2.1 -31.769 NM_025898.1 Napa 
374 819.7 2.2 85.412 NM_010875 Ncam1 
1169.7 782.4 -1.5 -20.124 NM_026554.2 Ncbp2 
294.5 415.3 1.4 34.067 AK052726 Nfkb1 
150.4 53.9 -2.8 -52.109 NM_013609.1 Ngfb 
200.2 120.4 -1.7 -21.027 NM_025623.1 Nipsnap3b 
109.9 56.5 -1.9 -21.408 NM_025623.1 Nipsnap3b 
144 214.9 1.5 21.451 NM_010924.1 Nnmt 
1205.4 661.6 -1.8 -35.315 NM_024193.1 Nol5a 
185.4 71.6 -2.6 -58.353 NM_145434.1 Nr1d1 
59.1 239.2 4.0 33.62 NM_009108.1 Nr1h4 
183.6 119.7 -1.5 -20.853 NM_026012.1 Nradd 
231.6 129.4 -1.8 -23.236 NM_011956.2 Nubp2 
132.2 75.8 -1.7 -20.296 NM_175360.2 Obfc1 
649.6 390.4 -1.7 -17.917 NM_011858 Odz4 
112.3 180.7 1.6 26.999 NM_033321 P2rx5 
737.8 425.5 -1.7 -35.056 NM_011119.1 Pa2g4 
178.5 972.1 5.4 143.525 NM_013743.1 Pdk4 
52.5 246.1 4.7 93.662 NM_011065.2 Per1 
140.1 60.7 -2.3 -38.186 NM_011067 Per3 
872.9 485.8 -1.8 -30.364 NM_009344.1 Phlda1 
4846 3309.5 -1.5 -21.844 NM_133779.1 Pigt 
432.1 205 -2.1 -22.859 NM_011117 Plec1 
126.7 75.5 -1.7 -17.769 NM_023900.1 Plekhj1 
4987.5 1393.2 -3.6 -69.344 NM_031191 Plf 
835.4 221.9 -3.8 -113.39 NM_031191.1 Plf 
1847.1 424.6 -4.4 -114.69 NM_011118.1 Plf2 
 








Score Accession Gene Symbol 
2667.4 1601 -1.7 -43.495 NM_152804.1 Plk2 
2785.8 1775.7 -1.6 -43.509 NM_031868.1 Ppp1ca 
1178.6 808.2 -1.5 -31.737 NM_016891.2 Ppp2r1a 
534.9 1519.6 2.8 79.579 NM_054077.2 Prelp 
338.8 223.6 -1.5 -21.192 NM_011158.2 Prkar2b 
154.9 88.6 -1.7 -25.937 NM_080469.2 Prnpip1 
108.3 51.6 -2.1 -21.884 NM_019564.1 Prss11 
1325.2 738.6 -1.8 -65.213 XM_128721.2 Prss15 
900.1 620.2 -1.5 -22.734 NM_011965 Psma1 
429.7 255 -1.7 -19.511 NM_011875 Psmd13 
1311.1 741.4 -1.8 -24.052 NM_010817.1 Psmd7 
782.2 511.4 -1.5 -42.547 NM_011190.2 Psme2 
314.4 163 -1.9 -24.428 NM_008974.2 Ptp4a2 
201.8 117.3 -1.7 -17.035 NM_009010.2 Rad23a 
196.9 134.1 -1.5 -17.696 NM_019930.1 Ranbp9 
3506.1 2221.5 -1.6 -28.211 NM_009031.2 Rbbp7 
3743.3 2314.3 -1.6 -24.605 NM_009031.2 Rbbp7 
205.5 101.8 -2.0 -20.965 NM_009034 Rbp2 
245.9 380.1 1.5 21.663 NM_023275.1 Rhoj 
210.7 325.4 1.5 39.087 NM_177620.2 Rin3 
166.8 92.2 -1.8 -17.274 NM_024242.2 Riok1 
136.7 74.2 -1.8 -20.53 NM_194054.1 Rtn4 
293.7 172.7 -1.7 -42.541 NM_019685.1 Ruvbl1 
167.8 104.1 -1.6 -22.917 NM_025614 Rwdd1 
118.3 184.9 1.6 26.293 NM_020568.1 S3-12 
122.5 223 1.8 24.141 NM_011315 Saa3 
238.6 148.2 -1.6 -21.894 NM_025516.2 Sdbcag84 
278.3 499.3 1.8 32.036 XM_125538.4 Sesn1 
470.4 291 -1.6 -27.013 NM_009186 Sfrs10 
758.1 447.6 -1.7 -19.425 NM_009159 Sfrs5 
1638.5 2704.7 1.7 40.524 NM_011361.1 Sgk 
116.2 63.1 -1.8 -18.472 NM_172507.2 Sh3bgrl2 
275.6 411.6 1.5 17.885 NM_011893 Sh3bp2 
257.6 138.9 -1.9 -26.415 NM_021389.3 Sh3kbp1 
196.5 124.6 -1.6 -23.381 NM_020618.3 Smarce1 
185.3 108.4 -1.7 -18.247 NM_019710.1 Smc1l1 
83.7 151.5 1.8 17.278 NM_021491.2 Smpd3 
193.5 126.9 -1.5 -22.177 NM_021535.2 Smu1 
285.4 193.1 -1.5 -23.551 NM_009224.2 Snrp70 
326.8 219.7 -1.5 -30.197 NM_015782.2 Snrpa 
493.1 301.4 -1.6 -48.579 NM_015782.2 Snrpa 
488.4 294.3 -1.7 -51.315 NM_015782.2 Snrpa 
371.6 624.4 1.7 29.975 NM_011451.1 Sphk1 
895.6 590.1 -1.5 -24.716 NM_009272.2 Srm 
781.1 494.4 -1.6 -53.248 NM_019879.1 Suclg1 
244.7 126.6 -1.9 -24.243 NM_028958.2 Taf7l 
362.4 238.8 -1.5 -20.796 NM_013686 Tcp1 
202.2 328.6 1.6 51.149 NM_011567.1 Tead4 
1208.2 424.9 -2.8 -128.27 NM_017376.2 Tef 
140.8 85.1 -1.7 -20.506 NM_011570.2 Tes 
 








Score Accession Gene Symbol 
2659.1 1722.4 -1.5 -27.907 NM_011595.1 Timp3 
184 112.8 -1.6 -18.018 NM_019793.2 Tm4sf8 
1507 910.7 -1.7 -17.676 XM_122498.1 Tm7sf1 
3272.5 2028.7 -1.6 -43.248 NM_013749.1 Tnfrsf12a 
472.3 290.5 -1.6 -39.531 NM_023680 Tnfrsf22 
182.7 79.9 -2.3 -30.451 NM_007987.1 Tnfrsf6 
182.1 107.2 -1.7 -26.396 NM_016788 Tnk2 
1372.1 933.6 -1.5 -19.069 NM_011623.1 Top2a 
274.4 153.2 -1.8 -30.374 XM_134274.3 Tpm4 
309.5 194.3 -1.6 -21.583 NM_175093.1 Trib3 
331.6 484.2 1.5 31.996 NM_144899.2 Tsrc1 
2365.4 1403.7 -1.7 -49.195 NM_011655.2 Tubb5 
228 131.3 -1.7 -36.365 NM_009454.2 Ube2e3 
406.5 234 -1.7 -33.679 NM_019748.1 Uble1a 
303.9 194.8 -1.6 -26.899 NM_019562.1 Uchl5 
340.4 206.3 -1.7 -43.135 NM_009471.1 Umps 
253.6 372.2 1.5 38.283 NM_009500 Vav2 
1761.7 1143.5 -1.5 -23.018 NM_018865.1 Wisp1 
325.9 191.8 -1.7 -34.324 NM_133756.2 Xab1 
273.3 181.2 -1.5 -21.523 XM_125902.4 Xpot 
399.8 260.6 -1.5 -22.264 NM_026570.1 Yeats4 
992.2 642.9 -1.5 -36.674 NM_011739 Ywhaq 
209.5 129.6 -1.6 -18.611 NM_080855.1 Zcchc14 
336.9 226 -1.5 -22.836 NM_145600.1 Zfp330 
243.6 167 -1.5 -18.149 NM_207302 Zranb1 
973.3 1925.1 2.0 61.439 X06328.1  
388 577.8 1.5 52.182 AK049469.1  
370.5 251.6 -1.5 -24.768 XM_127742.4  
201.8 113.3 -1.8 -31.586 AF411517.1  
762.3 406.1 -1.9 -26.635 AK077302.1  
122.7 48.8 -2.5 -35.957 XM_358429.1  
Listed from left to right, the average signal intensity of each gene in the vehicle treated control (0nM Cort), 
100nM corticosterone treated group (100nM Cort), the fold change in expression level from basal to 
corticosterone treatment, the significance value in Diff. score (Diff. 17 is equivalent to p=0.02, larger Diff. 
scores are lower p-values), the accession number, and the gene symbol for each gene regulated by 
corticosterone in HT-22 Parent cells. 
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Table 4-2 Ten genes most highly induced or repressed in response to corticosterone in HT-22 Parent and HT-22/MR16 cells. 








Score Accession Gene Symbol 
Fold 
Change Diff Score Accession Gene Symbol 
5.4 143.525 NM_013743.1 Pdk4 4.1 141.5 NM_008491.1 Lcn2 8.2 18.551 NM_008491.1 Lcn2 
4.7 138.754  D15Bwg0759e 3.8 46.5 NM_008581.1 Mela 6.0 18.931 NM_008581.1 Mela 
4.7 93.662 NM_011065.2 Per1 2.8 40.3 NM_007752 Cp 5.6 122.373 NM_011065.2 Per1 
4.0 33.62 NM_009108.1 Nr1h4 2.8 120.8 NM_054077.2 Prelp 5.2 43.735  D15Bwg0759e 
3.1 66.251 NM_008597.2 Mglap 2.6 23.9 NM_011065.2 Per1 4.8 112.369 NM_011451.1 Sphk1 
2.8 79.579 NM_054077.2 Prelp 2.6 76.0 NM_011451.1 Sphk1 4.7 115.757 NM_007752 Cp 
2.7 32.135 NM_008630.1 Mt2 2.5 21.8 NM_009504.2 Vdr 3.7 31.973 NM_010286.2 Dsip1 
2.2 85.412 NM_010875 Ncam1 2.4 30.1  D15Bwg0759e 3.5 53.705 NM_008630.1 Mt2 
2.1 37.381 NM_007752 Cp 2.4 58.3 NM_009108.1 Nr1h4 3.3 27.946 NM_013743.1 Pdk4 
2.1 18.856 NM_019389.1 Cspg2 2.0 50.6 NM_009504.2 Vdr 3.0 31.507 NM_054077.2 Prelp 
-2.6 -58.353 NM_145434.1 Nr1d1 -1.6 -34.9 NM_031191 Plf -3.8 -93.06 NM_011066.1 Per2 
-2.8 -27.293 NM_010516.1 Cyr61 -1.6 -24.0 NM_009344.1 Phlda1 -3.9 -51.159 XM_148699.3 Crebbp 
-2.8 -52.109 NM_013609.1 Ngfb -1.6 -25.8 NM_011066.1 Per2 -4.0 -60.684 NM_198416.1 Zzz3 
-2.8 -128.27 NM_017376.2 Tef -1.7 -17.1 NM_080428 Fbxw7 -4.1 -120.138 NM_145434.1 Nr1d1 
-3.3 -109.15 NM_010743.1 Il1rl1 -1.7 -20.2 NM_009263.1 Spp1 -4.2 -104.484 NM_031191.1 Plf 
-3.6 -50.369 NM_009701.1 Aqp5 -1.8 -19.1 NM_012019.2 Pdcd8 -4.5 -62.212 NM_007661.2 Cdc2l2 
-3.6 -69.344 NM_031191 Plf -1.9 -43.7 NM_145434.1 Nr1d1 -4.6 -33.761 AK017756 Hcapg-pending 
-4.3 -128.38 NM_011954.2 Mrpplf3 -1.9 -88.6 NM_017376.2 Tef -5.1 -27.083 NM_178930 Gbf1 
-4.4 -114.69 NM_011118.1 Plf2 -2.0 -38.8 NM_011067 Per3 -6.6 -68.88 NM_007887.1 Dub1 
-9.8 -244.63 NM_016974.1 Dbp -2.8 -155.1 NM_016974.1 Dbp -16.1 -370.442 NM_016974.1 Dbp 
Listed from left to right for each treatment group, the fold change in expression level from basal to corticosterone treatment, the significance value in Diff. score 
(Diff. 17 is equivalent to p=0.02, larger Diff. scores are lower p-values), the accession number, and the gene symbol for each gene. 
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of genes regulated in a category versus the expected number of genes for that category.  
To assign GO terms to the list of changed genes in the P100 group we used the Gene 
Ontology Tree Machine (http://bioinfo.vanderbilt.edu/gotm) website (GOTM).  GOTM 
was able to assign GO terms for 164 of the 252 genes submitted (65%).  Of the 164 GO-
termed genes that were regulated by corticosterone in the HT-22 Parent cell line, many 
different classes of genes were identified with the largest fraction falling into the 
categories of cellular physiological process, metabolism, and regulation of physiological 
process (Figure 4-2A).  Categories of genes that are classified as overrepresented in the 
data fall under broad cellular and physiological processes, such as cellular metabolism 
and cell growth, and include genes specifically involved in cell adhesion, regulation of 
transcription, intracellular protein transport, and intracellular signaling (phosphatases, 
kinases, and transcription factors).  Figure 4-2B represents a Venn diagram of 
overrepresented categories of genes that have changed in the P100 group relative to the 
vehicle-treated control as determined by the GoMiner Ontogeny Software Program.  This 
analysis also indicates that, by and large, the gene categories most affected by 
corticosterone treatment relate to cell growth.  Several other categories were identified in 
this analysis, including genes involved in the epigenetic regulation of gene expression, 
nuclear cytoplasmic transport and 6 genes involved in circadian rhythmic processes.  All 
together, there is a clear effect of corticosterone on expression of genes involved in 













Figure 4-2 Gene Ontology of genes regulated by 100nm corticosterone in HT-22 
Parent cells. 
A) Quantitation of genes that sort into different functional categories under the ontology 
of Biological Process as determined by GOTM software.  Categories in red denote an 
overrepresentation of regulated genes relative to the expected number of genes within 
that category.  B) Vennmaster diagram depicting overlapping functional categories of 
genes that were also determined to be overrepresented in the data as determined by 
GoMiner and VennMaster software. 
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Corticosterone-responsive genes activated or repressed by MR occupation: 
 The HT-22/MR16 clonal cell line expresses significant levels of both MR and 
GR.  However, treatment of these cells with 1 nM corticosterone would be expected to 
activate MR, with only a small effect on GR, due to their significant differences in 
corticosterone binding affinities. A comparison of the gene expression profiles from 
vehicle-treated HT-22/MR16 (M0) with the 1nM-treated cells (M1) resulted in the 
identification of 41 genes whose expression was significantly different between groups.  
Fifty percent of these genes were up-regulated and 50% of them were down-regulated 
(Table 4-3) and Table 4-2 lists the 10 genes that are induced and repressed to the greatest 
extent.  Of the 41 genes, 37 were identified as known genes (90%) and the other four 
were identified in the RIKEN Mouse Encyclopedia Project.  GO terms were assigned to 
38 of the 41 genes allowing for functional classification of gene classes.  The genes 
regulated by MR largely fit into the same functional classes as GR-regulated genes 
(Figure 4-3).  Categories of genes that were identified as overrepresented in the data 
include a number of proteins with kinase activity involved in cellular physiological 
processes such as cell adhesion, and most prominently, genes involved in circadian 
rhythm. 
 
Corticosterone-responsive genes activated or repressed by MR and GR occupation at 
100nM corticosterone: 
 Comparison of the gene expression profiles from vehicle-treated HT-22/MR16 
(M0) and 100nM corticosterone-treated cells (M100) resulted in the identification of 476 
genes that were significantly different between groups (Table 4-4) and Table 4-2 lists the 
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Table 4-3 Corticosterone responsive genes activated or repressed following MR 








Score Accession Gene Symbol 
 107.2 -1.6 -23.2 AK077748 5730594E01Rik 
191.1 317.9 1.7 17.7 NM_007489.1 Arntl 
350.3 207.5 -1.7 -31.2 AK046455 B230387C07Rik 
506.6 757.6 1.5 25.9 NM_009778.1 C3 
112.1 61.2 -1.8 -18.5 AK021175 C330004K01Rik 
263 166.1 -1.6 -26.8 NM_023850.1 Chst1 
955 611.3 -1.6 -27.0 NM_007739.1 Col8a1 
354.5 242.1 -1.5 -24.1 NM_007739 Col8a1 
58 162.4 2.8 40.3 NM_007752 Cp 
124.9 210.7 1.7 27.6 NM_019389.1 Cspg2 
3071 2171.9 -1.4 -22.9 NM_008176.1 Cxcl1 
181.3 116.2 -1.6 -18.4 NM_010516.1 Cyr61 
53.3 126.9 2.4 30.1  D15Bwg0759e 
554.1 195.9 -2.8 -155.1 NM_016974.1 Dbp 
254.3 172.6 -1.5 -18.7 NM_009468.1 Dpysl3 
137.2 82.9 -1.7 -17.1 NM_080428 Fbxw7 
311.3 457.3 1.5 27.9 NM_010220.2 Fkbp5 
253.8 390.4 1.5 17.2 NM_020583.4 Isg20 
267.5 1086.1 4.1 141.5 NM_008491.1 Lcn2 
31.6 119.2 3.8 46.5 NM_008581.1 Mela 
1166.1 1984.5 1.7 30.8 NM_008630.1 Mt2 
194 293.8 1.5 18.4 NM_010875.2 Ncam1 
703.2 479.5 -1.5 -21.5 NM_008688.2 Nfic 
239.6 127.8 -1.9 -43.7 NM_145434.1 Nr1d1 
104.2 248 2.4 58.3 NM_009108.1 Nr1h4 
103.2 163.8 1.6 18.9 NM_033321 P2rx5 
188.2 106.5 -1.8 -19.1 NM_012019.2 Pdcd8 
316.4 527.9 1.7 21.3 NM_013743.1 Pdk4 
52 137.4 2.6 23.9 NM_011065.2 Per1 
198.9 122.1 -1.6 -25.8 NM_011066.1 Per2 
176.6 86.8 -2.0 -38.8 NM_011067 Per3 
957.7 590 -1.6 -24.0 NM_009344.1 Phlda1 
187.9 118.3 -1.6 -17.4 NM_011113.2 Plaur 
3858.1 2377.3 -1.6 -34.9 NM_031191 Plf 
476.7 1329.3 2.8 120.8 NM_054077.2 Prelp 
1481 2002.3 1.4 19.1 NM_011361.1 Sgk 
1348.4 907.3 -1.5 -17.6 NM_019654.2 Socs5 
102.1 269.3 2.6 76.0 NM_011451.1 Sphk1 
1368.5 824.6 -1.7 -20.2 NM_009263.1 Spp1 
1549 806 -1.9 -88.6 NM_017376.2 Tef 
322.5 645.9 2.0 50.6 NM_009504.2 Vdr 
46.3 115 2.5 21.8 NM_009504.2 Vdr 
154.2 256.8 1.7 31.1 NM_016873.1 Wisp2 
Listed from left to right, the average signal intensity of each gene in the vehicle treated control (0nM Cort), 
1nM corticosterone treated group (1nM Cort), the fold change in expression level from basal to 
corticosterone treatment, the significance value in Diff. score (Diff. 17 is equivalent to p=0.02, larger Diff. 
scores are lower p-values), the accession number, and the gene symbol for each gene regulated in HT-
22/MR16 cells.
 





are needed to see this picture.
 
Figure 4-3 Gene Ontology of genes regulated by 1nm corticosterone in HT-22/MR16 
cells. 
Quantitation of genes that sort into different functional categories under the ontology of 
Biological Process as determined by GOTM software.  Categories in red denote an 
overrepresentation of regulated genes relative to the expected number of genes within 
that category. 
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10 genes that were induced or repressed to the greatest extent.  Of these 476 genes, 89% 
were down-regulated and 11% were up-regulated.  In this list of genes, 311 (65%) were 
identified as known genes and the other 35% were identified in the RIKEN Mouse 
Encyclopedia Project.  GO terms could be linked with 254 of the 476 genes (53%).  As 
with the other two groups, the greatest number of genes regulated by MR and GR fit into 
the functional classes of cellular physiological processes and metabolism (Figure 4-4A).  
Categories of genes that are overrepresented in the data include genes involved in cell 
differentiation and cell growth, circadian rhythm, and a large group of 23 genes that are 
involved in programmed cell death.  Figure 4-4B represents a Venn diagram of 
overrepresented categories of genes that have changed in the M100 group relative to the 
vehicle-treated control as determined by GoMiner ontogeny analysis.  This analysis also 
highlights the overrepresentation of genes involved in circadian rhythm, as well as the 
positive regulation of cell proliferation, and identifies a subset of the genes (8 of 23 
genes) in the programmed cell death category as being involved in the negative 
regulation of cell death. 
 
Comparison of corticosteroid-regulated genes between groups: 
 To identify genes that may be specifically regulated by GR homodimers, MR 
homodimers, and/or GR/MR heterodimers, the lists of regulated genes from the P0-P100, 
M0-M1, and M0-M100 groups were compared.  As the P0-P1 list only contained 4 genes 
it was not included in this analysis.  Figure 4-5 represents a Venn diagram of the three 
lists of regulated genes and the number of genes that overlap between each group, and 
Table 4-5 contains the lists of genes that are represented in each category.  Of the 252 GR  
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Table 4-4 Corticosterone responsive genes activated or repressed following MR and 








Score Accession Gene Symbol 
243.2 150.7 -1.6 -21.158  0610007N19Rik 
402.3 191.7 -2.1 -78.588 NM_025793.1 0610008N23Rik 
311 183 -1.7 -20.746 NM_025339.2 0610027O18Rik 
263.1 138 -1.9 -25.843 NM_172401.2 1110057K04Rik 
888.1 569.8 -1.6 -43.593 XM_147036.4 1190002N15Rik 
600.7 314.1 -1.9 -49.456 NM_025822.2 1200013F24Rik 
324.7 725.6 2.2 18.248 NM_133753.1 1300002F13Rik 
790.1 326.7 -2.4 -70.78 XM_132343.3 1500011J06Rik 
228 121.9 -1.9 -17.63 XM_356257.1 1500041I23Rik 
268.9 162.2 -1.7 -22.081 NM_026424.2 1500041J02Rik 
1152 714.7 -1.6 -39.585  1500041O16Rik 
57.6 144.6 2.5 38.021 AK006897 1700065O13Rik 
94.5 195.1 2.1 38.277 XM_283372.2 1700110N18Rik 
106.9 187 1.7 26.24 NM_026931.1 1810011O10Rik 
210.7 139.7 -1.5 -20.431 AK007762 1810043M20Rik 
287.8 162.8 -1.8 -25.496  2010205O06Rik 
450.4 220.3 -2.0 -59.912 NM_177157.2 2010323F13Rik 
559.8 308.9 -1.8 -65.221 NM_177157.2 2010323F13Rik 
133.2 62.9 -2.1 -28.99 AK008639 2200005K02Rik 
653.2 374.8 -1.7 -18.274  2210008N01Rik 
139.7 40.3 -3.5 -46.766  2210401K01Rik 
1311.1 798 -1.6 -59.752 XM_204313.2 2300009A05Rik 
116.5 189.2 1.6 21.834 XM_489155 2310001H17Rik 
1056.2 717.4 -1.5 -33.713 NM_028800 2310004N11Rik 
257.1 495.4 1.9 59.479 NM_027992 2310036D22Rik 
141 281.2 2.0 44.025 NM_027992.1 2310036D22Rik 
415.8 69.3 -6.0 -115.16 AK009823 2310045K21Rik 
93.7 186.2 2.0 31.306  2310051E17Rik 
530.4 242.1 -2.2 -74.663 NM_133784.1 2310058J06Rik 
732.4 489.7 -1.5 -27.866 NM_028013.1 2310067E08Rik 
1356.5 785.8 -1.7 -39.615 XM_204283.3 2410003B16Rik 
1312.8 898.4 -1.5 -23.015 NM_023203.1 2410015N17Rik 
1238.8 787.7 -1.6 -34.933 NM_030241.2 2410195B05Rik 
954.3 624.5 -1.5 -28.056 NM_030241.2 2410195B05Rik 
248.8 162.9 -1.5 -18.446 AK010848 2500002A22Rik 
320.3 166.1 -1.9 -50.05 NM_172947.1 2600001B17Rik 
816.2 471.7 -1.7 -30.318 NM_172947.1 2600001B17Rik 
753.7 471.5 -1.6 -36.294 NM_028244.1 2600005C20Rik 
172.7 41.6 -4.2 -31.488 AK011206 2600014C01Rik 
755.3 438.9 -1.7 -43.658  2610002F03Rik 
171.3 92.5 -1.9 -19.643 AK011403 2610015J01Rik 
8695.5 5608.9 -1.6 -19.777  2610019E17Rik 
421.7 265.8 -1.6 -35.164 AK011472 2610019N13Rik 
488.2 267.3 -1.8 -49.161 XM_110750 2610030H06Rik 
118.7 55.5 -2.1 -19.742 AK011690 2610036C07Rik 
337.7 211.5 -1.6 -33.407 NM_175364.2 2610208E05Rik 
 









Accession Gene Symbol 
420.2 286.6 -1.5 -28.301 NM_028818.1 2610511M17Rik 
272.5 114.2 -2.4 -29.217  2610528A11Rik 
802.7 497 -1.6 -23.723  2700023E23Rik 
1337.9 605.6 -2.2 -56.841 AK019219 2700079K05Rik 
245.7 138.2 -1.8 -25.546  2700083E18Rik 
1356.4 930.4 -1.5 -23.448 NM_026025 2700088M22Rik 
168.3 110.6 -1.5 -17.297 NM_026028.1 2700091N06Rik 
207.2 135.3 -1.5 -20.899 NM_025479.2 2810021B07Rik 
169.9 104.4 -1.6 -21.212  2810402E24Rik 
253.6 117.6 -2.2 -31.698 AK013109 2810417K24Rik 
237.1 131.8 -1.8 -19.331  2810468A05Rik 
294.6 107.9 -2.7 -41.321 XM_132966.3 2810474O19Rik 
200.3 67.2 -3.0 -36.391 AK013732 2900060F21Rik 
178.5 92.2 -1.9 -25.181 XM_127780.4 3110050K21Rik 
3458.4 1798.2 -1.9 -56.272 NM_026313.1 3300001P08Rik 
633.6 359.6 -1.8 -37.169 XM_196166 3300005D01Rik 
138.2 79 -1.7 -19.243  4633401G24Rik 
322.9 218.2 -1.5 -18.137  4833438C02Rik 
311 60.8 -5.1 -85.987 AK029517 4921511I23Rik 
284.6 80.3 -3.5 -90.747 XM_130287.5 4930432B04Rik 
108.3 47.3 -2.3 -25.69 XM_147531.1 4930527B16Rik 
722.2 493.4 -1.5 -28.125  4930563B10Rik 
115.5 64.7 -1.8 -18.043  4930568E02Rik 
327.7 213.2 -1.5 -28.768 NM_029404.1 4932409F11Rik 
273.3 184.1 -1.5 -23.359 XM_356109.1 4933407C03Rik 
177.7 79.4 -2.2 -17.499 AK077171 4933417E08Rik 
1203.8 664.8 -1.8 -23.936 XM_127929.3 4933421G18Rik 
145.1 86 -1.7 -20.256  4933431K14Rik 
398.2 250.3 -1.6 -35.709 XM_127301.2 5033430I15Rik 
325.6 124.1 -2.6 -83.653  5430405H02Rik 
116.7 55.1 -2.1 -24.053  5430411C19Rik 
272.7 178.4 -1.5 -18.837  5530400B01Rik 
473.8 171.1 -2.8 -117.92 AK077637 5730494J16Rik 
1441 781.4 -1.8 -86.452 NM_025690 5730555F13Rik 
422.6 147.5 -2.9 -52.394 AK030766 5730577G12Rik 
176.7 42.1 -4.2 -57.572 AK077748 5730594E01Rik 
280.4 169.1 -1.7 -26.396 XM_488874 5830406C17Rik 
311.3 167 -1.9 -50.164 NM_026583.2 5830415L20Rik 
515.5 322.7 -1.6 -42.761 NM_176921.2 6030419C18Rik 
744.9 1210.1 1.6 20.864  6330414G02Rik 
131.6 49.7 -2.6 -24.319 AK033615 9130202B12Rik 
701.2 426.7 -1.6 -26.755 NM_177206 9230101K24Rik 
226.3 83.1 -2.7 -44.055 XM_110546.2 9230115A19Rik 
228.9 136.7 -1.7 -20.258 AK020369 9330132O05Rik 
856 560.9 -1.5 -40.775 XM_355205 9430025M21Rik 
247.7 126.9 -2.0 -34.491 AK020610 9530055J05Rik 
1351.5 748.3 -1.8 -51.994 XM_489200 9530064J02 
232.2 133.1 -1.7 -25.764 AK079342 9630032J03Rik 
327.8 213.3 -1.5 -20.119  9930105H17Rik 
 









Accession Gene Symbol 
345.6 183.7 -1.9 -35.393 AK040788 A530025E09Rik 
1722.7 1065.4 -1.6 -24.843 AK079972 A530030G15Rik 
327.3 224.3 -1.5 -24.411 AK041191 A530089A20Rik 
146.1 46.8 -3.1 -53.077 AK041811 A630040A01Rik 
305.5 204.1 -1.5 -21.972 NM_177857 A930010I20Rik 
167.6 75.5 -2.2 -41.499 NM_177232 A930033H14Rik 
117.3 34.8 -3.4 -39.475 AK080758 A930101O15Rik 
301.7 139.9 -2.2 -61.289 NM_133237.1 AB023957 
309.1 172.6 -1.8 -24.33 NM_007382 Acadm 
6654.4 4476.8 -1.5 -25.923 NM_009636.1 Aebp1 
1134.5 740.7 -1.5 -18.748 NM_019914.2 AI839562 
1071.5 613.6 -1.7 -24.934 NM_198616.1 AI842788 
386.8 179.5 -2.2 -40.632 NM_194462.1 Akap9 
155.9 78.8 -2.0 -27.925 NM_011785.2 Akt3 
3604.2 1821.9 -2.0 -35.957 NM_009656.1 Aldh2 
81.2 143.6 1.8 21.023 NM_009667 Ampd3 
193.5 81.2 -2.4 -54.131 NM_011923.2 Angptl2 
743.5 316.5 -2.3 -30.527 NM_020581.1 Angptl4 
258.6 77.5 -3.3 -29.497  Ankhd1 
5043.6 3261.5 -1.5 -19.807 NM_007472.1 Aqp1 
445.7 223 -2.0 -41.632 NM_153800.2 Arhgap22 
105.2 52.6 -2.0 -20.217 NM_145996.2 Arid5a 
191.1 336.7 1.8 40.414 NM_007489.1 Arntl 
663.7 454.2 -1.5 -25.087 NM_145822.1 Ase1 
391.2 253.6 -1.5 -19.747 NM_138679.2 Ash1l 
590.2 383.4 -1.5 -21.636 NM_007496.1 Atbf1 
1648 1089.6 -1.5 -21.708 NM_007496.1 Atbf1 
199.9 115.1 -1.7 -23.154 NM_025983.2 Atp5e 
212.3 127.6 -1.7 -22.596 NM_007507 Atp5k 
557.8 344.7 -1.6 -24.064 NM_134034.1 AW011752 
1942.2 1229.3 -1.6 -44.857 NM_144879.1 B130052G07Rik 
360.7 148.1 -2.4 -34.191 AK045321 B130065G19Rik 
328.5 190.9 -1.7 -39.203 XM_130148.1 B230208H17Rik 
415.1 167.5 -2.5 -57.226 AK046451 B230386D16Rik 
350.3 148.2 -2.4 -62.665 AK046455 B230387C07Rik 
251.5 125.9 -2.0 -24.785 NM_178764.2 B930006L02Rik 
786.1 526.1 -1.5 -33.845 AK046967 B930008G03Rik 
158 241.8 1.5 21.989 NM_173002.1 BC003332 
299.2 185.8 -1.6 -22.367 NM_145430.1 BC017647 
646.7 424.8 -1.5 -29.424 NM_175002.1 BC025076 
474.1 230.7 -2.1 -66.198 NM_198167.1 BC026370 
248.9 168.4 -1.5 -19.446 NM_145943.1 BC031781 
807.1 548.3 -1.5 -35.772 XM_109956 BC037006 
276.3 177.2 -1.6 -18.1 NM_172761.1 BC052066 
270.8 120 -2.3 -27.44 NM_183208.2 BC065120 
952.3 625.8 -1.5 -28.204 NM_009740.1 Bcl10 
342.8 188.8 -1.8 -51.118 NM_009744.2 Bcl6 
1296 813.6 -1.6 -29.977 NM_011498.2 Bhlhb2 
884 476.3 -1.9 -67.129 NM_020508.2 Brd4 
 









Score Accession Gene Symbol 
207.2 97 -2.1 -27.809 NM_133195.1 Brunol4 
910.1 540.5 -1.7 -20.211 NM_133195 Brunol4 
362.6 178.6 -2.0 -34.08  C030034I22Rik 
211.3 108 -2.0 -36.421 AK048061 C130032J12Rik 
139.5 71.1 -2.0 -24.678  C130080N23Rik 
163.3 104.9 -1.6 -18.115 XM_110478.3 C330013J21Rik 
375.2 177.6 -2.1 -55.004 NM_139304.1 C430014D17Rik 
169 91 -1.9 -29.894  C730026J16 
144.2 71.4 -2.0 -27.373 NM_153547.2 C77032 
2942.1 2012 -1.5 -18.848 NM_009794.1 Capn2 
307.3 167.3 -1.8 -25.987 NM_009810.1 Casp3 
425.3 212.6 -2.0 -47.052 NM_007631.1 Ccnd1 
1346.5 779.4 -1.7 -37.103 NM_007631.1 Ccnd1 
569.3 333.4 -1.7 -53.853 NM_009829.2 Ccnd2 
1598.1 1038.1 -1.5 -17.988 NM_009831.1 Ccng1 
158.3 55 -2.9 -52.572 NM_054042.2 Cd164l1 
1080.6 552 -2.0 -47.885 NM_133654.1 Cd34 
1033.3 648.9 -1.6 -51.422 AK045226 Cd44 
171.3 86.1 -2.0 -34.736 NM_007658 Cdc25a 
136 30.2 -4.5 -62.212 NM_007661.2 Cdc2l2 
1783.3 1009.6 -1.8 -37.182 NM_007669.2 Cdkn1a 
1497.7 1024.4 -1.5 -24.487 NM_007669.2 Cdkn1a 
287.8 143 -2.0 -17.282 AK021188 Chd1 
118.1 61.8 -1.9 -17.392 NM_145979.1 Chd4 
129.7 261.3 2.0 26.237 NM_009893.1 Chrd 
263 92.4 -2.8 -92.66 NM_023850.1 Chst1 
379.2 165.1 -2.3 -81.342 NM_175554.3 Clspn 
827 489.8 -1.7 -59.871 NM_007725.1 Cnn2 
512.4 227.5 -2.3 -59.407 NM_016877.2 Cnot4 
480.8 292.9 -1.6 -30.767 NM_053007.1 Cntf 
326.7 165.3 -2.0 -52.736 NM_007743.1 Col1a2 
955 384.2 -2.5 -81.213 NM_007739.1 Col8a1 
354.5 157.4 -2.3 -83.061 NM_007739 Col8a1 
2631.5 1443.8 -1.8 -38.537 NM_011803.1 Copeb 
174.6 103.2 -1.7 -24.621 NM_025379.1 Cox7b 
58 270.3 4.7 115.757 NM_007752 Cp 
348.4 88.8 -3.9 -51.159 XM_148699.3 Crebbp 
171.9 53.6 -3.2 -32.405 XM_148699.3 Crebbp 
192.7 121.5 -1.6 -22.413 NM_133679.1 Cryzl1 
2083.7 1250.3 -1.7 -29.182 NM_007778.1 Csf1 
302.4 145.1 -2.1 -53.275 AK031617 Csnk2a1-rs3 
124.9 256.1 2.1 18.669 NM_019389.1 Cspg2 
849.5 567.2 -1.5 -18.772 NM_145529.1 Cstf3 
869.1 582.5 -1.5 -29.009 NM_198683.1 Cugbp1 
181.3 62 -2.9 -56.311 NM_010516.1 Cyr61 
172.2 68.1 -2.5 -44.666 NM_010516.1 Cyr61 
477.3 279 -1.7 -36.952 NM_146155.2 D030015G18Rik 
 









Accession Gene Symbol 
1009.7 546 -1.8 -51.13 NM_025602.1 D10Ertd718e 
101.3 52.7 -1.9 -17.946 AK051470 D130051G04Rik 
483.1 783.2 1.6 43.384 AK051669 D130063H01Rik 
53.3 274.5 5.2 43.735  D15Bwg0759e 
263 156.5 -1.7 -24.966 NM_023063.1 D15Ertd366e 
606.5 1079.7 1.8 60.028  D15Mit260 
161.2 78.7 -2.0 -30.645 NM_029648.3 D19Ertd737e 
1155.1 762.7 -1.5 -26.477 XM_129886.4 D1Bwg1363e 
268.7 181.1 -1.5 -23.057 XM_128090.5 D330037H05Rik 
350.4 234.3 -1.5 -26.842 NM_201372.1 D630044F24Rik 
452.4 299.4 -1.5 -22.985  D730003I15Rik 
370.4 196 -1.9 -25.452  D730044K07Rik 
554.1 34.5 -16.1 -370.44 NM_016974.1 Dbp 
464 310.8 -1.5 -20.324 NM_016765 Ddah2 
2093.8 1419.2 -1.5 -22.708 NM_010026.1 Ddef1 
1291.7 515 -2.5 -163.98 AK012125 Ddx21 
501.9 254.3 -2.0 -48.775 NM_020494.2 Ddx24 
1021.6 402.4 -2.5 -159.47 NM_007841.2 Ddx6 
619.4 245.5 -2.5 -32.941 NM_025900.1 Dek 
252.1 102.5 -2.5 -50.047 XM_147318.1 Dfna5h 
560.8 379.9 -1.5 -26.609 NM_019670.1 Diap3 
223.3 144.8 -1.5 -20.354 NM_019448.2 Dnmt3l 
84.7 166.1 2.0 17.653 NM_010070.3 Dok1 
82.5 183.1 2.2 35.535 NM_010070.3 Dok1 
2772.8 1813.7 -1.5 -22.193 XM_130951.1 Dpm3 
31.2 115.1 3.7 31.973 NM_010286.2 Dsip1 
134.4 20.5 -6.6 -68.88 NM_007887.1 Dub1 
412.9 837.7 2.0 24.271 NM_013642.1 Dusp1 
325.1 137 -2.4 -71.353 NM_176933.3 Dusp4 
206 128.5 -1.6 -20.591 NM_008748.1 Dusp8 
51.5 105.9 2.1 20.158 AK086999 E030019D07Rik 
485.8 331.4 -1.5 -19.423 NM_153791.1 E030034P13Rik 
8686.1 5669 -1.5 -34.804 AK053583 E130112E08Rik 
206.9 133.5 -1.5 -22.101 XM_127250 E2f3 
173.8 99.9 -1.7 -26.298 NM_177133.1 E330018D03Rik 
174.2 97.1 -1.8 -23.499 AK088068 E430003D02Rik 
258.9 130 -2.0 -26.841  E430024C06Rik 
1389.1 953.4 -1.5 -37.515 NM_011816.2 E430034L04Rik 
572.3 392.5 -1.5 -26.773 NM_175540 Eda2r 
793.4 541.2 -1.5 -34.998 NM_010336 Edg2 
1167.2 788.2 -1.5 -32.172 NM_021474.2 Efemp2 
2866.2 1893.9 -1.5 -45.838 NM_198303 Eif5b 
192.3 97.6 -2.0 -30.909 NM_033612.1 Ela1 
175.9 60 -2.9 -61.615 NM_023502.1 Elf2 
115.2 63.1 -1.8 -18.891 NM_133918.1 Emilin1 
556.6 343.5 -1.6 -31.801 XM_127139.5 Eml1 
199.5 129.6 -1.5 -18.575 NM_199466.1 Eml4 
7581 4570.5 -1.7 -36.473 NM_010128.3 Emp1 
4534.4 2684.6 -1.7 -52.792 NM_010129 Emp3 
 









Accession Gene Symbol 
161.4 78.2 -2.1 -35.178 AK020248 Enah 
147.2 64.6 -2.3 -35.788 NM_199016.1 Enpp4 
171 97.5 -1.8 -25.62 NM_010139.2 Epha2 
130.3 76.3 -1.7 -18.637 XM_204072.3 Ephb2 
2666.5 1698.7 -1.6 -24.336 NM_016903.2 Esd 
135.4 70.1 -1.9 -25.465 NM_008815 Etv4 
2022.6 1333.3 -1.5 -31.314 NM_025644.3 Exosc1 
586.9 227.3 -2.6 -48.159 NM_007971.1 Ezh2 
296.2 169.2 -1.8 -25.135 AK089303 F730003H07Rik 
4626.5 2840.7 -1.6 -42.33 NM_007992.1 Fbln2 
137.2 37.7 -3.6 -41.693 NM_080428 Fbxw7 
341.3 182.4 -1.9 -33.002 NM_080428.2 Fbxw7 
176.9 101 -1.8 -21.824 AK008093 Fibp 
311.3 697.9 2.2 24.552 NM_010220.2 Fkbp5 
70.8 137.2 1.9 24.257 XM_288949.2 Fmnl2 
170.2 62.6 -2.7 -29.839 NM_010235.1 Fosl1 
395 213.4 -1.9 -41.318 NM_008655.1 Gadd45b 
200.2 126.2 -1.6 -17.345 NM_013814.2 Galnt1 
111.8 22 -5.1 -27.083 NM_178930 Gbf1 
675.2 440.1 -1.5 -29.46 NM_019683.2 Gbif 
524.2 304 -1.7 -47.442 NM_019832.2 Gkap1 
2471.8 1409.2 -1.8 -51.035 NM_028608.1 Glipr1 
873.1 597.7 -1.5 -17.711 NM_023505.1 Glrx2 
247.4 145.1 -1.7 -19.581 NM_010320.2 Gng8 
584.9 370.7 -1.6 -42.923 NM_027681.1 Gnpda2 
422.9 210.2 -2.0 -47.243 NM_133852.1 Golga2 
346.9 147 -2.4 -32.57 NM_175193.2 Golph4 
2872 1877.7 -1.5 -35.939 NM_016696.1 Gpc1 
183.2 71.7 -2.6 -33.914 NM_177346.1 Gpr149 
474.7 257 -1.8 -28.658 AK012646 Grb10 
52 119.4 2.3 23.346 BC060377 Gsn 
1127.9 664.9 -1.7 -48.383 NM_008197.2 H1f0 
190.9 118.8 -1.6 -19.041 NM_013819.1 H2-M3 
135.9 29.7 -4.6 -33.761 AK017756 Hcapg-pending 
494.8 336.6 -1.5 -17.968 NM_020045.1 Hirip5 
279.7 158.9 -1.8 -40.911 NM_178187.2 Hist1h2ae 
35916.3 24285.5 -1.5 -29.178 NM_178185.1 Hist1h2ao 
1073.1 696.1 -1.5 -45.791 NM_010465.1 Hoxc6 
425.2 281.5 -1.5 -24.351 NM_010472.1 Hrb 
163.9 103.2 -1.6 -18.523 XM_147286.1 Hs6st1 
814.1 522.6 -1.6 -43.084 NM_133804.1 Hspa5bp1 
479.2 324.1 -1.5 -31.008 NM_133804.1 Hspa5bp1 
1627.2 925.3 -1.8 -31.073  Hspg2 
784.2 518.1 -1.5 -30.108 NM_031156.1 Ide 
893.4 585.6 -1.5 -23.198 NM_010517.2 Igfbp4 
608 414.8 -1.5 -23.465 NM_010517.2 Igfbp4 
2092.4 1440 -1.5 -22.993 NM_008344.1 Igfbp6 
2726 1593.1 -1.7 -68.716 NM_016721.1 Iqgap1 
1149.2 768.4 -1.5 -24.301 NM_016721 Iqgap1 
 









Accession Gene Symbol 
197.2 64.1 -3.1 -25.716 XM_192925.3 Itch 
562 377.7 -1.5 -19.049 NM_013565.2 Itga3 
524.4 221.3 -2.4 -42.689 NM_010578.1 Itgb1 
271.3 158.8 -1.7 -19.247 NM_010591.1 Jun 
799.3 520.9 -1.5 -29.612 NM_030887.2 Jundm2 
259.6 146.7 -1.8 -26.77 NM_010593.1 Jup 
315.8 150.7 -2.1 -66.866 NM_008433.2 Kcnn4 
742.4 460.5 -1.6 -41.966 NM_008443.2 Kif3a 
192.2 98.3 -2.0 -28.944 NM_010637 Klf4 
909.6 512.9 -1.8 -27.254 NM_010637.1 Klf4 
421.3 250.5 -1.7 -30.696 NM_010637.1 Klf4 
892.4 527.5 -1.7 -32.052 NM_033563.2 Klf7 
374.4 252 -1.5 -25.263 AK086122 Klf7 
352.5 235.5 -1.5 -22.634 NM_153513.1 L259 
267.5 2198.9 8.2 18.551 NM_008491.1 Lcn2 
1699.9 1138.8 -1.5 -42.401 NM_172589.1 Lhfpl2 
3438.3 2099.1 -1.6 -24.587 NM_019390.1 Lmna 
7165.7 4937.3 -1.5 -17.844 NM_019390.1 Lmna 
7915.4 5402.8 -1.5 -19.482 NM_010723.2 Lmo4 
126.8 67 -1.9 -22.155 XM_149324.1 LOC192195 
129.3 50.9 -2.5 -37.162 NM_199146.1 LOC209387 
435.1 231.5 -1.9 -58.563 XM_135569.2 LOC213480 
472.9 320.5 -1.5 -17.281 XM_128064.4 LOC223672 
148.9 91.5 -1.6 -18.863 XM_123193.2 LOC225021 
804.7 380.3 -2.1 -21.922 XM_135421.2 LOC235973 
749.6 514 -1.5 -27.742 XM_142547.2 LOC235979 
7023.2 4426.9 -1.6 -58.762 XM_143255.3 LOC242051 
156.7 54.3 -2.9 -22.439 XM_193524.2 LOC270589 
4142.1 2740.5 -1.5 -17.924 XM_287286.2 LOC329750 
1167.2 774 -1.5 -24.451 XM_284733.2 LOC331507 
477.7 315.9 -1.5 -22.405 XM_355056.1 LOC381140 
1001.6 674.9 -1.5 -30.44 XM_358649.1 LOC381739 
308.5 207.3 -1.5 -22.173 XM_355737.1 LOC381747 
489.2 173.3 -2.8 -51.318 XM_356225.1 LOC382128 
977.4 488.5 -2.0 -67.574 XM_356256.1 LOC382157 
138.7 64.6 -2.1 -21.127 XM_359014.1 LOC385959 
444.4 210.2 -2.1 -25.885 XM_359080.1 LOC386124 
447.1 287 -1.6 -20.936 XM_359173.1 LOC386330 
228.4 136.9 -1.7 -26.926 XM_359281.1 Lst1 
205.3 124.3 -1.7 -22.964 NM_033509.2 Ltap 
1499.2 3228.9 2.2 38.505 NM_010741 Ly6c 
124.7 297.5 2.4 19.745 NM_016693 Map3k6 
858.6 492 -1.7 -66.94 NM_138667.1 Map3k7ip2 
101 30.3 -3.3 -28.122 NM_020007.2 Mbnl1 
967.8 342.2 -2.8 -33.63 NM_008568.1 Mcm7 
293.6 163.2 -1.8 -44.924 NM_010789.1 Meis1 
31.6 188.7 6.0 18.931 NM_008581.1 Mela 
69 162.9 2.4 23.33 NM_008597.2 Mglap 
2155.9 1479 -1.5 -27.128 NM_008598.1 Mgmt 
 








Score Accession Gene Symbol 
990.6 635.5 -1.6 -25.319 NM_025569.1 Mgst3 
1758.8 1190 -1.5 -18.365 NM_025569.1 Mgst3 
201.6 379.5 1.9 20.138 AK085856 Mid2 
2362 1618 -1.5 -39.796 NM_021565.1 Midn 
1152.7 1805.7 1.6 18.385 NM_021462.2 Mknk2 
422.6 250.3 -1.7 -46.904 NM_010807.2 Mlp 
3962.5 2652.7 -1.5 -27.577 NM_027098.1 Mrpl30 
509.2 275.2 -1.9 -58.275 AK013126 Mrpl38 
919.9 248.1 -3.7 -38.588 NM_011954.2 Mrpplf3 
2586.7 1683.4 -1.5 -24.237 NM_080456.1 Mrps6 
23672 35348.5 1.5 17.333 NM_013602.2 Mt1 
1166.1 4057.3 3.5 53.705 NM_008630.1 Mt2 
681.8 295.4 -2.3 -80.752 NM_008634.1 Mtap1b 
1152.9 668.3 -1.7 -49.4 NM_013827.1 Mtf2 
176.9 58.1 -3.0 -33.219  mt-Nd4l 
190.2 101.2 -1.9 -25.145 NM_181390.1 Mustn1 
576.9 843.1 1.5 30.5 NM_177390 Myo1d 
439.6 772.9 1.8 40.814 NM_010875 Ncam1 
971.1 645.6 -1.5 -36.346 NM_026554.2 Ncbp2 
1119.7 733 -1.5 -31.286 NM_010880.2 Ncl 
2374 1505.8 -1.6 -43.936 NM_025316.2 Ndufb5 
283.9 158.8 -1.8 -20.328 NM_010901.1 Nfatc3 
703.2 201.8 -3.5 -139.96 NM_008688.2 Nfic 
172.8 64 -2.7 -56.574 NM_013609.1 Ngfb 
3298.2 1962.8 -1.7 -28.666 NM_018868.1 Nol5 
239.6 57.9 -4.1 -120.13 NM_145434.1 Nr1d1 
759 510.2 -1.5 -24.015 NM_008737.1 Nrp 
203.6 118.3 -1.7 -25.196 NM_008750 Nxn 
1470.1 957.2 -1.5 -29.418 NM_008750.2 Nxn 
731 1363.7 1.9 59.529 NM_053109.1 Ocil 
334.2 180.5 -1.9 -21.37 NM_133859.1 Olfml3 
880.3 511.2 -1.7 -56.375 NM_027881.1 Osbpl3 
626.9 377.8 -1.7 -37.989 NM_011119.1 Pa2g4 
2135.4 1353.4 -1.6 -28.218 NM_008776.1 Pafah1b3 
309.5 212.2 -1.5 -17.97 NM_026420.1 Paip2 
308.9 172.5 -1.8 -42.796 NM_011112.1 Papola 
246.3 132.6 -1.9 -32.355 NM_008793.1 Pcsk4 
125.7 73.3 -1.7 -18.085 NM_009981.2 Pcyt1a 
3351.5 1977 -1.7 -61.336 XM_132501.2 Pdap1 
188.2 60.3 -3.1 -32.109 NM_012019.2 Pdcd8 
635.9 350.7 -1.8 -28.921 NM_008808.2 Pdgfa 
1023.5 626.1 -1.6 -36.813 NM_008808 Pdgfa 
316.4 1030.6 3.3 27.946 NM_013743.1 Pdk4 
52 290 5.6 122.373 NM_011065.2 Per1 
198.9 51.9 -3.8 -93.06 NM_011066.1 Per2 
176.6 49.1 -3.6 -75.06 NM_011067 Per3 
245.5 356.2 1.5 22.633 NM_172783.1 Phka2 
957.7 321.6 -3.0 -65.461 NM_009344.1 Phlda1 
542.4 1077.2 2.0 48.417 NM_011085 Pik3r1 
 









Accession Gene Symbol 
206.7 128.7 -1.6 -24.168 NM_181585.3 Pik3r3 
793.8 501.5 -1.6 -41.926 XM_136134.3 Pir 
1244.2 808.8 -1.5 -39.909 NM_144859.1 Pja2 
384.1 249.3 -1.5 -22.756 NM_018807.3 Plagl2 
187.9 70.8 -2.7 -39.862 NM_011113.2 Plaur 
421.3 174.2 -2.4 -82.029 NM_011117 Plec1 
607.7 146.4 -4.2 -104.48 NM_031191.1 Plf 
3858.1 1002.3 -3.8 -100.80 NM_031191 Plf 
1330 410.4 -3.2 -38.405 NM_011118.1 Plf2 
2457.4 1391.9 -1.8 -57.192 NM_152804.1 Plk2 
652 443.8 -1.5 -30.944 NM_148932.1 Pom121 
530.2 215.4 -2.5 -121.52 NM_080555.1 Ppap2b 
141.8 69.6 -2.0 -29.274 NM_175934.2 Ppp1r10 
3430.8 2064.8 -1.7 -30.714 NM_008913.1 Ppp3ca 
476.7 1443 3.0 31.507 NM_054077.2 Prelp 
2679.8 1685.5 -1.6 -42.699 NM_011100.3 Prkacb 
308.2 194.8 -1.6 -30.48 NM_011158.2 Prkar2b 
214.4 122.2 -1.8 -28.746 NM_011101.1 Prkca 
381.4 233.4 -1.6 -20.478 NM_022999.1 Prrg2 
281.8 137.9 -2.0 -26.138 NM_011127.1 Prrx1 
713.7 391.9 -1.8 -40.57 NM_133948.2 Psip1 
2373 1382.9 -1.7 -33.792 NM_011191.1 Psme2b 
208.4 107.2 -1.9 -40.531 NM_008969.1 Ptgs1 
2104.3 1215.9 -1.7 -53.061 NM_008973.1 Ptn 
275.7 490.8 1.8 19.658 NM_023587 Ptplb 
267.9 102.4 -2.6 -84.577 NM_011202.2 Ptpn11 
396.4 240.8 -1.6 -21.375 NM_011221.1 Purb 
115.8 59.1 -2.0 -18.042 NM_009021.1 Rai1 
135.1 71 -1.9 -23.887 NM_028712.3 Rap2b 
258.8 474.9 1.8 52.396 NM_009025.1 Rasa3 
439.7 240.3 -1.8 -35.045 NM_148930.2 Rbm5 
2261 1545.5 -1.5 -29.797 NM_011254.2 Rbp1 
412.8 247.1 -1.7 -39.169 NM_054048.1 Rcor1 
342.5 205.8 -1.7 -39.393 NM_009041 Rdx 
785 1249.9 1.6 20.751 NM_133955.1 Rhou 
187 275.3 1.5 20.837 NM_177620.2 Rin3 
347.6 176.8 -2.0 -62.402 NM_133242.1 Rnpc2 
649.8 447.8 -1.5 -19.061 NM_145620.3 Rnu3ip2 
393.2 223.4 -1.8 -36.044 NM_018739.1 Rp9h 
1705.5 921.3 -1.9 -60.181 NM_009083.2 Rpl30 
247.4 132.2 -1.9 -39.043 NM_009088 Rpo1-4 
127.2 58.5 -2.2 -19.258 NM_009821.1 Runx1 
364.7 176.8 -2.1 -31.946 NM_011310.1 S100a3 
86.1 156.4 1.8 20.62 NM_011315 Saa3 
2156.4 1429 -1.5 -35.826 NM_009125.1 Sca2 
912.8 1395.7 1.5 36.973 NM_138741.1 Sdpr 
106 49.3 -2.2 -17.77 NM_009153.1 Sema3b 
276.7 184.4 -1.5 -19.086 NM_144851.2 Senp1 
591.5 190.5 -3.1 -86.935 NM_198247.1 Sertad4 
 










Accession Gene Symbol 
227.2 435.5 1.9 55.793 XM_125538.4 Sesn1 
1481 2488.6 1.7 45.63 NM_011361.1 Sgk 
402.9 192.5 -2.1 -49.134 NM_013665.1 Shox2 
241.1 153.5 -1.6 -26.116 NM_009177.2 Siat4a 
1543.7 695.1 -2.2 -54.989 NM_013612.1 Slc11a1 
267.7 154.4 -1.7 -34.94 XM_147798.4 Slc4a7 
895.1 566.8 -1.6 -20.179 NM_016769 Smad3 
135.9 80.2 -1.7 -19.096 AK028739 Smcx 
69.9 127.7 1.8 20.025 NM_021491.2 Smpd3 
1613.8 864.1 -1.9 -23.931 NM_009214 Sms 
62.8 120.6 1.9 18.398 NM_010831.1 Snf1lk 
1348.4 529.6 -2.5 -73.252 NM_019654.2 Socs5 
102.1 487.8 4.8 112.369 NM_011451.1 Sphk1 
307.4 169.9 -1.8 -41.112 NM_133903.2 Spon2 
1368.5 756.4 -1.8 -22.468 NM_009263.1 Spp1 
275.2 165 -1.7 -34.794 AK080894 Srb1 
253.1 161.3 -1.6 -21.587 NM_025527.1 Srp19 
8653.2 5828.5 -1.5 -32.211 AK080830 Srr 
556.5 375 -1.5 -33.279 AK043819 Srr 
134.5 43.9 -3.1 -47.902 NM_147155 Tagap 
100.9 26.5 -3.8 -24.184 NM_019512.1 Tcerg1 
3038.2 1955 -1.6 -29.806 NM_011552.1 Tcof1 
203.3 327.7 1.6 19.032 NM_011567.1 Tead4 
1549 463.2 -3.3 -194.87 NM_017376.2 Tef 
170.7 96.7 -1.8 -26.824 XM_109868 Tens1 
1305.8 736.9 -1.8 -76.024 NM_009371.2 Tgfbr2 
398.8 723 1.8 55.251 NM_011578 Tgfbr3 
774.8 502.3 -1.5 -21.495 NM_009372.2 Tgif 
3436.4 2145.6 -1.6 -31.818 NM_011593 Timp1 
2251.1 1484 -1.5 -32.819 NM_011595.1 Timp3 
272.3 170.8 -1.6 -29.995 NM_144792.2 Tmem23 
3383.6 2048.8 -1.7 -50.187 NM_013749.1 Tnfrsf12a 
110.3 45.5 -2.4 -28.592 NM_009393.1 Tnnc1 
280.5 190.5 -1.5 -17.469 NM_133673.2 Tor1b 
1011.1 633.1 -1.6 -22.532 NM_145853.2 Tpcn1 
700.4 456.7 -1.5 -28.907 NM_024427 Tpm1 
1424.4 699.5 -2.0 -32.809 NM_022314 Tpm3 
102 53.7 -1.9 -17.735 NM_144549 Trib1 
264.6 126.2 -2.1 -52.584 NM_201373.1 Trim56 
3939.9 2642.1 -1.5 -23.623 NM_053100.1 Trim8 
290.1 164.1 -1.8 -21.19 NM_011653 Tuba1 
293 150.2 -2.0 -30.247 NM_008807.1 Tulp2 
1708.1 1138.6 -1.5 -43.616 NM_007855.1 Twist2 
547.9 311.5 -1.8 -26.208 NM_172253.1 Twistnb 
442.6 254.5 -1.7 -39.948 NM_172253.1 Twistnb 
275.7 149.1 -1.8 -31.803 NM_029770.1 Unc5b 
349.9 185.3 -1.9 -24.047 NM_146144.2 Usp1 
 









Accession Gene Symbol 
288.4 184.8 -1.6 -29.02 NM_009462.1 Usp10 
290.2 145.8 -2.0 -51.708 NM_176972 Usp37 
360.5 153.8 -2.3 -29.705 XM_135857.4 Utp14a 
2375.1 1406.7 -1.7 -42.628 NM_011693.2 Vcam1 
1094 688.7 -1.6 -28.392 NM_009505.2 Vegfa 
141.7 72.8 -1.9 -25.811 NM_027462.2 Wars2 
1099.3 705.3 -1.6 -42.304 NM_031877.2 Wasf1 
1160.3 676.1 -1.7 -24.362 NM_009517.1 Wig1 
1794.8 1020 -1.8 -39.86 NM_018865.1 Wisp1 
123.3 66.1 -1.9 -21.061 AK049134 XEDAR  EDA-A2R 
131.9 71.6 -1.8 -21.956 NM_178074.2 Xpnpep2 
16931 10123.3 -1.7 -36.19 AK029441 Ybx3 
472.5 137.8 -3.4 -47.969 NM_010731.1 Zbtb7 
229.6 129.8 -1.8 -22.591 NM_153538.1 Zcchc6 
180.3 85.5 -2.1 -21.181 NM_027494.1 Zcchc8 
281.8 115.5 -2.4 -69.495 NM_018759.1 Zfp326 
205.3 137.8 -1.5 -18.039 NM_011759.1 Zfp41 
103.2 52.5 -2.0 -19.081 NM_173364 Zfp445 
317.8 78.7 -4.0 -60.684 NM_198416.1 Zzz3 
2981.1 1144.2 -2.6 -72.14   
895.7 388 -2.3 -84.092 AK081844.1  
1963.9 990.9 -2.0 -24.852 AK002910.1  
11284.2 7170.2 -1.6 -21.622 BC029319.1  
223.6 147.6 -1.5 -21.798 AK053042.1  
243.2 150.7 -1.6 -21.158  0610007N19Rik 
402.3 191.7 -2.1 -78.588 NM_025793.1 0610008N23Rik 
311 183 -1.7 -20.746 NM_025339.2 0610027O18Rik 
263.1 138 -1.9 -25.843 NM_172401.2 1110057K04Rik 
888.1 569.8 -1.6 -43.593 XM_147036.4 1190002N15Rik 
600.7 314.1 -1.9 -49.456 NM_025822.2 1200013F24Rik 
324.7 725.6 2.2 18.248 NM_133753.1 1300002F13Rik 
790.1 326.7 -2.4 -70.78 XM_132343.3 1500011J06Rik 
228 121.9 -1.9 -17.63 XM_356257.1 1500041I23Rik 
Listed from left to right, the average signal intensity of each gene in the vehicle treated control (0nM Cort), 
100nM corticosterone treated group (100nM Cort), the fold change in expression level from basal to 
corticosterone treatment, the significance value in Diff. score (Diff. 17 is equivalent to p=0.02, larger Diff. 
scores are lower p-values), the accession number, and the gene symbol for each gene regulated in HT-
22/MR16 cells. 
 








Figure 4-4 Gene Ontology of genes regulated by 100nm corticosterone in HT-22 
MR16 cells. 
A) Quantitation of genes that sort into different functional categories under the ontology 
of Biological Process as determined by GOTM software.  Categories in red denote an 
overrepresentation of regulated genes relative to the expected number of genes within 
that category.  B) Vennmaster diagram depicting overlapping functional categories of 
genes that were also determined to be overrepresented in the data as determined by 
GoMiner and VennMaster software. 
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QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
 
Figure 4-5 Venn diagram representing the overlap between cell treatment groups of 
genes that are regulated by corticosterone. 
P0-P100=HT-22 Parent 100nM corticosterone, M0-M1=HT-22 MR16 1nM 
cortiocsterone, and M0-M100=HT-22 MR16 100nM corticosterone
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Table 4-5 Corticosterone-responsive genes per group from venn diagram in Figure 5. 
P0-P100  
(192) 
  M0-M100 









P100 & M100 & 
M1 (21) 
AL033326 Hspd1 Snrp70 Acadm E2f3 Lhfpl2 Rap2b Wasf1 C3 Chrd 5730594E01Rik Nr1h4 Arntl 
Abcf2 Idb2 Snrpa Aebp1 EDA-A2R Lmna Rasa3 Wig1 C330004K0ik1R D15Mit260 B230387C07Rik P2rx5 Chst1 
Acas2 Idh3g Srm Akap9 Eda2r Lmo4 Rbm5 XEDAR Cxcl1 Dnmt3l Fbxw7  Col8a1 
Akr1c12 Il1rl1 Suclg1 Akt3 Edg2 Lst1 Rbp1 Xpnpep2 Dpysl3 Dusp1 Lcn2  Cp 
Anapc5 Irak1 Taf7l Aldh2 Efemp2 Ltap Rcor1 Ybx3 Isg20 Dusp4 Mela  Cspg2 
Ankrd1 Itgb7 Tcp1 Ampd3 Eif5b Map3k7ip2 Rdx Zbtb7 Vdr Dusp8 Nfic  Cyr61 
Anxa4 Khdrbs1 Tes Angptl2 Ela1 Mbnl1 Rhou Zcchc6 Wisp2 Epha2 Pdcd8  D15Bwg0759e 
Aptx Lynx1 Tm4sf8 Angptl4 Elf2 Mcm7 Rnpc2 Zcchc8  Esd Per2  Dbp 
Aqp5 Man2a1 Tm7sf1 Ankhd1 Emilin1 Meis1 Rnu3ip2 Zfp326  Hs6st1 Plaur  Fkbp5 
Arf5 Mapk6 Tnfrsf22 Aqp1 Eml1 Mgmt Rp9h Zfp41  Jun Socs5  Mt2 
Arpc1a Mat2a Tnfrsf6 Arhgap22 Eml4 Mgst3 Rpl30 Zfp445  Klf4 Spp1  Ncam1 
Asns Mbd3 Tnk2 Arid5a Emp1 Mid2 Rpo1-4 Zzz3  LOC329750   Nr1d1 
Atf4 Mbtps1 Top2a Ase1 Emp3 Midn Runx1   Ly6c   Pdk4 
Atic Mrpl3 Tpm4 Ash1l Enah Mlp S100a3   Map3k6   Per1 
Atp6ap2 Mrpl48 Trib3 Atbf1 Enpp4 Mrpl30 Sca2   Mglap   Per3 
Aup1 Msln Tsrc1 Atp5e Ephb2 Mrpl38 Sdpr   Mknk2   Phlda1 
Bnip1 Msn Tubb5 Atp5k Etv4 Mrps6 Sema3b   Mrpplf3   Plf 
Brd7 Mtch1 Ube2e3 Bcl10 Exosc1 Mt1 Senp1   Ncbp2   Prelp 
Btg1 Mybbp1a Uble1a Bcl6 Ezh2 Mtap1b Sertad4   Ngfb   Sgk 
C1qbp Myc Uchl5 Bhlhb2 Fbln2 Mtf2 Shox2   Pa2g4   Sphk1 
Camk1 Napa Umps Brd4 Fibp Mustn1 Siat4a   Plec1   Tef 
Cdh2 Nfkb1 Vav2 Brunol4 Fmnl2 Myo1d Slc11a1   Plf2    
Cdk4 Nipsnap3b Xab1 Capn2 Fosl1 Ncl Slc4a7   Plk2    
Cryab Nnmt Xpot Casp3 Gadd45b Ndufb5 Smad3   Prkar2b    
Cryz Nol5a Yeats4 Ccnd1 Galnt1 Nfatc3 Smcx   Rin3    
Csda Nradd Ywhaq Ccnd2 Gbf1 Nol5 Sms   Saa3    
Ctps Nubp2 Zcchc14 Ccng1 Gbif Nrp Snf1lk   Sesn1    
Dhps Obfc1 Zfp330 Cd164l1 Gkap1 Nxn Spon2   Smpd3    
Dysf Odz4 Zranb1 Cd34 Glipr1 Ocil Srb1   Tead4    
Eef2 Pigt  Cd44 Glrx2 Olfml3 Srp19   Timp3    
Eif2b1 Plekhj1  Cdc25a Gng8 Osbpl3 Srr   Tnfrsf12a    
Eif3s8 Ppp1ca  Cdc2l2 Gnpda2 Pafah1b3 Tagap   Wisp1    
Eif3s9 Ppp2r1a  Cdkn1a Golga2 Paip2 Tcerg1       
Eif4a2 Prnpip1  Chd1 Golph4 Papola Tcof1       
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Table 5. Continued 
P0-P100  
(192) 
  M0-M100 









P100 & M100 & 
M1 (21) 
Eif5a Prss11  Chd4 Gpc1 Pcsk4 Tens1       
Eps8 Prss15  Clspn Gpr149 Pcyt1a Tgfbr2       
Etfa Psma1  Cnn2 Grb10 Pdap1 Tgfbr3       
Fancl Psmd13  Cnot4 Gsn Pdgfa Tgif       
Fdps Psmd7  Cntf H1f0 Phka2 Timp1       
Figf Psme2  Col1a2 H2-M3 Pik3r1 Tmem23       
Flnb Ptp4a2  Copeb Hcapg-
pending 
Pik3r3 Tnnc1  
     
Fn1 Rad23a  Cox7b Hirip5 Pir Tor1b       
Fosl2 Ranbp9  Crebbp Hist1h2ae Pja2 Tpcn1       
Fxr2h Rbbp7  Cryzl1 Hist1h2ao Plagl2 Tpm1       
G3bp Rbp2  Csf1 Hoxc6 Pom121 Tpm3       
G6pc3 Rhoj  Csnk2a1-rs3 Hrb Ppap2b Trib1       
Gadd45a Riok1  Cstf3 Hspa5bp1 Ppp1r10 Trim56       
Glrx1 Rtn4  Cugbp1 Hspg2 Ppp3ca Trim8       
Gna11 Ruvbl1  Ddah2 Ide Prkacb Tuba1       
Gnas Rwdd1  Ddef1 Igfbp4 Prkca Tulp2       
Gpiap1 S3-12  Ddx21 Igfbp6 Prrg2 Twist2       
Grwd1 Sdbcag84  Ddx24 Iqgap1 Prrx1 Twistnb       
Gtf3a Sfrs10  Ddx6 Itch Psip1 Unc5b       
Herpud1 Sfrs5  Dek Itga3 Psme2b Usp1       
Hnrpa2b1 Sh3bgrl2  Dfna5h Itgb1 Ptgs1 Usp10       
Hnrpk Sh3bp2  Diap3 Jundm2 Ptn Usp37       
Hoxd8 Sh3kbp1  Dok1 Jup Ptplb Utp14a       
Hrbl Smarce1  Dpm3 Kcnn4 Ptpn11 Vcam1       
Hspca Smc1l1  Dsip1 Kif3a Purb Vegfa       
Hspcb Smu1  Dub1 Klf7 Rai1 Wars2       
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regulated genes in the P0-P100 group, 192 (76%) of them were exclusive to this group, 
suggesting that they may be genes that are regulated exclusively by GR.  In the M0-M100 
category, 86% (407 of 476) of the corticosterone-regulated genes were specific for this 
group.  In the M0-M1 category, only 7 of the 41 genes (17%) were specific for this 
group.  The most striking feature of this figure is the small degree of overlap between the 
P0-P100 and the M0-M100 groups- only 58 genes (23% of the P0-P100 group and 12% 
of the M0-M100 group) overlapped between them, suggesting distinct sets of GR and 
MR/GR responsive genes. 
 
Quantitative RT-PCR (Q-RT-PCR) confirmation of microarray results: 
 Q-RT-PCR was performed on 5 genes in the circadian rhythm category of genes 
that was identified as having been significantly overrepresented in all three treatment 
groups.  This category contained genes that were common to the P0-P100, M0-M1, and 
M0-M100 groups, and one gene, Per2, that was only regulated in the M0-M1 and M0-
M100 groups.  None of the genes were regulated in the P0-P1 treatment group.  To first 
confirm that the genes of interest are expressed in HT-22 cells, RT-PCR was performed 
with cDNA from HT-22 cells using primer pairs specific to each gene and the amplified 
products were separated on 2% agarose gels along with a DNA ladder to demonstrate that 
the amplification products were the expected sizes (Figure 4-6A).   
 To determine whether corticosterone regulates the expression of these genes in a 
similar manner to that observed in the microarray, cDNA was made from the same stocks 
of RNA that were utilized for the microarray experiment and Q-RT-PCR was performed 
on vehicle treated and corticosterone treated samples with the same primer pair used in 
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A. 
Per2 Per3 TEF NR1D1 DBP TBP
154bp
134bp





HT22 MR16: Fold Change HT22 Parent: Fold Change 
Gene qRT-PCR Microarray  Gene qRT-PCR Microarray 
Per2    Per2   
1nM -1.2 -1.6  1nM -1.2 NC 
100nM -2.2 -3.8  100nM -1.3 NC 
Per3    Per3   
1nM -1.6 -2  1nM -1.1 NC 
100nM -3.8 -3.6  100nM -2.6 -2.3 
Dbp    Dbp   
1nM -2.3 -2.8  1nM -1.1 NC 
100nM -7.3 -16.1  100nM -4.9 -9.8 
TEF    TEF   
1nM -1.4 -1.9  1nM -1.2 NC 
100nM -3.1 -3.3  100nM -3.9 -2.8 
NR1D1    NR1D1   
1nM -1.4 -1.9  1nM NC NC 
100nM -1.4 -4.1  100nM -1.2 -2.6 
Figure 4-6 Quantitative RT-PCR confirmations of microarray data 
A) Amplified fragments of gene specific cDNAs from HT-22 cells.  cDNA was generated 
from unstimulated HT-22 cells and PCR was performed with primer pairs specific for 
each gene listed.  The expected amplicon sizes are depicted below each lane.  B) Q-RT-
PCR confirmations of corticosterone responsive genes from microarray. 
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the test RT-PCR. Figure 4-6B depicts the Q-RT-PCR data from the 1nM and 100nM 
treated HT-22 Parent and HT-22 MR16 cells as fold change over vehicle treated cells.  
The corresponding fold change in expression of the same gene from the microarray data 
is shown for comparison.  Comparison of the Q-RT-PCR data with the microarray data 
for all of the genes analyzed reveals fairly consistent results.  Overall, the Q-RT-PCR 
fold change values were slightly less than the corresponding microarray fold change 
values, but the same pattern of regulation was observed.  None of the genes in the HT-22 
Parent 1nM corticosterone treated group appeared to be regulated by corticosterone to 
any significant degree in either the microarray or Q-RT-PCR. 
 
Discussion: 
 Using the Illumina Whole Genome Expression Arrays (BeadChips), we have 
identified 677 corticosterone-responsive genes in HT-22 and HT-22/MR16 cells.  In the 
HT-22 Parent cell line that expresses only GR, 252 genes were identified as 
corticosterone-responsive after incubation with 100nM corticosterone.  In HT-22/MR16 
cells that express both MR and GR, 41 genes were regulated by 1nM corticosterone while 
476 genes were identified as regulated by 100nM corticosterone.  Gene ontology analyses 
demonstrate the largest number of genes regulated by corticosterone in each group are 
involved in cellular metabolism, intracellular signaling cascades, and the regulation of 
transcription.   
Several studies have suggested that the Illumina bead array platform is a very 
sensitive and reliable expression profiling technique (Liu, Shin et al. 2006).  Consistent 
with this, we have identified many corticosteroid-responsive genes in our study in HT-22 
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cells whose expression was previously shown to be regulated by corticosterone in 
hippocampus.  For example, the well known glucocorticoid target gene, serum and 
glucocorticoid regulated kinase (SGK1) was clearly upregulated in M1, M100, and P100 
samples.  Metallothionein 1 (Mt1) was up-regulated in HT-22/MR16 cells in response to 
100nM corticosterone, and metallothionein 2 (Mt2) was up-regulated in M1, M100, and 
P100.  These genes are regulated in the hippocampus in vivo through adrenalectomy and 
stress (Gasull, Giralt et al. 1994; Belloso, Hernandez et al. 1996).  More generally, the 
effects of corticosterone on cellular energy metabolism have also been described 
(Plaschke, Muller et al. 1996), consistent with the pathway analysis of regulated genes in 
these cell lines.  However, it should be noted that our study did not identify some genes 
that have been shown to be corticosteroid-responsive in hippocampus such as the 
serotonin receptor 1a (5HT1a).  This suggests that the level of sensitivity of this 
microarray may still preclude the identification of low abundance transcripts that may in 
fact be regulated by GR and/or MR.  A recent paper addressing the sensitivity of large-
scale transcriptome monitoring across different platforms (Serial Analysis of Gene 
Expression [SAGE] and Affymetrix Gene Chips) found that a large percentage of low 
abundance genes are not reliably detectable (Evans, Datson et al. 2002).  In the present 
study, the low abundance genes (average intensity values < 100) were not included in the 
analysis as high variability in expression between the triplicate samples precluded an 
efficient analysis of their patterns of gene expression.  
Our experimental design allowed for the detection of genes that were regulated 
exclusively by GR in HT-22 cells and genes that were regulated predominately by MR or 
both MR and GR together in the HT-22/MR16 cells. Interestingly, however, only 58 
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genes overlapped between the HT-22 100nM (P100) and HT-22/MR16 (M100) groups 
(23% of P100, and 12% of M100), suggesting that when MR and GR are activated 
together, different sets of genes may be activated compared to those activated by GR 
alone.  In HT-22/MR16 cells treated with 1nM corticosterone (predominant MR 
activation), 41 genes were differentially expressed from vehicle treated cells.  Of these 41 
genes, 7 (17%) were exclusive to the 1nM treated group, while 21 (51%) overlapped with 
both the M100 and P100 groups and 11 (27%) were found to overlap with the M100 
group, suggesting that greater than 75% of MR responsive genes are also responsive to 
MR/GR together.  
These results largely confirm and extend the studies by Datson et al. that 
identified corticosteroid-responsive genes in rat hippocampus using SAGE. They used 
ADX rats that had been replaced with low or high levels of corticosterone to study MR-
responsive and GR/MR-responsive genes.  Similar to results here, they found that a large 
percentage of the corticosteroid-reponsive genes were involved in cellular processes such 
as metabolism, energy expenditure, protein synthesis and signaling.  Similar to our 
results, they also found that approximately 50% of MR-responsive genes were negatively 
regulated by corticosteroid, while significantly greater than 50% of the GR/MR-
responsive genes were negatively regulated by corticosterone.  However, it should be 
noted that their SAGE studies identified only 203 corticosterone-responsive genes, while 
our gene expression profiles identified 485 corticosterone-responsive genes in HT-
22/MR16 cells (most similar to their experimental groups).  In addition, our studies in the 
parent HT-22 cells identified an additional 192 corticosterone-regulated genes.  Thus, the 
increased sensitivity of our studies and additional comparison with HT-22 cells (GR-
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responsive genes) significantly increased the information on glucocorticoid-regulated 
gene expression profiles in hippocampus.  
It was most interesting to note that one of the significant differences in the gene 
ontology profiles between GR-activated genes (P100) and MR/GR activated genes 
(M100) was negative regulation of apoptosis.  Several studies have shown that high 
levels of corticosteroids can have deleterious effects on hippocampal neurons, greatly 
enhancing the likelihood that subsequent insults, such as increased levels of glutamate, 
will kill cells in region CA1.  The molecular mechanisms underlying these processes are 
not completely understood, but evidence suggests that a balance in the expression and 
activation levels of MR and GR may be important. A predominance of GR activation 
may be responsible for many of the adverse effects of corticosterone on the hippocampus, 
while MR activation may provide more of a neuroprotective role (Herman and Seroogy 
2006).  
Of particular interest, two pro-apoptotic genes caspase-3 and calpain-2 are down-
regulated exclusively in HT-22/MR16 cells treated with 100nM corticosterone.  
Additionally, metallothionein I, which was also exclusively up-regulated in HT-22/MR16 
cells treated with 100nM corticosterone, has been shown to enhance cell survival 
following exposure to oxidative stress (Levadoux-Martin, Hesketh et al. 2001).  These 
data suggest that when the expression patterns of large numbers of genes are changed by 
the concurrent activation of MR and GR together relative to GR activation alone, the 
expression patterns of categories of genes with potentially biologically significant effects 
relevant to hippocampal structure and function may also be altered. 
In addition to interesting pathways of genes that were altered differentially 
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between these two cell lines, there was one pathway of genes in particular that was 
identified as being regulated by corticosterone in M1, M100, and P100.  Of the 21 genes 
that were in common between these three groups, 6 (29%) of them were genes involved 
in circadian rhythmic processes including Per1, Per3, NR1D1 (REV-ERBα), Dbp, Tef, 
and Arntl (Bmal1).  Furthermore, Per2 was also found to be regulated by 1nM and 
100nM corticosterone, but only in HT-22 MR16.  We have confirmed these changes in 
HT-22 cell lines using Q-RT-PCR.  The altered expression of many of these circadian 
rhythm genes has been associated with several mood disorders, including seasonal 
affective disorder (SAD) (Partonen, Treutlein et al. 2007) and bipolar disorder (Mansour, 
Wood et al. 2006; Nievergelt, Kripke et al. 2006).  Interestingly, some recent papers have 
suggested that neurogenesis in the hippocampus fluctuates in a circadian fashion and that 
progenitor cell proliferation in the dentate gyrus is inhibited by Per2 (Borges 2004; 
Guzman-Marin, Suntsova et al. 2007). These data suggest that the improper regulation of 
circadian control genes in the hippocampus by corticosterone may be important in many 
hippocampal functions including mood disorders. 
Finally, however, it should be noted that within the HT-22/MR16 cells treated 
with 100nM corticosterone, it is not possible to distinguish between genes that are 
regulated by the activation of homodimers versus heterodimers.  In addition, as all of 
these cells were treated with corticosterone for 24 hours, it is not possible to tell whether 
the regulation of any particular gene is due to a primary action of MR or GR as a 
transcription factor on the promoter, or a secondary or even tertiary regulation of a 
downstream effector.  The analysis of gene expression in these cells using a time-course 
analysis starting as soon as 1 hour or less after the addition of corticosterone would be 
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appropriate for the identification of large numbers of genes that may be primarily 
regulated by direct MR/GR/promoter interactions. 
In conclusion, using the Illumina Bead Array microarray system, we have 
identified 677 corticosterone-responsive genes in HT-22 Parent and HT-22/MR16 cells 
under different corticosterone concentrations.  This system has allowed us to identify 
genes that are regulated by GR alone, MR alone, and MR and GR co-activation.  
Furthermore, this system has allowed us to determine the effects of an altered MR:GR 
ratio on global gene transcription output in response to the same dose of corticosterone.  
Gene ontologies that are overrepresented in the data suggest that corticosterone has 
significant effects on the expression patterns of genes involved in cellular metabolism 
and circadian rhythm.  Gene ontologies that are overrepresented differentially between 
HT-22 Parent and HT-22/MR16 cells suggest that the co-activation of MR and GR versus 
GR activation alone results in altered expression patterns of a number of genes that are 
involved in the regulation of apoptosis and cell proliferation.  Together, these results 
provide possible insights into both the similar and differential modes of action for GR 
and MR in mediating a wide variety of hippocampal functions, including neuronal 
survival and proliferation. 
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Chapter 5 
Conclusions and future directions 
 
Summary of contributions: 
Introduction: 
Glucocorticoids in the brain influence neuroendocrine function, neuronal 
excitability, neuronal plasticity, cognition, neurogenesis, and neurodegeneration.  While 
many studies have examined the role of GR in mediating the effects of glucocorticoids in 
the brain, much less is known about the function of MR in mediating the effects of 
glucocorticoids in the central nervous system.  The goal in this thesis has been to address 
the role of MR in these processes using both in vivo techniques to understand 
physiological and behavioral consequences of MR action, and in vitro techniques to 
understand cellular consequences of MR action. 
 
Mineralocorticoid receptor influences HPA axis activity and anxiety-like behavior: 
Chapter 2 addressed the physiological and behavioral consequences of MR action 
using a mouse model that overexpresses MR specifically in forebrain regions.  Several 
important conclusions can be drawn from this chapter.  First, the actions of MR in the 
forebrain can include the negative feedback regulation of HPA axis activity in response 
to stress.  Second, overexpression of MR in the forebrain results in decreased anxiety-
related behaviors.  Third, overexpression of MR in the forebrain has significant effects on 
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the basal expression patterns of other genes that are involved in the modulation of both 
HPA axis activity and anxiety-related behaviors, including decreased GR mRNA 
expression in region CA1 of the hippocampus and increased expression of 5HT-1a also in 
region CA1 of the hippocampus.   
Over the last few decades, antagonist studies have suggested that the activity of 
MR is necessary for the maintenance of proper HPA axis activity under basal conditions.  
While several studies have suggested that the combined activity of both MR and GR may 
be required to restrain HPA axis activity during stress, this is the first study to suggest 
that an increase in MR levels alone is sufficient to decrease HPA axis activity in response 
to stress.  The findings of decreased anxiety-related behavior, and of increased expression 
of 5HT1a in the hippocampus are especially salient with respect to our understanding of 
MR action because they were not expected.  The decreased anxiety-related behavior is 
interesting as it demonstrates that long-term increases in MR expression can result in a 
phenotype that directly contrasts with the proposed function of short-term activation of 
MR.  This finding is also interesting because increased expression of GR in the forebrain 
has the opposite effect of increasing anxiety-like behavior.  These data serve to highlight 
the opposite roles that MR and GR play in anxiety-like behavior and emphasize the 
importance, at a behavioral level, of a proper balance in MR and GR expression levels.  
The finding of increased expression of 5HT1a in the hippocampus is interesting in that it 
also contrasts with in vitro data suggesting that MR represses 5HT1a expression at an 
nGRE found in its promoter, as well as in vivo data (adrenalectomy and corticosterone 
replacement) suggesting that glucocorticoids also repress 5HT1a expression.  Even 
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though this result is unexpected, it does provide a possible mechanism underlying the 
decrease in anxiety-like behavior. 
 
Mineralocorticoid receptor protects HT-22 cells from glucocorticoid endangerment: 
There is good evidence that high levels of corticosteroids can endanger neurons, 
leading to possible deleterious effects on the structure and function of the hippocampus.  
Studies in chapter three of this thesis have focused on the cellular consequences of 
glucocorticoid exposure with the goal of determining the roles of MR and GR in this 
process of glucocorticoid endangerment.  For these studies, we chose the hippocampal 
cell line HT-22.  This cell line had previously been shown to express GR, be very 
sensitive to glutamate toxicity, and to be sensitive to glucocorticoid exacerbation of 
glutamate toxicity.  In subsequent studies we were able to demonstrate that these cells do 
not express MR, allowing us to make stable clones of HT-22 cells that express MR in 
addition to GR, and determine in side-by-side experiments with the HT-22/Parent cell 
line, the ability of glucocorticoids to exacerbate glutamate toxicity.  In line with many 
other studies suggesting a neuroprotective role for MR, we were able to determine that 
while the parent cell line exhibited an enhancement of glutamate toxicity when pre-
exposed to glucocorticoids, clone HT-22/MR16 no longer displayed this phenomenon, 
suggesting that MR can attenuate glucocorticoid mediated enhancement of glutamate 
toxicity.   
While the exact mechanism underlying this effect remains to be determined, 
several mechanisms by which MR may play a neuroprotective role in neuronal cells have 
been proposed.  In single CA1 cells, it has been shown that predominant MR activation 
can alter the ratio NMDA receptor subunit genes (increase NR2A:NR2B) leading to 
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overall decreased NMDA receptor activity and reduced calcium flux (Nair, Werkman et 
al. 1998).  MR signaling has also been shown to up-regulate anti-apoptotic enzymes Bcl-
2 and Bcl-xL and down-regulate p53 expression (Almeida, Conde et al. 2000).  
Additionally, other studies have shown that the manipulation of MR activity both in vivo 
and in vitro can influence cell survival through apoptosis related mechanisms (McCullers 
and Herman 1998; McCullers and Herman 2001; Crochemore, Lu et al. 2005). 
In line with effects on apoptotic mechanisms, we have shown preliminary 
evidence that when MR and GR are co-activated in HT-22/MR16 cells, the protective 
effect may come in part through the decreased activation of apoptotic enzymes.  It was 
shown previously that the addition of MR to PC12 cells was able to provide a certain 
level of neuroprotection to multiple insults including staurosporine and oxygen/glucose 
deprivation.  If the addition of MR to HT-22 cells is capable of altering apoptotic 
processes, then it would be interesting to test whether HT-22/MR16 cells are more 
resistant to additional insults such as oxygen/glucose deprivation and staurosporine. 
 
Altering the ratio of MR to GR significantly changes global transcriptional output 
relative to GR activation alone: 
There are several reported instances where hyperactivity of the HPA axis is 
associated with increased susceptibility to neuronal damage or to negative effects on 
learning and memory as well as mood.  In these instances, alterations in the ratio of 
MR:GR expression in the hippocampus are often found.  MR and GR are ligand activated 
transcription factors that both bind glucocorticoid hormones and regulate the expression 
patterns of gene networks.  Previous research has shown that when MR and GR are 
  
    176
expressed together, their activity on a specific promoter can result in transcriptional 
regulation that differs from activation of either MR or GR alone.  What hasn’t been 
appreciated before is the extent to which variations in the levels of the receptors can alter 
the transcriptional output on a global scale.   
The findings from chapter 4 are important in two ways.  First, they suggest that 
altering the ratio of MR to GR expression in a hippocampal cell line can drastically 
change the global transcriptional output in response to the same level of hormone.  
Second, gene ontology analyses of the changed genes in each cell line suggest that when 
MR and GR are activated together, different classes of genes are regulated compared to 
when GR alone is activated.  These include classes of genes that are involved in cell 
survival and cell proliferation, providing possible insight into how decreased ratios of 
MR to GR seen in some pathological states may be functionally significant.   
 
Future directions: 
There are several features that stand out from this body of work.  First, it is 
obvious from the in vivo results that short-term activation or blockade versus long-term 
increases or decreases in receptor level can often yield opposite results; however, the 
mechanisms underlying the differences in short-term activation of MR and long-term 
increases in MR levels remain unclear.  Korte, a prominent researcher in the field of 
glucocorticoid actions in fear and anxiety, suggests that “Corticosteroids do not regulate 
emotional behavior, rather they induce chemical changes in particular sets of neurons, 
making certain behavioral outcomes more likely in a certain context, as a result of the 
strengthening or weakening of particular pathways” (Korte 2001).  To extend this 
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concept, one could suggest that glucocorticoid actions on behavior can perhaps be 
divided into multiple realms.  In a shorter time frame, glucocorticoids can influence 
cellular responses that, in turn, influence behavior at that moment, or over a period of 
hours.  Over longer periods of exposure to increased glucocorticoid levels, or to long-
term alterations in corticosteroid receptor levels, other aspects of cellular properties can 
also be influenced, such as energy metabolism, that will make that particular set of 
neurons respond differently perhaps leading to a different behavioral or physiological 
output.  Clearly, if a particular set of neurons that is involved in modulating a particular 
behavioral output in response to glucocorticoids is now altered in its function, then that 
set of neurons could now respond differently to glucocorticoids relative to the naïve state.  
The fact that it is the same hormone that is participating in both aspects of these cellular 
properties (behavioral modulation versus energy metabolism) suggests that the influence 
of MR on behavior is context dependent.   
In the context of mice that overexpress MR in the forebrain, it may then be 
interesting to repeat some of the original MR antagonist studies where it was determined 
that MR blockade reduces anxiety-like behavior.  If MR blockade in MRov mice results 
in a further decrease in anxiety-like behavior, above the already decreased anxiety 
background, then this could suggest that the immediate actions of MR activation increase 
anxiety-like behavior, but that long-term elevations in MR levels may serve to influence 
overall cellular properties in a manner that reduces anxiety under basal conditions.  In 
this case an appropriate question may be: Do neurons that overexpress MR exhibit 
different basal properties compared to neurons that do not overexpress MR?  If so, are 
these differential properties responsible for altered behavior?  
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 In MRov animals, one can address the basal properties of MR overexpressing 
neurons at multiple levels.  This could include a microarray analysis of laser-captured 
neurons from specific CA regions or the dentate gyrus.  As MR and GR are only 
expressed in the granule and pyramidal layers of the hippocampus, this would be a 
powerful way of examining changes in a very region-specific manner and would remove 
the problems that accompany microarray analysis from hippocampal tissue as a whole, 
mainly the loss of sub-region specificity, and the dilution of low abundant transcripts 
amongst the rest of the hippocampal tissue.  There are many different kinds of 
comparisons one could make with this approach.  In addition to trying to find genes that 
are regulated by corticosterone differentially in WT and MRov mice (such as 
adrenalectomy to low or high corticosterone replacement), it may also be interesting to 
find genes that are expressed differentially between WT and MRov animals under 
specific conditions, such as the circadian trough and peak or in a perturbed system such 
as chronic unpredictable stress.   
Another important approach would be to address the cellular properties of 
hippocampal neurons that overexpress MR.  It was recently shown in forebrain specific 
MR-KO mice that non-genomic, MR mediated actions are required for proper glutamate 
signaling (Karst, Berger et al. 2005).  The overexpression of MR in the hippocampus may 
specifically alter aspects of cellular properties that could contribute to the behavioral and 
physiological phenotypes observed in these animals.  If this is the case, one very 
interesting question is whether the MR can transduce glucocorticoid signaling by acting 
at the membrane.  How could this occur?  Could MR activation at the membrane 
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modulate traditional intracellular second messenger pathways such as the MAPK and 
PI3K pathways? 
Research that is especially pertinent to our understanding of the interactions 
between HPA axis regulation and mood disorders includes studies that address chronic 
stress.  Previous studies have shown that conditions that lead to chronic elevations in 
glucocorticoids, such as chronic unpredictable stress (CUS), can have several effects on 
the structure and function of the hippocampus including increased susceptibility of 
neurons to toxic insults, decreased neurogenesis, increased anxiety-like behavior, and 
decreased learning and memory.  These studies suggest that there may be alterations in 
the ratios of MR to GR in the hippocampus and that these changes may contribute to 
hippocampal structure and function.  If increased levels of MR in the hippocampus lead 
to decreased anxiety under basal conditions, it would be very interesting to determine the 
effects of increased MR on all these aspects of hippocampal structure and function under 
conditions of chronic stress. 
 
MR and GR balance in glucocorticoid signaling: 
The second prominent feature that arises from both the in vivo and in vitro 
research in this thesis, as well as similar work from other labs, is the idea that a proper 
ratio of MR to GR in the hippocampus is important for multiple aspects of appropriate 
physiological, behavioral and cell survival processes.  Considering the importance of the 
combined roles of MR and GR signaling in the same cell, it is surprising how little is 
actually known concerning the mechanisms underlying heterodimer versus homodimer 
action.  For example, we know that GR can either repress or activate AP1 activity when it 
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is composed of cJUN/cFOS heterodimers or cJUN/cJUN homodimers, respectively, at 
either a cGRE or juxtaposed simple GRE and AP1 binding site (Diamond, Miner et al. 
1990; Pearce, Matsui et al. 1998).  It has been shown that while MR can bind to this same 
site with equal affinity, it has no effect on AP1 activity (Pearce and Yamamoto 1993).  
However, nothing is known regarding the effects of MR/GR heterodimers on cGRE 
activity.   
Liu and colleagues reported that the co-expression of MR and GR was capable of 
inhibiting the levels of induction of reporter gene activity as compared to GR activation 
alone (Liu, Wang et al, 1995).  This study used a reporter gene containing 3 tandem 
GREs in the promoter, and they propose that this MR-mediated inhibition of GR activity 
may be due to an MR-mediated disruption of GR self-synergy at the GRE multimer.  
However, the reporter gene used in our studies also contained a multimer of 5 GREs in 
the promoter and in contrast to the effects observed by Liu and colleagues, we found 
greatly increased levels of reporter gene activity when MR was present at different levels 
along with GR, suggesting that MR does not restrict GR self-synergy in all contexts.  
Additionally, we know that MR and GR can interact with distinct sets of coregulators, but 
we know nothing of the interactions of MR:GR heterodimers with coregulators.  On a 
given promoter, are the same coregulators recruited by a heterodimer as the respective 
homodimers?  Are receptor specific coregulators still recruited to a heterodimer?  It may 
be possible to address some of these questions with the MR and GR point mutants 
developed by Liu and colleagues (Liu, Wang et al. 1995).  These mutants can only 
heterodimerize, thus allowing one to determine if an MR specific coregulator (FAF-1) 
can still be recruited relative to MR:MR homodimers. 
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As the N-terminal regions of MR and GR are responsible for many of the 
interactions they have with other coregulators, and they share only 15% amino acid 
identity, one could hypothesize that heterodimer action is largely mediated by differential 
interactions of heterodimers with coregulators.  To test this hypothesis, it would be 
interesting to swap the N-terminal domain of MR with the N-terminal domain of GR.  
After making stable clones of HT-22 cells with this chimera, one could test if it is largely 
the same or different genes that are being regulated relative to the HT-22/Parent cell line 
at the same dose of corticosterone.  
Beyond the use of the MRov mice used in this project, it would also be interesting 
to generate other mouse models that could further test the idea that the ratio of MR to GR 
is important in hippocampal function.  While mice that are lacking MR in the forebrain 
do not appear to have any disturbances in anxiety-related behavior, it could be fruitful to 
develop mice that have decreased levels of MR rather than a complete loss of MR.  The 
decreased ratio of MR to GR in the hippocampus in transgenic mice may more closely 
resemble decreased ratios of MR to GR that accompanies chronic stress or aging.  
Additionally, it would be very interesting to develop forebrain specific knock-in mice 
with a dimerization defective MR, or even to generate knock-in animals that are only 
capable of generating MR/GR heterodimers using the salt-bridge mutants that were 
developed by (Liu, Wang et al. 1995).  These mice could be used to study the 
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Conclusions and perspectives: 
Diseases of affect produce a very large burden, both emotionally and financially 
on individuals, families, and ultimately the community and overall economy.  Major 
depression and anxiety disorders are extremely complex diseases.  It may very well be 
true that, in a manner analogous to cancer, the overall expression of the disease state in 
any one individual might be due to many different underlying causes, both genetic and 
environmental.  Not every depressed patient exhibits hypersecretion of glucocorticoids 
and not every depressed patient is treatable with the same, or even any, antidepressants, 
suggesting that we are still far from a complete understanding of the mechanisms leading 
to anxiety and depression.   
Research that addresses novel therapeutic strategies for major depressive 
disorders suggests that one common theme in depression may be disturbances in neural 
plasticity pathways.  Glucocorticoids have powerful effects on neural plasticity, ranging 
from modulating LTP in hippocampal neurons to affecting neuronal survival in response 
to toxic insults, to facilitating glutamate transmission, to regulating the expression of 
neurotrophic factors (Carlson, Singh et al. 2006).  Dysregualtion of the HPA axis is often 
seen depression, as well as other mood disorders, suggesting that variations in 
glucocorticoid levels, or levels of their receptors, may contribute to the underlying causes 
of some mood disorders.   
While there are still many questions regarding the underlying mechanisms by 
which MR and GR, both individually and together, mediate glucocorticoid effects, the 
research in this thesis extends our understanding of the role of MR in mediating 
glucocorticoid effects in the central nervous system by demonstrating roles for MR that 
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are both similar to and distinct from the roles of GR.  In vivo, the overexpression of MR 
in the forebrain can suppress HPA axis activity during stress, in a manner that is similar 
to the proposed role for GR, and decrease anxiety-like behavior, in a manner that is 
distinct from the proposed role of GR.  In vitro, research in this thesis also demonstrates 
that the co-activation of MR and GR in a hippocampal cell line can attenuate the 
glucocorticoid endangerment effect mediated by activation of GR alone, suggesting 
distinct roles for GR and MR in mediating effects on neuro-endangerment versus 
neuroprotection.  Finally, research presented in this thesis demonstrates that when MR 
and GR are co-activated in a hippocampal cell line, entirely different sets of genes may 
be regulated compared to when GR alone is activated, suggesting how altered ratios of 
MR:GR in the same cell may significantly affect glucocorticoid regulation at the 
transcriptome level.
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